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ABSTRACT
PrEP Use and Barriers to Use Among Adult and Young Sexual Minority Men in the United
States
By
Thomas H.F. Whitfield
Advisor: H. Jonathon Rendina
Pre-exposure prophylaxis (PrEP) was approved for all individuals 13 years of age and
older in May 2018. However, research pertaining to uptake has mostly focused on adult sexual
minority men (SMM), leaving out many barriers and facilitators that may exist for those under
18 years of age. Two of the most important precursors leading to PrEP uptake identified in prior
research are the perception of self as a PrEP candidate and having intentions to begin PrEP.
Developmental and dual processing theories suggest that individuals who are younger make
behavioral decisions differently from those who are older. Developmental theories suggest that,
compared to those who are older, those who are younger make decisions by placing more weight
on social approval, as opposed to individual benefits. Dual processing theories suggest that, as
individuals age, they utilize more ‘cold’ cognitive processing and conscious thought in their
decision making; thus, those who are younger utilize more ‘hot’ affective processing. Taken
together, theories of development and dual processing suggest that those who are younger may
make decisions about PrEP use differently from those who are older. Current interventions
aiming to increase PrEP uptake among adults may need to be altered to include the specific
differences among decisions making in younger populations. As such, the aims of this
dissertation were to: (1) examine PrEP use experience among both young sexual minority men
(YSMM; ages 13-24) and SMM (25 years of age and up); (2a) investigate the role of age as a
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moderator between affective and cognitive dimensions of HIV risk perception as associated with
self-perception of PrEP candidacy and PrEP intentions among YSMM who are at-risk for HIV
seroconversion; and (2b) investigate the role of age as a moderator between perceived benefits of
PrEP use and PrEP stigma as associated with PrEP intentions among YSMM.
To achieve these aims, data were analyzed from a larger study of SMM living across the
United States. As part of this project, participants first completed an online survey and then once
enrolled, completed a baseline assessment. Utilizing data collected from the screener survey, in
Study 1, I tested a series of hypotheses examining differences in PrEP use within an agestratified sample of YSMM and adult SMM. In bivariate analyses, I found that PrEP utilization
was lowest among those 13-24 years of age. In regression analyses, stratified by age group and
predicting PrEP use (i.e., former, and current), compared to never having used PrEP, I found that
the odds of being a current PrEP user increased by 31% for each year of age for YSMM.
Additionally, I found that while controlling for age, YSMM who were on their parent or
guardian’s medical insurance had decreased odds of PrEP use compared to those on their own
health insurance. There were also various demographic and behavioral differences that
distinguished PrEP use history within the two age groups. These differences included sexual
orientation, race, ethnicity, relationship status, region, medical insurance, and recent behavioral
and sexual risk. Taken together, the findings from the first aim suggest there are many variables
that need to be further investigated before PrEP uptake among YSMM is likely to increase.
Data for the second aim of this dissertation came from baseline data collected as part of
the parent project, UNITE, a longitudinal cohort study examining the psychosocial and biological
predictors of HIV seroconversion among SMM (UG3-AI133674). Utilizing these data, in Study
2, I investigated a series of theoretically grounded hypotheses predicting the associations
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between cognitive and affective dimensions of HIV risk and the two primary precursors to PrEP
uptake (i.e., perceived PrEP candidacy, and PrEP intentions) among only YSMM (16-24 years of
age, M = 21.2). I found that affective dimensions of HIV risk were significantly positively
associated with PrEP candidacy and that this association was stronger among olderYSMM.
Additionally, I found that cognitive dimensions of perceived HIV risk were significantly
negatively associated with PrEP candidacy, and this association was weaker among older
YSMM. Next, I tested affective and cognitive dimensions of HIV risk on PrEP intentions,
mediated by perceived PrEP candidacy. I found support for perceived PrEP candidacy
significantly mediating the associations between both affective and cognitive dimensions of
perceived HIV risk and PrEP intentions. Lastly, I tested a model assessing whether age
moderated the effects of perceived benefits of PrEP use and PrEP stigma on PrEP intentions. I
found that perceived benefits of PrEP use were positively associated with PrEP intentions, and
this association was stronger among older YSMM. In contrast, I found PrEP stigma was
negatively associated with PrEP intentions, and this association was weaker among older
YSMM. Findings from this dissertation highlight differences in factors that are known to change
with increased age that significantly affects YSMM and may impede PrEP uptake.
There are many potential places for interventions to be made at different levels, including
clinical, medical, and public health and policy. In order for the HIV epidemic to end in the
United States, changes at all levels may be necessary, including interventions that focus on both
young SMM and their caregivers. These intervention adaptations and future research ideas are
discussed in the conclusions, as well as the limitations to this research.
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CHAPTER ONE
Introduction
Sexual minority men (SMM) are disproportionately affected by human
immunodeficiency virus (HIV) in the United States (U.S.) and accounted for 83% of all new
HIV diagnoses among men in 2016 (The Center for Disease Control and Prevention [CDC],
2018a). Of particular concern are young sexual minority men (YSMM; ages 13-24) who, in
2015, made up 92% of all new infections among men in their age group (CDC, 2018b).
In 2012, the United States Food and Drug Administration (USFDA) approved preexposure prophylaxis (PrEP), a once-daily pill that has been shown to be 92-99% effective in the
prevention of HIV for individuals 18 years of age and older (CDC, 2012, 2015; Volk et al.,
2015). Since the approval of PrEP, research has focused mainly on examining group differences
in uptake with samples consisting of SMM who are 18 years of age and older (Ayala et al., 2013;
Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Galea et al., 2011; Gallagher et al., 2014;
Golub et al., 2013; Grov et al., 2015; King et al., 2014; Mimiaga, Case, Johnson, Safren, &
Mayer, 2009; Mustanski et al., 2013; Parsons et al., 2017; Rendina et al., 2017; Smith, Toledo,
Smith, Adams, & Rothenberg, 2012). However, emerging research has demonstrated that PrEP is
both safe and effective for individuals as young as 15 years of age (Hosek et al., 2017). On May
15th, 2018, the USFDA approved PrEP for use by individuals under 18 years of age (National
Institute of Child Health and Human Development [NICHD], 2018). With only limited research
done to examine PrEP use among YSMM, it is impossible to know what other barriers exist that
impede YSMM from beginning a PrEP regimen.
Addressing the unique barriers to PrEP uptake for YSMM is central to the successful
implementation of PrEP use for this vulnerable population. In Chapter 2, I briefly review the
safety and effectiveness of PrEP and the numerous factors that have already been shown to

increase and decrease PrEP uptake among adults. In Chapter 3, I discuss how the Theory of
Planned Behavior (TPB) and Health Belief Model (HBM) further suggest there are various
points along PrEP uptake models that may be intervened upon to increase uptake among YSMM.
In Chapter 4, I examine different dual processing and developmental theories that suggest there
may be different pathways to PrEP uptake among younger populations compared to adult SMM.
In Chapter 5, I detail the proposed research, including both studies and theoretically grounded
hypotheses. In Chapter 6, I provide details of the methods for both studies, including recruitment
of the samples, data collection, measures, and the analytic plan. In Chapter 7, I provide the
results of the first aim of this dissertation, along with a brief summary of the findings. In Chapter
8, I provide the results of the second aim of this dissertation, along with a brief summary of the
findings. Lastly, in Chapter 9, I discuss how these findings fit into other literature, their clinical
implications, how these findings can be used to increase PrEP uptake, and limitations to this
work.
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CHAPTER TWO
Pre-Exposure Prophylaxis for HIV Prevention
There are now more options than ever to prevent HIV transmission. The World Health
Organization (WHO) suggests it is possible to stop new HIV transmission globally by the year
2030 (WHO, 2016). They have stated that in order to achieve this goal, changes in both sexual
risk behavior and medication utilization are necessary. Medication utilization includes adherence
to antiretroviral therapy (ART) medication for individuals who are HIV-positive to achieve an
undetectable viral load, and post-exposure prophylaxis (PEP) and PrEP use for HIV-negative
individuals at risk for seroconversion (WHO, 2018). Understanding PrEP use among at-risk
populations in the U.S. will help to identify factors that can be intervened upon to increase
uptake, and thereby lower the number of new transmissions as 2030 moves closer. In the
following chapter, I briefly discuss the current rates of HIV transmission for SMM before
reviewing the current literature on PrEP uptake. This includes a review of the clinical trials and
demonstration projects that show the efficacy and effectiveness of PrEP use for HIV prevention.
I then discuss the importance and utilization of PrEP uptake models to increase uptake among
SMM. Lastly, I argue there are additional unexplored developmental factors that may be
additional barriers to PrEP use among YSMM. These additional barriers, along with those
already identified for SMM, must be examined and intervened upon before uptake is likely to
increase among HIV at-risk YSMM.
HIV and Sexual Minority Men
SMM are disproportionately affected by HIV in the U.S. and accounted for 83% of all
new HIV diagnoses among men in 2016 (CDC, 2018a). As such, they remain a high priority in
both psychological and public health research aimed at lowering rates of HIV in the U.S. Rates
of new infections are particularly high among SMM of color, with recent estimations indicating
3

1 in 4 Latino and 1 in 2 Black SMM will be diagnosed with HIV in their lifetime (CDC, 2016).
Additionally, age disparities also exist for SMM. Of particular concern, and the focus of this
dissertation is YSMM, who made up 92% of all new infections among men in their age group in
2015, and 21% of new diagnoses among all SMM (CDC, 2018b). As such, new developments in
HIV prevention that target at-risk groups should include YSMM. However, not enough research
has been conducted with this population to understand their specific needs in terms of PrEP
utilization.
PrEP - Clinical Trials, Effectiveness, and Recommendations
PrEP, in the form of a once-daily pill, is comprised of two antiretroviral medications
(tenofovir disoproxil fumarate [TDF] and emtricitabine [FTC]), and optimal daily adherence can
protect HIV-negative individuals from seroconverting in the event of HIV exposure (CDC, 2014;
USFDA, 2012). Prior to approval by the USFDA, multiple randomized clinical trials (RCTs)
were conducted to demonstrate both the safety and efficacy of PrEP use (Baeten et al., 2012;
Choopanya et al., 2013; Grant et al., 2010; Sokal et al., 2013; Thigpen et al., 2012; Van Damme
et al., 2012). Clinical trials consisted of a variety of populations, including SMM at high risk for
HIV acquisition (Grant et al., 2010), serodiscordant couples (Baeten et al., 2012), transgender
individuals (Grant et al., 2010), heterosexuals (Baeten et al., 2012; Sokal et al., 2013; Thigpen et
al., 2012; Van Damme et al., 2012), and injection drug users (Choopanya et al., 2013). RCTs
examined multiple forms of PrEP, including oral TDF alone, oral TDF and FTC, and TDF
vaginal gel. Equivocal results were reported for each form of PrEP across different populations.
Overall, use of oral TDF alone resulted in an HIV reduction rate of 49-67% (Baeten et al., 2012;
Choopanya et al., 2013), oral TDF and FTC resulted in an HIV reduction rate of 44-75% (Baeten
et al., 2012; Grant et al., 2010; Thigpen et al., 2012), and use of TDF vaginal gel resulted in a
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risk reduction of 39% (Sokal et al., 2013). Given the safety and efficacy across RCTs for all
populations, and the focus of this dissertation, I herein only focus on those studies that were
conducted using at least some SMM.
Across RCTs, adherence was shown to be the most significant predictor of efficacy. For
example, further statistical analysis of the iPrEx study sample demonstrated an increase from a
44% risk reduction of seroconversion to 99% for those with drug levels that suggested daily
adherence (Anderson et al., 2012). Non-adherence resulted in TDF/FTC being non-efficacious,
and thus resulted in the discontinuation of two RCTs, the Vaginal and Oral Interventions to
Control the Epidemic (VOICE) and the Preexposure Prophylaxis Trial for HIV Prevention
among African Women (FEM-PrEP) (Marrazzo et al., 2015; Van Damme et al., 2012). Due to
the findings from these RCTs, it is understood that in order for PrEP to have the highest efficacy,
it is imperative that high drug levels be present at the time of exposure.
In 2012, the USFDA approved once-daily PrEP for use by individuals at risk of HIV
acquisition (USFDA, 2012) and two years later, the CDC recommended that PrEP be used in
concordance with other safe-sex practices by individuals 18 years of age and older, and at
substantial risk for HIV (CDC, 2014) . The CDC defined substantial risk via sexual contact as
one of the following criteria: having an HIV-positive sexual partner, a recent bacterial STI, a
high number of sex partners, a recent history (3-6 months) of inconsistent or no condom use, or
be a commercial sex worker in an area of high prevalence of HIV. In addition to meeting the
behavioral eligibility to begin a PrEP regimen, clinical guidelines suggest potential users must
also have a documented HIV-negative test result, no sign/symptoms of acute HIV infection,
normal renal function, no contraindicated medications, and no hepatitis B virus infection and/or
vaccination status. Additionally, guidelines also state that once all of the behavioral and clinical
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eligibility for substantial risk is determined, providers can prescribe PrEP for daily dosing in less
than or equal to a 90-day supply. These are only clinical guidelines, and there is currently no
policy that enforces any or all of these steps.
Closely following the CDC Guidelines for recommended care may present potential PrEP
users with barriers to acquiring and maintaining a prescription. Quarterly doctor’s visits include
both HIV testing and prescription refills. Discussions between the provider and patient are also
required and should cover sexual risk reduction behaviors, STI symptoms, side effect symptoms,
and medication adherence. Additionally, STI testing is required every six months (CDC, 2014).
For PrEP users, these appointments can be both costly and time-consuming, particularly for
those without health insurance. Similarly, for providers, these guidelines may require more time
and training to ensure users’ needs are met. Aside from these guidelines, there are social and
psychological barriers to uptake that have appeared in the literature. Examples of these barriers
include, potential users not viewing themselves as someone who should be on PrEP,
experiencing stigma associated with PrEP use, and not having accurate information on where to
obtain PrEP. The following section will further review the current literature on barriers and
facilitators to PrEP uptake among SMM.
Understanding Processes Leading to Uptake
PrEP uptake in the U.S. has increased since first approval in 2012. Since the release of
PrEP, more than 140,000 individuals have begun a regimen, and there are an estimated 61,000
current users as of the end of 2017 (Sullivan et al., 2018). This number is far below the estimated
1.5 - 4.5 million SMM in the U.S. that may meet CDC criteria for uptake and could benefit from
PrEP use (Rawlings, 2016; Sullivan et al., 2018). To increase uptake of PrEP among those at-
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risk for seroconversion, it is important we understand what psychological, social, and structural
barriers impede the uptake process.
One way to conceptualize processes that lead to PrEP uptake is through the use of a PrEP
uptake model, often times framed in terms of a continuum or cascade. Multiple uptake models
have been developed yet operationalized in different ways. The first came from Kelley and
colleagues (2015), who based theirs on the HIV Care Continuum (Gardner, McLees, Steiner, Del
Rio, & Burman, 2011; McNairy & El-Sadr, 2014). Their model proposed four steps:
awareness/willingness; access to healthcare; likely to receive prescription; and adherence and
efficacy. The first step includes awareness of PrEP, risk/benefit perceptions, and barriers to
seeking PrEP. The second focuses on the individual having health insurance, access to a primary
care doctor, being able to afford the medication, and having accessible transportation for care.
The third includes focussing on the healthcare provider (i.e., awareness of PrEP, willingness to
prescribe PrEP, and ability to determine a patient's eligibility) and the patient (i.e., accurately
report risk behavior, and PrEP non-contraindicated). The fourth, and final, step includes
medication tolerance, risk compensation, dosing schedules, long-term adherence, and PrEP care
continuation. Following the development, these researchers projected their model onto a sample
of 562 SMM living in Atlanta, Georgia. Of all sexually active SMM in the sample, 50% reported
being aware and willing to begin PrEP, 43% reported access to healthcare, 30% were likely to
receive a prescription based on their behavior, and 15% were projected to be adherent based on
an estimate provided by the iPrEx open-label extension (Grant et al., 2014). Results for the use
of this uptake model indicate the most significant drop off being at the beginning of the model,
focused around PrEP awareness and acceptability. Thus theoretically, by increasing awareness
and willingness to begin PrEP, percentages in the respective steps should also increase.
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Building off of the Kelley and colleagues (2015) model, Nunn and colleagues (2017)
expanded the model into nine stages among three steps. The first step, awareness, includes
identifying individuals at highest HIV risk, enhancing self-perceived HIV risk awareness, and
raising PrEP awareness. The second step, uptake, includes facilitating PrEP access, linkage to
PrEP care, obtaining a prescription to PrEP, and initiating PrEP. The third, and final step,
adherence, and retention, includes adherence to prep and retention in PrEP care. At the time of
publication, this article did not project numbers into these stages to yet understand where it may
catch people the Kelley and colleagues (2015) model did not. Both models suggest the high
importance of early steps to increase uptake, including PrEP awareness and access.
Parsons and colleagues (2017) created another PrEP uptake model, titled the Motivational
PrEP Cascade. This model utilized the Transtheoretical Model of Change, which conceptualizes
behavior change over time as a series of smaller decisions that lead to the larger behavioral
change (Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 1998).
Beginning with objective identification for PrEP candidacy, the model theorizes there are an
additional four stages individuals must pass through before resulting in maintenance and
adherence. After meeting the CDC requirements for objective identification, the second stage is
PrEP contemplation, which consists of men being both willing to take PrEP and self-identifying
as a PrEP candidate. The third stage, PrEParation, describes individuals who must have a
potential PrEP provider and also be intending to begin taking PrEP. The fourth stage, PrEP
action and initiation, include those who have spoken to a medical provider about PrEP and are
currently prescribed PrEP. The fifth stage, PrEP maintenance and adherence, includes
participants maintaining at least four doses per week and continuing to return for quarterly
testing. If an individual stops taking PrEP, they would move back to stage one, and if someone
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seroconverts they would move to the HIV Care Continuum (CDC, 2011; Gardner, McLees,
Steiner, Del Rio, & Burman, 2011). This model frames PrEP uptake as steps that include
processes of behavior change via decision making and again, like other PrEP uptake models,
emphasizes the importance of PrEP knowledge, acceptability, and intentions, for increasing
uptake.
In developing the Motivational PrEP Cascade, Parsons and Colleagues (2017) applied it
to a sample of over 1,000 SMM from across the U.S. Their findings indicated that 63.9% (n =
636) of their sample met CDC criteria for PrEP uptake. However, 52.7% (n = 301) of those were
either unwilling or did not view themselves as a candidate for PrEP and were considered to be
pre-contemplative. Among those that were willing and self-identified as a candidate, just over
81% had a provider they believed would be willing to prescribe PrEP, and slightly more than
half (57.5%) stated they planned to begin taking PrEP. Of those that had a provider and intended
to begin (n = 152), 70.4% had spoken to a provider, and 53.9% had a current PrEP prescription
(n = 82). Of those with a prescription, the majority (97.6%) reported taking at least four doses
per week, and most (72.0%) attended the recommended quarterly doctors’ visits required to
maintain a prescription. Overall, these numbers indicate that of the 636 SMM who met objective
identification, only 58 (9.12%) were both adhering and maintaining their PrEP regimen. Like the
other models, they reported their most massive drop off between acceptability and viewing
oneself as a candidate.
Across models, all researchers focused on PrEP knowledge, acceptability, and intentions
as essential steps leading to PrEP uptake. SMM may be aware of PrEP and behaviorally eligible
for PrEP, but not view themselves are someone who would benefit from PrEP. Gardner and
colleagues (2011) and Parsons and colleagues (2017) showed this in both of their models. Self-
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identification as a PrEP candidate is the step along their models where the most significant drop
off was reported. Intentions to begin a PrEP regimen were reported in the Motivational PrEP
Cascade, but not the other models. This factor may be a key to getting SMM past awareness and
acceptability to begin uptake, as intentions reflect real-world scenarios (Rendina, Whitfield,
Grov, Starks, & Parsons, 2017). Additionally, the Motivational PrEP Cascade includes
discontinuation of PrEP instead of ending at adherence. This additional step takes into account
the “seasons of risk” hypothesis, which suggests that long-term PrEP use may not be a perfect
solution for everyone and that some users are likely to use PrEP only during periods of increased
sexual risk (Baeten, Haberer, Liu, & Sista, 2013; Haberer et al., 2015). With this model, when
SMM discontinue use, they move back to the first step, meeting objective identification. This is
an important step in the uptake model, as it suggests that PrEP use may not be a medication that
is appropriate for everyone throughout time, or an individual may decide to stop using PrEP.
Further, individuals may move in and out of meeting objective identification as a PrEP candidate
based on current risk behaviors. In the following section, I examine barriers to PrEP uptake using
the Motivational PrEP Cascade as a framework for conceptualizing the biopsychosocial variables
associated with PrEP uptake. Primarily, I will focus on the two psychological precursors shown
to be most predictive of actual PrEP uptake (i.e., PrEP acceptability and PrEP intentions).
Using the Motivational PrEP Cascade as a Framework to Increase Uptake
As indicated in The PrEP Motivational Cascade, knowledge of PrEP is imperative for an
individual to consider beginning a regimen. The knowledge about the potential for taking ART
medication while HIV-negative, to prevent seroconversion, began to spread before any RCTs
examining PrEP use began. One of the earliest studies measuring knowledge of using such
medications as prophylaxis comes from 2006. Kellerman and colleagues (2006) collected
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responses from 1,041 individuals at gay pride events in five large cities in the U.S. Across all
cities, a total of 248 (25%) of respondents reported having heard of ART use as PrEP, and 50
(5%) reported having ever used ART as PrEP. Both use and awareness of ART as PrEP was
associated with having received an HIV test within the prior twelve months. Shortly after, in
2008, other researchers administered surveys on PEP and PrEP use to 1,819 SMM. These
participants were recruited at three circuit parties and two city clinics in the San Francisco Bay
Area counties. In total, 849 (47%) had previously heard of PEP, whereas 296 (16%) were aware
of PrEP (Liu et al., 2008). Shortly after, some researchers began to investigate behavioral and
social factors that may deter some individuals from starting a regimen of PrEP should it be
shown to be effective (Golub, Kowalczyk, Weinberger, & Parsons, 2010). They anticipated that
even if individuals were aware of PrEP, researchers would have to find ways to help individuals
accurately process information pertaining to their risk behavior, frame the effects of the
medication for the potential user, and address the role of HIV medication related stigma. These
studies illustrate some awareness of PrEP as a potential for HIV prevention among SMM before
the shown efficacy of the RCTs and that some researchers were already preparing for barriers to
implementation.
Awareness of PrEP increased quickly among SMM following its approval by the
USFDA. One study assessed knowledge one month before the approval versus one month after
and reported an increase of knowledge from 13% - 19% (Krakower et al., 2012). Another
examined changes in knowledge from pre-approval in 2011 to post-approval in 2014 among
SMM in Miami and D.C. Both cities exhibited an increase in knowledge over time. Miami went
from 19.4% to 41.2%, and D.C. from 39.1% to 73.8% (Patrick et al., 2017). Significant
differences were revealed between geographic locations, such that those in D.C. were more
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likely to be aware of PrEP. This finding suggested that PrEP knowledge differed for SMM by
location. Other researchers have reported similar findings (Elopre, Kudroff, Westfall, Overton, &
Mugavero, 2017; Kuhns, Hotton, Schneider, Garofalo, & Fujimoto, 2017; Ojikutu et al., 2018;
D. M. Santa Maria et al., 2018). Furthermore, disparities in geographic location are reflected in
the finding that more than 50% of all PrEP prescriptions in the U.S. are located in only five
states: California, Florida, Illinois, New York, and Texas (aidsvu.org, 2018; Siegler et al., 2018).
Overall, awareness of PrEP has increased over time across the U.S., but to what end individuals
outside of large metropolitan areas have accurate knowledge of PrEP has not been reported.
Another important factor associated with PrEP uptake is acceptability of PrEP. The
literature on PrEP acceptability has reported varying results based on how questions are asked, as
the acceptability of PrEP may not reflect real-world demands. For example, when asking about
the acceptability of PrEP, differing dosing schedules are sometimes presented, and have included
anywhere from intermittent dosing (Holt et al., 2012; Mustanski, Johnson, Garofalo, Ryan, &
Birkett, 2013; Shrestha et al., 2018) to daily adherence (Aghaizu et al., 2013; Al-Tayyib, Thrun,
Haukoos, & Walls, 2014; Barash & Golden, 2010; Galindo et al., 2012; Grov, Whitfield,
Rendina, Ventuneac, & Parsons, 2015; Holt et al., 2012; Mustanski et al., 2013; Rendina et al.,
2017). Different levels of effectiveness have also been shown to influence acceptability, such
that less effectiveness is associated with less acceptability (Al-Tayyib et al., 2014; Golub,
Gamarel, Rendina, Surace, & Lelutiu-Weinberger, 2013; Golub, Kowalczyk, et al., 2010; Kahle,
Sullivan, & Stephenson, 2018; Mustanski et al., 2013; Rendina et al., 2017). Acceptability has
also been measured across studies under the assumption that the medication is free (Golub et al.,
2013; Golub, Kowalczyk, et al., 2010; Grov et al., 2015), which may not mirror real-world use,
as in many locations PrEP can cost as much as $14,000 yearly without insurance coverage (San
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Francisco AIDS Foundation, 2015). PrEP acceptability measures if an individual would begin
taking PrEP in the best-case scenarios, meaning the easiest, fastest, and cheapest, as well as
being the most effective.
Predictors of acceptability have primarily been confined to knowledge of PrEP and
descriptive differences. Demographic variables predicting acceptability, such as age, income,
education, race, and sexual identity, have resulted in conflicting evidence. Being younger has
been shown to be a significant predictor of acceptability in some research (Aghaizu et al., 2013;
Barash & Golden, 2010; Holt et al., 2012), but not others (Goedel, Halkitis, Greene, & Duncan,
2016; Golub et al., 2013; Grov et al., 2015; Mustanski et al., 2013). Similarly, having lower
income (Barash & Golden, 2010) has been predictive of being more willing to begin PrEP,
whereas, in other studies, income was not predictive of acceptability (Goedel et al., 2016; Golub
et al., 2013; Grov et al., 2015). Education has also resulted in conflicting findings, such that
having more than a high school education has been associated with more acceptability
(Mustanski et al., 2013), lower education associated with more acceptability (Grov et al., 2015),
and in another study, education was not predictive of acceptability at all (Golub et al., 2013).
Similarly, both Grov and colleagues (2015), and Mustanski and colleagues (2013) reported no
difference regarding race, whereas Golub and colleagues (2010) reported Black participants were
more than two times as likely to report acceptability, compared to White participants. Few
differences in acceptability have been observed between men who identify as gay versus
bisexual (Goedel et al., 2016; Holt et al., 2012; Mustanski et al., 2013). Unsurprisingly, those
who are single are more likely to be accepting, versus those who are in relationships (Golub et
al., 2013). Overall, there are very few consistent demographic predictors of PrEP acceptability
across studies.
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In addition to demographic predictors, psychological and behavioral predictors of
acceptability have also been studied. More PrEP acceptability has been associated with a higher
perception of oneself as at risk for HIV (Biello, Edeza, Montgomery, Almonte, & Chan, 2019;
Blumenthal et al., 2019; Bull et al., 2018; Golub, Fikslin, Goldberg, Peña, & Radix, 2019; Holt
et al., 2012; Ojikutu et al., 2018; Rana et al., 2018; Underhill et al., 2018; Whitfield, John,
Rendina, Grov, & Parsons, 2018b), fewer concerns about side effects (Goedel et al., 2016;
Halkitis et al., 2018; Holt et al., 2012; Whitfield et al., 2018b), having previous experience with
biomedical prevention such as PEP (Aghaizu et al., 2013; Holt et al., 2012), and having
experience with a sexual health clinic (Aghaizu et al., 2013; Barash & Golden, 2010). In order
for someone to be accepting of taking PrEP, it is crucial they view themselves as someone who
would benefit from PrEP use. One study that assessed PrEP uptake reported that those who had
higher HIV risk perception, greater actual risk in the past three months, and those in
serodiscordant relationships had higher odds of actual uptake than those who did not engage in
risk or viewed their behavior as risky (Golub et al., 2019). Additionally, having experience with
sexual health clinics, which may include having previously used PEP, may provide potential
users with either more knowledge of PrEP, the familiarity of sexual health services, or aid in the
perception they are at risk- all leading to more PrEP acceptability.
Behavioral risk factors associated with PrEP uptake have also produced different
findings. Before the release of PrEP, many providers and researchers expressed concern that
behavior risk would increase for individuals who began taking PrEP (Eaton & Kalichman, 2007;
Golub, Kowalczyk, et al., 2010; Guest et al., 2008; Marcus et al., 2013; Youle & Wainberg,
2003). Research conducted with PrEP users has shown different results, with some showing an
increase in risk behavior (Beymer et al., 2018; De Wit et al., 2015; Liu et al., 2013; Newcomb,
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Moran, Feinstein, Forscher, & Mustanski, 2018; Oldenburg et al., 2018; Prestage et al., 2019)
and some without (Guest et al., 2008; Koester et al., 2017; Liu et al., 2013; Marcus et al., 2013;
Sagaon-Teyssier et al., 2016). One longitudinal study was even able to show that risk of
condomless anal sex (CAS) increased while users were taking PrEP, but decreased when they
stopped (Parsons, Whitfield, Rendina, & Grov, 2017).
Specific to actual uptake, sexual risk is vital as the perception of being at risk for HIV
acquisition has been shown to be associated with more acceptability and intentions to begin
taking PrEP. However, results of objective behavioral risk have produced divergent findings with
some showing more risk as predicting more acceptability (Aghaizu et al., 2013; Golub,
Kowalczyk, et al., 2010; Holt et al., 2012), and no association between behavioral risk and PrEP
acceptability among others (Barash & Golden, 2010; Blumenthal et al., 2019; Mustanski et al.,
2013). One study examined the perceived risk of HIV, PrEP eligibility, and actual PrEP use
among YSMM (16-25 years of age) living in Washington, D.C. (Yellin et al., 2018). Just under
10% of all 188 participants reported current PrEP use. Compared to those that perceived their
risk as low, those who perceived their risk to be moderate or high had a higher likelihood of
viewing them self as an eligible candidate and had more willingness to take PrEP.
One of the strongest predictors of future behavior is intentions (Albarracin, Johnson,
Fishbein, & Muellerleile, 2001; Webb & Sheeran, 2006). However, an individual may have
intentions to begin taking PrEP and come across provider-related barriers that inhibit use. A
provider must first know about PrEP and be willing to prescribe the medication. Providers have
voiced many concerns about prescribing PrEP, including the ability to accurately assess
behavioral PrEP eligibility (Bacon et al., 2017), the cost of medication, cost of continued
appointments, and cost of STI/HIV testing (Krakower, Ware, Mitty, Maloney, & Mayer, 2014).
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Providers may also be concerned about the effects of the medication, including potential side
effects associated with continued use (Bacon et al., 2017; Hakre et al., 2016; Krakower et al.,
2014), the ability to adhere to the medication (Hart-Cooper, Allen, Irwin Jr, & Scott, 2018;
Krakower et al., 2014) and potential drug resistance to ARVs should the user seroconvert while
taking PrEP (Karris, Beekmann, Mehta, Anderson, & Polgreen, 2013). Some providers have also
stated concerns that users will engage in increased sex risk behavior that may lead to other STIs
(Blackstock et al., 2017; Krakower et al., 2014; Morrison, Dortche, & Fadul, 2018; Petroll et al.,
2017). These concerns are demonstrated across studies that include both primary care providers
(PCPs) and HIV care providers, suggesting that even if an individual is both willing and
intending to begin PrEP, they may not have a doctor that is willing to prescribe the medication,
and thus fewer intentions to actually begin taking PrEP.
Potential PrEP users may also be unsure of where to go to access PrEP. Multiple studies
have shown that HIV care providers are both more knowledgeable and more willing to prescribe
PrEP compared to PCPs (Blackstock et al., 2017; Hakre et al., 2016; Krakower et al., 2015;
Krakower et al., 2014; Petroll et al., 2017; Seidman, Carlson, Weber, Witt, & Kelly, 2016;
Smith, Mendoza, Stryker, & Rose, 2016; Tripathi, Ogbuanu, Monger, Gibson, & Duffus, 2012;
White, Mimiaga, Krakower, & Mayer, 2012). This may make it more difficult for some SMM to
obtain PrEP, as they will likely not have an HIV care specialist because they are HIV-negative
and may have to seek out new care. Fear of HIV-related stigma may also potentially impede
some HIV-negative SMM from seeking treatment via an HIV specialist. Additionally, there are
discrepancies among providers about who should be prescribing PrEP. To describe this barrier,
researchers Krakower and colleagues (2014) coined the term “purview paradox,” which
describes how neither PCPs nor HIV specialists consider PrEP care to fall within their domain.
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Along with the various steps it takes to begin a PrEP regimen, continuing one requires quarterly
doctor’s visits that are intended to include HIV testing, sexual risk assessment, STI symptoms
assessment, and medication adherence counseling- a variety of things that not all PCPs have time
for and experience doing.
Together, these findings suggest many factors will impede movement along PrEP uptake
models. In order for an individual to consider beginning PrEP, they must have a basic awareness
of the medication, view themselves as someone who would benefit from its use, and have access
to care (i.e., a doctor to prescribe, the ability to pay for the medication and quarterly
appointments including STI/HIV testing). All of these have been shown to be predictive of PrEP
uptake. Further, many of the above-reviewed studies highlighted age as a factor that
differentiates many of these variables related to uptake, suggesting that developmental factors
may play a role in why some individuals access PrEP whereas others do not.
Summary
PrEP uptake includes many steps, which have been examined among adult SMM, and
examined through the lens of PrEP uptake models aimed at increasing uptake. Across these
models, it is consistently shown and theorized that for individuals to begin taking PrEP, and stay
engaged in PrEP care; they must first view themselves as someone that would benefit from PrEP
and then have intentions to begin a regimen. In order to develop interventions aimed at
increasing uptake, it is imperative that focus is placed on understanding PrEP candidacy and
PrEP intentions, the two primary precursors to PrEP uptake. Many SMM may be at risk for HIV,
but they may not perceive themselves to be at risk. Understanding the processing that leads to the
perception of self as a PrEP candidate may be a key area for intervention. Additionally, although
viewing oneself as a candidate for PrEP may make someone more likely to begin a regimen, it
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does not necessarily mean the individual has intentions to begin a regimen. As such,
understanding what other factors lead to intentions is also imperative to increase uptake. Further,
how these precursors to uptake apply to YSMM, or what additional barriers may exist, is yet
unknown. Based on the findings of the studies reviewed in this chapter, it is also clear that age
may be a determining factor, and as such, developmental factors for intervention may be
appropriate. In the following chapter, I present two prominent theories of behavioral change that
will help to illuminate decision-making processes that underlie SMM’s PrEP utilization and may
be able to be intervened upon.
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CHAPTER THREE
Theories of Behavior Change
The Health Belief Model (HBM) and the Theory of Planned Behavior (TPB) are two
widely accepted theoretical models used for predicting behavior change, both of which grew out
of Social Cognitive Theory (Bandura, 1986). The HBM has been utilized to explain healthrelated behaviors by examining an individual’s perceived threat of illness and the pros or cons of
enacting health-related behavior. The TPB examines predictors for the intentions to enact a
behavior including an individual’s attitudes, their social surroundings, and their perceived
control over the behavior. In the following chapter, I describe each model, how they have been
previously used to predict behavior, and how their use in PrEP interventions may lead to
increased PrEP uptake.
The Health-Belief Model
Godfrey Hochbaum, Stephen Kegels, and Irwin Rosenstock, three social psychologists
working for the U.S. Public Health Service in the 1950s, developed the HBM (Figure 1) (Becker,
1974). Up until the development of the HBM, predictors of health-related behaviors were
primarily limited to demographic variables (e.g., socioeconomic status, gender, age, race, and
ethnicity). The HBM aims to assess belief patterns or individual characteristics that shape
behavior and are modifiable through socialization, as predictors of the likelihood of engaging in
health-promoting behaviors. Since its inception, the HBM has evolved while keeping similar
representations of health and health behavior. The model initially consisted of factors of only
threat perception and behavioral evaluation, while future applications of the model included cues
to action and self-efficacy (Conner & Norman, 2005).
Threat perception consists of two factors, perceived susceptibility and perceived severity
of an illness or health problem. Perceived susceptibility refers to an individual’s perception of
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their odds of acquiring a condition that negatively affects their health. Perceived severity refers
to the concern an individual has about how a particular health condition may negatively affect
them overall. Taken together, higher perceived susceptibility and severity of a condition suggests
a higher threat, and therefore should lead to a higher likelihood of enacting a protective healthrelated behavior. In terms of PrEP use, perceived susceptibility of acquiring HIV should lead to
higher PrEP uptake. However, perceived susceptibility is not the same as actual susceptibility,
and as presented in the previous chapter, not all risk perception is in line with actual risk.
Similar to threat perception, behavioral evaluation also consists of two distinctly different
constructs, perceived benefits and perceived barriers. Perceived benefits refer to the positive
aspects an individual believes will be gained or experienced for enacting a specific health-related
behavior. Perceived barriers refer to the costs of enacting the same behavior. These two
constructs create a decisional balance for the individual where the more heavily weighted
construct predicts the likelihood of behavior engagement. For example, someone who perceives
more benefits to the behavior change is more likely to enact the behaviors, whereas someone
who perceives more barriers is less likely to enact the behavior. Individuals who are
contemplating PrEP use may find themselves having to weigh the options of the benefits of PrEP
use versus the barriers. Depending on the age of the individual, these barriers are likely to
change, with some becoming less important and others more important.
The two constructs later added to the HBM are cues to action and self-efficacy (Becker,
Maiman, Kirscht, Haefner, & Drachman, 1977). Cues to action refer to internal or external
stimuli presenting the individual with a cue leading to the behavior. The measurement used to
assess factors associated with cues to action has varied greatly and included interpersonal
communication (e.g., doctor, parent, and friend), mass media influences (e.g., advertisements in
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magazines, tv, film, radio), and internal responses to threat stimuli (e.g., the perception of risk).
For health-related behaviors, a cue to action may include a person, advertisement, or perceived
threat suggesting that a change in behavior may lead to more positive outcomes. Self-efficacy is
one’s belief in the individual’s ability to succeed in accomplishing a specific task. Higher levels
of self-efficacy should be predictive of an individual being more likely to enact a behavior.
Together, these two factors add constructs measuring if an individual has been alerted to a
potential threat and if they believe themselves to have the power to enact the positive health
behavior. For PrEP use, cues to action could include advertisements of the medication and who
they are marketing the medication for, what their social circles say about the medication, and
again, the perception of their own HIV risk. These cues to action could either be ignored by the
individual, meaning they do not apply the cues to them self, or the cues could resonant with them
and result in suggestions to use PrEP.
In short, these factors were theorized to influence an individual’s decisions around health
behaviors, and by intervening on them, an individual would become more or less likely to enact a
behavior change (Becker et al., 1977). This model was first utilized to examine decision making
to obtain chest x-rays for early detection of tuberculosis (Hochbaum, 1958), and due to the
flexibility of constructs within the model, it has since been used across a variety of health-related
behaviors. Screening-related behavior utilizing the HBM have included hypertension (J. B. King,
1983), cervical cancer (Orbell, Crombie, & Johnston, 1996), colorectal cancer (Hay et al., 2003),
and mammography (Aiken, West, Woodward, Reno, & Reynolds, 1994). Risk behaviors have
also been examined via the HBM and included smoking (Giannetti, Reynolds, & Rihn, 1985;
Mullen, Hersey, & Iverson, 1987; Pederson, Baskerville, & Wanklin, 1982; Stacy & Loyd,
1990), alcohol (K. H. Beck, 1981; Gottlieb & Baker, 1986; Portnoy, 1980), and changes in diet
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(Aho, 1979; Langlie, 1977; Weitkunat et al., 2003). Other uses have included dental care (Chen
& Land, 1986; Chen & Tatsuoka, 1984; Kegeles, 1963), medication adherence (Bradley et al.,
1987; Cummings, Becker, Kirscht, & Levin, 1982; Hershey, Morton, Davis, & Reichgott, 1980;
Kirscht & Rosenstock, 1977; Nelson, Stason, Neutra, Solomon, & McArdle, 1978; Taylor,
1979), and HIV risk (McCusker, Stoddard, Zapka, Zorn, & Mayer, 1989; Winfield & Whaley,
2002; Wolcott, Sullivan, & Klein, 1990). All of these studies have provided evidence that not
only is the HBM effective in understanding patient decision making but also that the different
predictors within the models are better at predicting outcomes depending on the population and
target health behavior.
Perceived susceptibility and seriousness are two critical factors associated with
examining potential PrEP use among SMM and have been examined in some research. Perceived
susceptibility refers to the individual's perception of their risk for HIV-acquisition, whereas
perceived seriousness refers to an individual’s belief about how becoming HIV-positive may
negatively affect their lives. Both more perceived susceptibility and seriousness have been
shown to be highly associated with more intentions to begin taking PrEP (Aghaizu et al., 2013;
Holt et al., 2012; Parsons, Rendina, et al., 2017). Together these findings across studies suggest,
that to increase uptake of PrEP, it is imperative that those who are at-risk for HIV also view
themselves as at-risk and perceive seroconversion would negatively impact their lives.
Other research on PrEP uptake and SMM has examined the benefits and barriers, or PrEP
decisional balance, of beginning a PrEP regimen (Ayala et al., 2013; Galea et al., 2011; Golub et
al., 2013; Holloway, Tan, et al., 2017; Young, Flowers, & McDaid, 2014). Benefits reported in
research include feeling a sense of control over one’s sexual health, having more protection
against HIV, and avoiding psychological distress should a condom break or not be used. Barriers
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reported include high cost, not having health insurance, high PrEP related stigma, not having
accurate knowledge of PrEP, and not knowing how to access PrEP. As the model suggests,
individuals who perceive more benefits, compared to barriers, to beginning PrEP have a higher
likelihood of engaging in PrEP use (Ayala et al., 2013; Golub et al., 2013; Grov et al., 2015).
Further, self-efficacy for PrEP use is likely an important factor for men beginning a PrEP
regimen. Beginning and continuing a PrEP regimen may be more difficult for some SMM
because it is a process that includes regular doctors’ appointments, HIV/STI testing, and
prescription refills, requiring a substantial amount of self-efficacy (CDC, 2017).Lastly, cue to
action is defined as a construct in many different ways (Mattson, 1999; Schwarzer, 2014).
Regarding PrEP research and SMM, perceived risk of HIV could be considered perceived
susceptibility, as well as what those closest to the individual think of the medication. PrEP
stigma, or a set of negative beliefs that a society or group of people have about PrEP use, may
influence someone to not begin a PrEP regimen due to fear of negative social consequences of
use (Calabrese & Underhill, 2015; Eaton & Kalichman, 2007; Haire, 2015; Liu, Cohen, et al.,
2014). As I will discuss later, social expectations are factors more closely related to adolescent
behaviors than an adult.
With the HBM in mind, the perceived threat of an illness or condition is the first factor
that must be examined in order to increase PrEP uptake among any population. It is unlikely that
an individual will weigh the benefits and barriers to use, acknowledge their ability to begin
enacting a behavior, or be swayed by a cue to action if they do not first perceive themselves to be
at risk. This is mirrored in the Motivational PrEP Cascade, where the first stage is meeting
objective identification as a PrEP candidate and the second includes self-identification as a PrEP
candidate. Additionally, in stage two of the cascade, individuals are asked how likely they would
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be to take PrEP if it were 90% effective and available for free. Both of these could be considered
perceived benefits and barriers to uptake, two important factors in the HBM. An individual could
perceive 90% to be very high, whereas another could believe this is too low. Further, “free”
would be a benefit for almost all individuals, but may not reflect reality (e.g., accessibility, health
insurance). Stage three and four of the cascade include finding a medical provider and actually
discussing it with a provider. Discussing PrEP with a provider may be difficult for some SMM,
and one study showed that SMM who are not out to their providers are less likely to ask about
PrEP (Tan et al., 2019). To achieve these steps, self-efficacy is required, another factor in the
HBM. Lastly, the HBM includes cues to actions, which may include knowing that PrEP exists
and understanding your own risk behavior as pertaining to PrEP candidacy, again, part of the
first step of the Motivational PrEP Cascade.
Although there are many ways the HBM and the Motivational PrEP Cascade overlap,
they are not synonymous with each other. As presented in Figure 1, the HBM suggests that all of
these factors influence the likelihood of a behavior change. However, they are presented as
variables that may be equal to the effect of the behavior change. The Motivational PrEP Cascade
utilizes many of the same concepts. However, they are presented as a series of steps where one
must be accomplished before moving to the next. Further, the HBM stops at likelihood, and the
cascade ends with the maintenance of the behavior change. In terms of HIV prevention, among
both models, it is necessary that an individual views HIV as serious and themselves as
susceptible for the other factors will become increasingly important in a decision around PrEP
uptake.
The Theory of Planned Behavior
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In addition to the HBM, the TPB (Ajzen, 1991) is another theoretical framework
consistently used to predict behavior change, and often in health behavior research. The aim of
both these frameworks is to understand the factors that lead to behavior change, however the
HBM focuses on internal constructs (i.e., perceived benefits, barriers, seriousness, susceptibility,
self-efficacy, and cues to action) whereas the TPB condenses these into an overall attitude about
the behavior change and incorporates social constructs (subject norm) and perceived behavioral
control. Additionally, the TPB extends the HBM by including intentions for the behavior change,
and it’s association with the actual change. There are strengths and limitations to both models as
HBM may provide a more nuanced look at internal constructs, but the TPB includes social
constructs and belief in self. In the following section, I will discuss the TPB and how it suggests
other factors outside of internal factors are equally important to PrEP uptake.
The TPB theory is an extension of the theory of reasoned action (TRA; Fishbein &
Ajzen, 1975 ). Both theories aim to explain how unobservable factors (i.e., attitudes, subjective
norms) lead to intentions for a behavioral change, and then ultimately the change itself. The TRA
was developed for utilization with only easily amendable behaviors, whereas the TPB also takes
into account the role of behavioral control or the ability one has to enact a behavioral change
(Ajzen, 1987, 1991). In the following section, I briefly describe the TRA and the adjustments
made for the TPB, how the TPB is used in research about health-prevention, and how it may be
best used for understanding decisions leading to PrEP uptake.
The TRA aims to explain how two unobservable factors (i.e., attitudes and subjective
norms) lead to volitional behavioral change via intentions (Figure 2). Fishbein and Ajzen (1975,
p. 6) defined attitudes as “a learned disposition to respond in a consistently favorable or
unfavorable manner with respect to a given object,” the object is representing the cue for
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behavior change. If someone has more positive attitudes about the change, they should have
higher intentions to enact the change. Conversely, more negative attitudes about the change
should lead to lower intentions to enact the change. A subjective norm represents the perceived
social pressure from significant others to either perform or not perform the behavior change.
Important others could be individuals and groups whose opinions of the behavior are essential to
the individual. As such, if someone perceives those significant to them to be supportive of the
change, they are more likely to have intentions to enact the change. Further, subjective norms are
also likely to influence the attitudes an individual has about the behavior change and vice-versa.
Lastly, intentions represent the link between these unobservable cognitive processes and the
behavior itself. Intentions and actual behavior are highly associated as individuals who have
intentions for a behavior tend to engage in the behavior (Ajzen, 1987). Together, attitudes and
subjective norm are predictive of intentions, which is then predictive of actual behavior. In terms
of PrEP use, social norms are becoming more heavily researched in literature. Stigma to PrEP
use has been reported by many PrEP users and has been shown to deter some from use
(Calabrese & Underhill, 2015; Dubov, Galbo Jr, Altice, & Fraenkel, 2018; Franks et al., 2018;
Golub, 2018; Grace, Jollimore, MacPherson, Strang, & Tan, 2018; Haire, 2015).
The TPB (Figure 3) builds upon the TRA by including the factor of perceived behavioral
control and thus expanding the utility of the model to include behaviors that may not be within
an individual’s volitional control. Behavioral control consists of the perception of the
individual’s ability to perform a behavior is seen as easy or difficult. This factor is best viewed as
a continuum where behaviors that are efficiently executed are on one end, and those more
difficult on the other. For example, slowly walking across a flat football field will be more easily
achieved than running a marathon and coming in the first place. The latter is more difficult and
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requires training and specialized skills. Behavioral control is also theorized to be directly related
to an actual enacted behavior and may or may not go through intentions. Similarly, self-efficacy
is important in behavioral control as self-efficacy is the belief that one can accomplish their goals
(Bandura, 2010). Self-efficacy is important for YSMM to engage in PrEP use, as it may be
required to find a provider, attend regular appointments, and pay expense not covered by
insurance. Together, this model places attitudes, subjective norms, perceived behavioral control,
and self-efficacy as predictors of behavioral intentions.
Similar to the HBM, the TPB has also been examined among a variety of health-related
behaviors. This has resulted in many reviews and meta-analyses focused on exercise (Blue,
1995; Hagger, Chatzisarantis, & Biddle, 2002; Hausenblas, Carron, & Mack, 1997), substance
use (Godin & Kok, 1996; Hausenblas et al., 1997; McEachan, Conner, & Lawton, 2005), and
condom use (Albarracin et al., 2001; Godin & Kok, 1996; Sheeran & Taylor, 1999). Due to PrEP
being an HIV-prevention method, I briefly review the two meta-analyses that examine HIVprevention.
The first was a meta-analysis conducted by Albarracin et al. (2001), which examined
condom use among 96 studies that had utilized the TPB. Across studies, attitudes, subjective
norms, and perceived behavioral control explained 50% of the variance in intentions for condom
use. Attitudes explained the most variance (33.6%), followed by perceived behavioral control
(20.3%) and subjective norm (15.2%). Another meta-analysis, examining condom use and safersex behaviors among 17 studies, reported that 49% of the variance for intentions was explained
across the same three domains (attitudes, subjective norm, and perceived behavioral control)
(McEachan et al., 2005). Like the first meta-analysis, attitudes were the strongest predictor and
explained 18.5% of the variance, but unlike the first, subjective norms was second (14.4%) and
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lastly, perceived behavioral control (12.3%). Attitudes about condom use were the strongest
predictor of condom use and safer sex behaviors across both studies. These findings suggest that
more positive attitudes about the change are more likely to result in increasing both behaviors.
However, according to the model, attitudes are also influenced by both subjective norms and
perceived behavioral control. Given the results of these meta-analyses, the two factors that are
most likely to influence PrEP intentions are the attitudes and subjective norm an individual has
about PrEP.
The PrEP cascade views PrEP uptake as a progressive series of steps where an individual
moves from acceptability to intentions and then eventual uptake. Acceptability as a construct is
generally assessed via questions of if an individual would begin taking PrEP if they could get if
for free (Golub et al., 2013; Golub, Kowalczyk, et al., 2010; Grov et al., 2015; Parsons, Rendina,
et al., 2017; Rendina et al., 2017). Conceptually, this could also be a measurement of an
individual’s attitudes towards their use of PrEP, and as the TPB suggests, a more positive
attitude about the behavior leads to intentions. Additionally, social stigma for PrEP use is
determined by the social norms of the people around the individual and has been shown to be a
significant predictor of PrEP intentions (Calabrese & Underhill, 2015; Haire, 2015). Further,
subjective norms for PrEP use may be of substantial importance for SMM as they are part of a
sexual minority population and are more influenced by social norms of others who share the
same sexual identity as them (Terry & Hogg, 1996). This may be especially important for PrEP
use as more PrEP stigma is associated with less PrEP uptake (Calabrese & Underhill, 2015;
Haire, 2015). Overall, the TPB suggests that those who have more positive attitudes about PrEP,
have significant others who are supportive of PrEP and perceive themselves to have higher levels
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of behavioral control to start taking PrEP, should have higher intentions, and therefore be more
likely to begin taking PrEP.
Summary
The HBM suggests that those who perceive themselves to be at higher risk of illness, and
believe the illness would negatively impact their lives, are more likely to enact a behavioral
change to avoid the illness. The TPB also examines similar constructs but includes subjective
norms, which have been shown to be more impactful for individuals of minority populations
(Terry & Hogg, 1996). Together these models suggest that to create interventions aiming to
engage more HIV at-risk SMM in PrEP care, there are two critical areas that must first be better
examined. One area includes examining how SMM perceive their sexual risk behavior, and how
they believe they would be perceived by the significant relationships in their life for beginning a
PrEP regimen. Multiple PrEP uptake models and research aiming at increasing uptake have
stated those who view themselves as at-risk for HIV are more likely to be willing to use PrEP,
have intentions for PrEP use, and begin taking PrEP (Kelley et al., 2015; Nunn et al., 2017;
Parsons, Rendina, et al., 2017). Similarly, experiencing stigma associated with PrEP use has
been shown to negatively influence potential PrEP use (Calabrese & Underhill, 2015; Golub,
2018; Haire, 2015).
It is clear from the data presented by the various PrEP uptake models that beginning a
PrEP regimen is a series of steps where not all variables are equal for all individuals. Based on
the PrEP literature reviewed above, age likely also influences many of these variables. For
example, it is possible that those who are younger perceive their sexual risk and social influences
differently. Further, those who are younger may have additional developmental barriers to
uptake, for example, sexual identity development, outness to others, and access to health
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insurance. If this is true, many of these factors may present areas that are able to be intervened
upon. Not everyone who is at substantial risk for HIV begins taking PrEP. In order to increase
uptake via new interventions, it is crucial that researchers examine how those at-risk for HIV
come to the conclusion they are, or are not, at-risk and if PrEP is the right choice for them. In the
following chapter, I discuss affective-cognitive processing, developmental theories, and
developmental factors that I believe should be explored and utilized to expand current PrEP
interventions to include the unique factors that may affect PrEP uptake among YSMM.
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CHAPTER FOUR
Decision Making and Development
In the previous chapters, I discussed how different theoretical frameworks could and have
been utilized in the literature pertaining to increasing PrEP uptake. These frameworks included
the HBM, which focuses on internal constructs related to increasing the likelihood of a behavior
change, and the TPB, which includes internal and social constructs leading to intentions for a
behaviors change and eventual change. I also presented these frameworks as associated with the
Motivational PrEP Cascade (Parsons, Rendina, et al., 2017), which presents stages of PrEP
uptake as a series of steps, all of which include decision making. Lastly, I suggested that these
decisions may be made differently for YSMM due to a number of developmental factors and
milestones.
According to the CDC’s most recent HIV surveillance data, SMM made up 82% of all
new HIV diagnoses among men in the U.S. (CDC, 2018a). There are many disparities among
this at-risk population, one of them being among individuals 13-24 years of age. The CDC
estimates that those who are 13-24 years of age made up 21% of all new diagnoses in 2017
(CDC, 2018a) and 93% of those were among sexual minority youth. Further, the CDC reported
that this disparity in age has been stable over time, and those who are younger are least likely to
have access to treatment and be virally suppressed. This is a group of individuals who are at
high-risk for HIV infection, and yet least likely to access care once infected. PrEP use among
this population is also extremely low. The Rollins School of Public Health at Emory University
collected longitudinal data on PrEP use across the U.S., and their most recent report shows that
those who are 24 years of age and younger are one of the two lowest PrEP using age groups
(11%). Only those who are 55 years of age and older made up a smaller percentage of PrEP users
(7%) (aidsvu.org, 2018; Siegler et al., 2018). The age group that made up the largest percentage
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of users were those 25-34 years of age (39%). In order to increase PrEP use among those 24
years of age and younger who are at-risk for HIV, it is imperative that researchers investigate
differences that may exist for these YSMM.
In the following chapter, I first briefly discuss the literature that led to the expansion of
PrEP for younger populations. I then discuss dual-processing theories in decision making, which
theorize those who are younger make decisions based on different information than those who
are older (i.e., affect, cognition, social norms, and benefits). Next, I discuss different
developmental theories, which suggest there are specific reasons that those who are younger may
make decisions differently than those who are older. Lastly, I briefly examine developmental
literature that is unique to the population focus of this project, YSMM. These factors include
sexual orientation development, the coming out process, relationship importance, and substance
use. Together, these sections show there are substantial reasons to believe that younger versus
older SMM view their sexual risk and PrEP candidacy differently and might, therefore, arrive atp
different conclusions about their intentions to begin taking PrEP. Thus, in order to best
implement PrEP use among those who are adolescents and emerging adults, interventions must
be tailored to their specific developmental stage.
PrEP Approval for YSMM Under 18 Years of Age
On May 15th, 2018, the USFDA announced the approval of PrEP for use among anyone
meeting behavioral criteria for uptake and weighing at least 77 pounds (NICHD, 2018).
Approval for PrEP use in individuals under 18 years of age comes on the heels of a
demonstration project by Hosek (2017). This study involved 67 HIV-negative males who were
between 15 and 17 years of age. As part of participation, enrolled individuals were educated on
what PrEP is and how it works. Additionally, they were provided an individual behavioral risk
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reduction session and a once-daily PrEP prescription. Participants then completed visits monthly
for the first three months and then quarterly until the completion of the study (48 weeks). At all
visits, participants received an HIV prevention package that included HIV and sexually
transmitted infection (STI) testing, counseling assessing sexual health and adherence promotion,
and safety assessments for side effect symptoms. Additionally, participants completed computerassisted self-interviews that addressed their behaviors, received condoms, and were provided
their next set of PrEP doses. Regarding safety, overall TDF/FTC was well tolerated aside from
one participant who dropped out due to weight loss, potentially related to the medication. Other
results showed no renal events, bone fractures, or heightened serum creatinine levels. Regarding
sexual risk behaviors, there were no significant changes over time for the number of sexual
partners, or CAS acts. STI rates overtime did increase from the first 24 weeks of treatment to the
second, but not significantly (ARR = 1.93; 95% CI, 0.62-5.96; p = 0.25). Adherence was an issue
and indicated that at the beginning of the study, 54% of participants were taking at least four
doses per week, whereas, by week 48, only 22% were. Three participants seroconverted
throughout the study follow-ups; however, all had levels of TDF/FTC consistent with less than
two doses of medication per week. Overall, results from this project demonstrated that PrEP is
both safe and effective for use among individuals under 18 years of age.
The results of this study highlight that PrEP is effective for YSMM under 18 years of
age. The HBM states that in order for someone to engage in health-promoting behavior (e.g.,
beginning a PrEP regimen), the individual must first have higher perceived benefits, more
perceived threat, more self-efficacy, and more cues to action. Similarly, the TPB utilizes
attitudes, subjective norm, and perceived behavioral control as precursors to intentions for a
health behavior change. Further, previous cascades developed to increase PrEP uptake have
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focused on adult SMM (Kelley et al., 2015; Nunn et al., 2017; Parsons, Rendina, et al., 2017),
thus largely ignoring the differences in development that may differentiate YSMM from adult
SMM. Before interventions can be implemented that help YSMM access PrEP, we need more
research on how younger populations of at-risk SMM make decisions about PrEP use. In the
following section, I present theoretical frameworks that aim to explain decision making and how
these processes change throughout development. Decision making pertaining to risk perception,
susceptibility, and identity development may differently affect YSMM and therefore present
unique areas for intervention.
Decision Making
According to the HBM, an individual who views illness as a threat is more likely to enact
preventive health behaviors than someone who does not view the illness as a threat (Becker,
1974). However, not everyone who is at risk for HIV acquisition views themselves as at-risk
(Parsons, Rendina, et al., 2017). In order to increase uptake among these individuals, it is
imperative that we understand how individuals perceive their risk. As discussed previously,
research examining HIV risk perception and PrEP uptake has been limited mainly to samples
consisting of all adult SMM. However, YSMM are at high risk for HIV and least likely to begin
taking PrEP (CDC, 2018b). Expanding our understanding on how YSMM perceive their HIV
risk will help to inform interventions aiming to increase PrEP use.
Many theories have emerged that explain differences in decision making. The HBM and
TPB are decision-making models that focus on health behaviors; however, others have focused
on cognitive and developmental aspects of decision making. Some of these such theories have
focused entirely on cognitive processing driving decision making (Frederick, 2005; Miller,
2003), while others have focused on or incorporated affective processing (Baker, Piper,
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McCarthy, Majeskie, & Fiore, 2004; De Houwer & Hermans, 2001; Zajonc, 1980). Theories that
have focused on both are commonly called dual-process theories and, amongst many uses, have
been used to explain differences in reasoning (Chaiken & Trope, 1999; James, 1884; Mischel &
Shoda, 1995; Petty & Cacioppo, 2012). There are many different proposed theories of dual
processing, and in the following section, I briefly review three frameworks that I think best apply
to this dissertation focused on adolescent decision making and perception of risk.
Affective and Cognitive processing in Decision Making
Dual processing theories suggest that there are two forms of processing, affective and
cognitive, that are independent features that also work together symbiotically in behavioral
responses to stimuli. Affective processing in decision making, sometimes called ‘hot’ cognition,
is implicit, quick, automatic, often the outcome of emotions or subjective feelings, and
developed earliest in age (Mischel & Shoda, 1995; Zajonc, 1980). Subjective feelings are those
that occur without conscious thought, for example, the automatic like or dislike of a smell, a
person, or a place (Zajonc, 1980). These could also be considered gut reactions to stimuli. ‘Hot’
processing is developed first, considered to be more primal and might be the only form of
processing among animals that may not have the brain functioning abilities for ‘cold’ cognitive
processing (Zajonc, 1980). Cognitive processing in decision making, sometimes called ‘cold’
cognition, is explicit, controlled, independent of emotional involvement, includes conscious
processing, and is developed over time (Metcalfe & Mischel, 1999; Mischel & Shoda, 1995). An
example of completely ‘cold’ cognitive processing is solving a simple math problem requiring
the order of operations. Different processing theories have commonly agreed that ‘hot’
processing is developed before ‘cold’ processing (Casey, Jones, & Hare, 2008; Ernst et al., 2005;
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Galvan et al., 2006; Hare et al., 2008; Steinberg, 2005; van Duijvenvoorde, Jansen, Visser, &
Huizenga, 2010).
Research on affective processing among humans has theorized its role in decision making
differently over time. Some researchers have argued that affect in decision making only occurs
after careful cognitive processing (James, 1884; Lange & James, 1922), and others that both
affective and cognitive processes happen simultaneously (i.e., dual processing) (Metcalfe &
Jacobs, 1996; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995; Prencipe et al., 2011;
Rendina, 2015; Zelazo & Carlson, 2012). Both theories agree that both cognitive and affective
processing occurs during decision making. Theories of dual processing state affective and
cognitive processing do not work entirely independently of each other, but rather ‘hot’
processing is a lower-order process developed at an earlier age and often leading to ‘cold’
cognition (Barrouillet, 2011; Chaiken & Trope, 1999; Metcalfe & Mischel, 1999; Sloman, 1996;
Slovic, Finucane, Peters, & MacGregor, 2004).
James (1884) is often credited as being the first to consider affect and cognition as part of
the decision making process. Later, Zajonc (1980) published “Feeling and Thinking: Preferences
Need No Inferences,” which changed how many psychologists thought about decisions making.
In this seminal piece, he argues there are eight “notions” that support the important role of affect
in decision making. These include: affective reactions are primary; affect is basic; affect
reactions are inescapable; affective judgment tends to be irrevocable; affective judges implicate
the self; affective reactions are difficult to verbalize; affective reactions need not depend on
cognition, and affective reasons may be separated from content. His review of the decisionmaking literature examined the role of affect and the importance it plays in judgment and
behavior. Ultimately, he concluded that affective processing develops earlier in life and happens
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before cognitive processing can occur. This work directly influenced the development of modern
dual processing models (Metcalfe & Mischel, 1999).
Metcalf and Mischel (1999) described a theoretical framework where ‘hot’ affective
processing and ‘cold’ cognitive processing are two different functions that run parallel to each
other, and connections develop over time that lead to a simultaneous function of behavioral
decision. They suggested that each processing system is made up of either ‘cold’ or ‘hot’ nodes,
which connect to each other and produce a reaction to stimuli. They argue that at the beginning
of development, ‘hot’ processing is the default of mental processing; however, as an individual
gains experience and learns, ‘cold’ processing emerges, functioning alongside ‘hot’ processing.
Further, the nodes of each processing system begin to interact, and pathways are created from
‘hot’ nodes to ‘cold’ nodes. As suggested by cognitive behavior theory, behavioral pathways
become more salient over time based on the positive and negative outcomes of the behavior
(Beck, 2011). Similarly, the pathways created via ‘hot’ and ‘cold’ processing are either
strengthened or weakened over time depending on the outcomes of the individual’s behaviors
(i.e., does this behavior lead the person closer toward or further from their goal).
In terms of PrEP use and development, the model presented by Metcalf and Mischel
(1999) suggests that those who are younger may make decisions pertaining to PrEP use utilizing
more affective ‘hot’ processing compared to cognitive ‘cold’ processing. As shown in the
literature already reviewed for this project, one of the first decisions a potential PrEP user must
make if they view themselves as someone who is at-risk for HIV. This processing theory
suggests that it’s possible those who are younger may come to conclusions about their risk
utilizing more ‘hot’ affective processing. An example of this is an individual who is at-risk for
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HIV focusing on if they affectively feel they are at risk as opposed to cognitively measuring and
assessing their risk.
The Elaboration Likelihood Model of Persuasion (ELM) (Petty & Cacioppo, 2012) is
another dual-processing theory and examined attitude change along two paths or processes,
central and peripheral. The central route is the ‘cold’ cognitive processing route, which occurs
when someone has the ability and motivation to think critically about a particular message and is
persuaded by the strength of that message. The peripheral route ‘hot’ affective processing occurs
when someone has low ability or is unmotivated to think critically about a particular message.
Persuasion can happen along both paths; however, the expected long-term change is different.
Those who are persuaded via the central ‘cold’ cognition route, will have given critical thought
to the message, and the effects will be enduring, resistant, and predictive of future behavior.
Those who are persuaded along the peripheral ‘hot’ affective route, will be due to byproducts of
superficial cues outside of the relevance of the message and are less durable, or not integrated at
all (Petty & Cacioppo, 2012). ELM explains why some individuals are presented with the same
information multiple times; however, do not process and integrate it into their decision making
the first time. Oppositely, an individual who perceives the information as pertinent to them in the
current moment may begin to process and integrate the information immediately. Similarly, to
Metcalf and Mischel (1999), these two routes run parallel to each other and interact to elicit
decisions. However, information being passed along the peripheral ‘hot’ affective route may also
be integrated by the person presented with the stimuli. As such, individuals may pick up
information and integrate it into their central ‘cold’ cognitive route without consciousness.
Not everyone who is aware of and eligible for PrEP use views themselves as eligible and
the ELM (Petty & Cacioppo, 2012) suggests they may be perceiving information about the
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medication or their risk level along the peripheral ’hot’ pathway as opposed to the central ’cold’
pathway. The individual may have the information, but has not internalized it or applied it to
themselves, which requires ’cold’ cognitive central processing of the information. Specific to
YSMM, and discussed further below, there are developmental variables that may also influence
how a young person at-risk for HIV processes PrEP related information. For example, sexual
identity develops over time, and some men who are engaging in sexual risk with other men may
not self-identify as gay. PrEP is often marketed as a medication for SMM, and as such, if the
individual does not identify as a sexual minority, the information may be utilized along the
peripheral ’hot’ pathway, and not the central ‘cold’ pathway. As such, their interpretation could
be, “I am not gay, and therefore, this medication is not for me,” regardless of if they meet the
objective criteria for uptake. This may be opposite of a person who identifies as a sexual
minority and interprets PrEP use as, “I am gay, and therefore, this medication is for me.”
Lastly, the Prototype Willingness Model (Gerrard, Gibbons, Houlihan, Stock, & Pomery,
2008) is a dual processing model aiming to explain differences in health risk behaviors among
adolescents. Like other dual-processing theories, these researches theorized that decision making
exists along two paths. However, they deemed these paths to be a reasoned and social reaction.
The reasoned path is based on the theory of reasoned action and the social reaction path, a
response perceived to be more socially desirable to the individual. Garrard et al., (2008) wanted
to understand why adolescents make decisions that appear to result in negative outcome
personally, but positive outcome socially, or vice-versa. This theory is the result of much of these
researchers work that focused on smoking and drinking (Gerrard et al., 2002; Gerrard, Gibbons,
Stock, Lune, & Cleveland, 2005; Gibbons & Gerrard, 1995), engaging in casual or unprotected
sex (Gibbons, Gerrard, Blanton, & Russell, 1998; Gibbons, Helweg-Larsen, & Gerrard, 1995),
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and driving under the influence of alcohol (Gibbons, Lane, Gerrard, Pomery, & Lautrup, 2002).
Across studies, they found that adolescents who viewed others more favorably, who either
engaged or didn’t engage in such behaviors, were more likely to engage or not engage in the
behavior themselves. They theorized adolescent behaviors were not based in the positive and
negative outcomes for themselves but based on how others might perceive them.
In terms of PrEP use, the Prototype Willingness Model (Gerrard, Gibbons, Houlihan,
Stock, & Pomery, 2008) suggests that how someone’s social network perceives PrEP use may
move someone towards or away from PrEP use. If the individuals' social network is perceived as
having negative views of PrEP use, the person considering using may fear experiencing the
social consequences of use (i.e., stigma). Stigma can be experienced at any point in someone’s
life, however, some developmental theories point to teenage years and early adulthood as times
where stigma may have the most effect on a young person’s decision making. This
developmental factor as a potential variable affecting PrEP uptake is expanded further in the
following section.
All of these theories state that dual processing coexists within decision making and that
one path, process, or route interacts with the other to varying degrees, resulting in behaviors.
They also suggest that these processes develop and change over time, and individuals eventually
utilize both; however, ‘hot’ processing is developed at an earlier age. As such, developmental
differences between childhood and adulthood must play a significant role in how information is
processed and how decisions are made.
Developmental Theory
The HBM and TPB both stress the importance of an individual perceiving themselves as
at-risk before either intending or taking a step towards enacting a health-promoting behavioral
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change. Dual-processing theories suggest that decisions are made along pathways that include
both affective and cognitive processing, however they function differently depending on various
factors, including age. ‘Hot’ affective and ‘cold’ cognitive processes in decision making change
over time and throughout development. As such, it is important to understand what and when
developmental literature suggests are some of the pivotal moments and changes that occur
throughout these processes. Specifically, in order to increase PrEP uptake among YSMM, the
processes occurring during these periods of development are of increased significance. In the
following section, I will briefly discuss some of the prominent theories of development and how
they pertain to YSMM and PrEP use.
Much psychological research aims to understand how the mind works and what
differences exist within individuals who make different decisions at different times. For example,
when the same individual under the same circumstances decides to go on PrEP versus when they
decide not to. Dual-processes theories suggest some of these differences may be due to changes
in the utilization of more cognitive versus affective processing. By understanding decisionmaking processes, psychologists can treat individuals who have contradictory cognition and aid
them in making decisions that have a higher potential of leading to more positive outcomes.
Throughout the history of psychology, there have been many developmental theories aiming to
understand individuals’ decision making. One of the most well-known and well-respected
theories is Erikson’s eight-stage theory of personality (1959, 1993). This theory states that
personality develops in a predetermined order of steps where the completion of one step builds
onto the next, known as the epigenetic principle (Erikson, 1994). Non-completion of the previous
step makes completion of the next more difficult and can result in a less functional personality
type making adulthood more difficult. In the following section, I discuss differing developmental
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theories that may all be useful in attempting to explain within-person differences in decision
making, and ultimately how development affects an individual's perception of sexual risk and
intentions of beginning a PrEP regimen.
Erikson (1959) developed the eight stages of psychosocial development and included
society and culture as important factors in development. Further, he argued that development
does not conclude following puberty, but instead extends into adulthood. Erikson stated that
every individual experience crisis at each stage, and the outcome is either positive or negative for
personality development. Erikson theorized the crises come from conflicts between the
individual’s psyche and the needs of society, the self-other relationship (Crain, 2015). Positive
outcomes at each stage result in what’s known as virtues, or behaviors and beliefs indicative of
showing high moral standards (Erikson, 1959). Due to the topic of this dissertation, I briefly
provide background information on two of the middle stages of Erickson’s theory as they focus
on changes from adolescence to adulthood.
Adolescence begins during the fifth stage, identity versus role confusion (twelve to
eighteen years of age) (Erikson, 1959). During this period the individual is asking themselves
questions about who they are, where they are going in life, and wondering how they fit into their
social groups (i.e., family, friends, and society) (Erikson, 1993). These questions are answered
by the individual exploring their own beliefs, values, and goals for the future. This transition of
exploring internal mechanisms mirrors the theories of dual-processing and suggest more
integration of ‘cold’ cognitive processing. For an individual to assess and discover their own
beliefs, values, and goals, they must be able to internally hold and manipulate different
information and apply it to themselves (i.e., cognitive processing), which does not mean they
will no longer be swayed by affective processing, but rather dueling mechanisms active in
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decision making. Additionally, during this stage, Erikson (1959) theorized that if the parents
push the child to take on a particular role or identity the result may be role-confusion and the
child may try out many different roles. However, if the child is allowed to explore, they will
consolidate at their identity. Part of the identity development includes examining the future for
relationships, career, family, and learning about the role they wish to play in society. The role of
society is vital during this stage; individuals generally want to fit into society and as such, may
make decisions based on where they wish to fit in (Rice & Dolgin, 2005).
According to Erikson, adolescence is a period of time where someone is attempting to
discover their identity and questioning who they are in relation to these others. For those who are
in this stage (approximately 12-18 years old according to Erikson), someone may not view the
use of PrEP as being socially acceptable and therefore in order to avoid being othered, decide not
to use the medication. Similarly, the Prototype Willingness Model of dual-processing suggests
that during this period, an individual may be making decisions based more on social
consequences to the behavior as opposed to individual internal benefits.
This stage has also been closely examined in terms of sexual identity development. SMM
may find themselves living a false identity to appear heterosexual while younger, and then
developing a different identity as a gay man later in life (DuBay, 1987; Milton & MacDonald,
1984; Peacock, 2000; Troiden, 1988). Successful completion of this stage should result in the
individual having a strong sense of self and a distinct view of where they fit into society. For
SMM, completion of this stage may be more complex than for heterosexual men.
Erickson’s (1959) developmental theory has influenced many other theories of
development, including Levinson’s Seasons of a Man’s Life (1978) and Arnett’s Theory of
Emerging Adulthood (Arnett, 2000). Levinson’s (1978) theory spans the lifecycle, including four
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eras, pre-adulthood (0-22 years old), early adulthood (17-45 years old), middle adulthood (40-65
years of age), and late adulthood (60 years old to the end of life). In short, the earliest era of
Levinson’s theory focuses on the individual making a distinction between “me” and “not me,”
similar to Erickson’s (1959) theorized passing from adolescence to adulthood, and mirroring the
Prototype Willingness Model of dual-processing. Levinson (1978) recognized the end of this
first era as a period where an individual is deciding who they want to be and begins thinking in
terms of who they are alone, as opposed to whom they are among society, suggesting again the
integration of ‘cold’ cognitive processing in decision making. His eras overlap, and as such,
early adulthood begins while pre-adulthood is ending. During pre-adulthood, Levinson argues
that individuals experience the “greatest energy and abundance and greatest contradiction and
stress” (Levinson, 1986, p. 5). Similar to Erickson’s identity versus role confusion (1959),
Levinson sees this period as involving decisions about love, occupation, friendship, and values.
In both Erickson’s and Levinson’s theories, it is suggested individuals pass quickly from child to
adult, while Arnett (2000) theorized differently.
Arnett (2000) theorized there is a distinct stage between late teens and through the
twenties that is unique to industrialized societies. This stage, emerging adulthood, primarily
focuses on a period of time lasting from 18 years of age to 25 years of age. He defined this time
as a period of exploration where individuals are continuing their education, dating, and living
away from home for the first time. In more industrialized societies, the age of entering into
marriage is increasing, and he argues that this is due to the freedom of self-exploration. He
considered self-exploration to lead to the creation of identity without the pressure of marriage
and family. Further, and similarly to Levinson (1986) and Erickson (1959), Arnett (2000)
believes that this is a period where an individual develops more intimacy and asks the question
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“given the kind of person I am, what kind of person do I wish to have as a partner through life?”
(Arnett, 2000, p. 473). Again, moving away from attention on how society views an individual
and towards how individuals view themselves, their own wants and needs (i.e., The Prototype
Willingness Model).
Development and Sexual Identity
There have been many different models that have attempted to explain how individuals
develop their sexual identities, specifically why some individuals are attracted to and have
romantic feelings for individuals of the same-sex. One such model, and often credited as the first
to discuss homosexual development as normative, came from Cass (1979) and is referred to as
The Cass Identity Model. She theorizes that individuals who eventually identify as a nonheterosexual pass through a series of stages, including identity confusion, identity comparison,
identity tolerance, identity acceptance, identity pride, and identity synthesis. At each stage, an
individual overcomes an obstacle that ultimately results in their sexual identity integration. Other
stage models were also developed and varied in the number of stages, but ultimately ending in a
similar place (Fassinger, 1991; Savin-Williams, 1990; Troiden, 1979, 1988). Later models
integrated these stages into processes with society. One prominent model was developed by
D’Augelli (1995) and suggested that, along with developing a personal identity, sexual minority
individuals also develop a social identity in the LGBTQ community, develop a sexual minority
intimacy status, identify as LGBTQ offspring (i.e., come out), and also enter the gay community.
Along with the additional emphasis on the role of society, this model also states that’s these
events can happen in an order, or occur concurrently, unlike the stage models. Sexual identity
development is complex, and there is no one size fits all model that encompasses the many
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different factors that may impact how a sexual minority individual comes to acceptance of their
identity.
There are multiple aspects of these stages and processes that could potentially impact
how or when an individual considers accessing PrEP. According to the HBM (1974), if an
individual perceives too many barriers to health-promoting behavior, they are less likely to
engage in that behavior. In terms of sexual identity development, self-identity as a sexual
minority could be a barrier to PrEP uptake as the medication is largely marketed towards sexual
minorities, and HIV acquisition is commonly associated with SMM. Thus, even if a YSMM is
engaging in sexual risk behaviors with other YSMM, they may not identify as a sexual minority
and thereby not consider PrEP use or view themselves as an appropriate candidate for PrEP use.
The ELM (Petty & Cacioppo, 2012) also suggests that an individual who is engaging in such
risky behaviors but not identifying with the behaviors may be provided information about PrEP
and process the information along the peripheral pathways as opposed to the central (i.e., not
apply it to one's own behavior).
Another barrier specific to those still in the processes of early sexual identification is
coming out or telling others about your sexual identity. The period when an individual begins to
disclose their sexual orientation has changed significantly over time, with people coming out
younger each generation (Dunlap, 2016). For YSMM who do consider themselves to be good
candidates for PrEP use, coming out may be a barrier to their beginning a regimen. In order to go
on PrEP, an individual must take many risks that could potentially lead to being out about their
sexual orientation to more or different people than they may prefer. For example, going on PrEP
requires an individual to disclose their sexual behavior to their medical provider and feel
comfortable picking up their medication from a pharmacy. Further, in the U.S. an individual can
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be on their parent/caretakers’ health insurance until they are 26 years of age, and as such many
may risk having to disclose their sexual orientation to their parent/caretaker in order to access
their insurance. Additionally, even if an individual is open about their sexual orientation to their
medical provider and parent/caretakers’, they may be uncomfortable engaging in a conversation
about their sexual risk behavior with either. Coming out as a sexual minority is not required to
gain access to PrEP. However, it is likely a barrier for many YSMM who may view themselves
as an appropriate candidate for PrEP. A recent study of 156 young adults (18-25 years of age)
were asked about being on their parent’s insurance and accessing PrEP (Moore Jr et al., 2019).
Those who reported being on their parent’s insurance also reported lower willingness to begin
taking PrEP compared to those that were on their own insurance. Engaging in a conversation
about sexual risk and sexual orientation are likely to continue to be barriers to PrEP use among
those on their parent’s insurance.
Sexual identity development is often more complex for individuals with sexual minority
status and may take longer. However, Erikson (1959) theorized that following this stage is the
first stage of adulthood, intimacy versus isolation. He theorized this stage begins around eighteen
years of age and continues through forty years of age. Here individuals are engaging in dating,
marriage, starting families, and deepening relationships. The individual is consistently making
choices that will either lead them towards or away from their goals, ultimately creating the future
they view themselves as able to obtain. Intimacy becomes import in relationships, and those who
can experience it are likely to feel cared for, safety, and a sense of commitment (Rosenthal,
Gurney, & Moore, 1981). The inability to create intimate relationships may leave the adult
feeling isolated and alone.
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For SMM, Erikson’s intimacy versus isolation stage may also be different complicated,
and intimacy may be developed later in life compared to heterosexual men (Christian & Keefe,
1997; Peacock, 2000). Associations between intimacy and HIV-prevention among SMM have
also been established in the literature. One study consisting of over 300 highly sexual active
SMM in NYC tested a model utilizing risk reduction benefits of condom use and beliefs that
condoms reduce intimacy as predictors for the percentage of CAS acts (Golub, Starks, Payton,
& Parsons, 2012). They found that beliefs that condoms reduce intimacy explained three times
the amount of variance in the model than perceived risk reduction benefits of condom use.
Regarding PrEP use, another study examined intimacy motivations for CAS as associated with
intentions to begin taking PrEP and found that higher intimacy motivations for CAS were
associated with a higher likelihood of intentions to begin taking PrEP (Gamarel & Golub, 2015).
Someone who is in the earlier parts of the intimacy versus isolation stage may be considering a
multitude of factors to increase the possibility of longterm intimacy. For many at this stage, this
may include PrEP use as an HIV-preventive technique to help increase the odds of ongoing
health and also allowing for increased sexual intimacy via the decision to forego condom use.
Although Erikson did not discuss the utilization of ‘cold’ or cognitive processing, it is
clear from the dual processing theories discussed in this dissertation that in order for an
individual to achieve many adult goals (e.g., college, occupation, family), some ‘cold’ cognitive
processing is required (Gerrard et al., 2008; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995;
Petty & Cacioppo, 2012). These individuals moving into adulthood are more likely to focus on
the behaviors they believe will lead to their long-term goals independent of what the social
groups around them may argue (Arnett, 2000; Levinson, 1978, 1986; Zajonc, 1980).
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Together, Erikson, Levinson, and Arnett align in their argument that across the lifespan,
individuals focus on their decision-making changes from how others see them, to how they see
themselves. The importance of an identity that is separate from society emerges, and individuals
begin to make choices that will potentially impact their occupations, educational attainment, and
intimate lives. These processes begin with first creating a self-identity, which requires the ability
to utilize cognitive processing to guide their internalization of information into identity
formation. However, this process of identity development is differently complicated for SMM
and may continue into further stages than their heterosexual counterparts.
Summary
The period of time between childhood and adulthood has been theorized to contain
different stages, steps, and eras. Across all three of the developmental models reviewed above,
(Arnett, 2000; Erikson, 1959; Levinson, 1978), a common finding is that, between childhood and
adulthood, an individual’s attention changes from how others see them, to how they see
themselves. This is similarly reported in the dual processing literature reviewed for this
dissertation (Gerrard et al., 2008; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995; Petty &
Cacioppo, 2012). Those who are at different periods of their life have different goals. A person’s
focus might have previously including fitting in with those closest to them, slowly transitions
into focus on individual accomplishments, goals, and plans for the future. These facts may have
important implications in the implementation of PrEP for YSMM.
To begin taking PrEP, individuals must first view themselves as those who would benefit
from PrEP use (Parsons, Rendina, et al., 2017) and as those who PrEP is for. This may include
identifying as a sexual minority, and also that the behavior they are engaging in includes HIV
risk. Further, this may also include coming out to others about their sexual orientation (e.g.,
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parent/caretakers’, medical provider). Dual processing theories suggest that individuals could
come to conclusions about their risk behavior by both a ‘cold’ cognitive and a ‘hot’ affective
response to their risk behavior (Metcalfe & Jacobs, 1996; Metcalfe & Mischel, 1999; Mischel &
Shoda, 1995; Prencipe et al., 2011; Rendina, 2015; Zelazo & Carlson, 2012). Further, much of
the work by Gerrard and colleagues (1995, 1998, 2002, 2005) suggests that those who are
younger do not necessarily view their own behavior as risky. As such, according to ELM (Petty
& Cacioppo, 2012), risk perception may be happening along the peripheral path, resulting in an
individual not completely integrating their own knowledge of risk to their own behaviors.
Additionally, if an individual does not self-identify as a sexual minority, despite sexual behavior,
information about PrEP may also happen along the peripheral path and result in the individual
not applying the information to themselves.
Gerrard’s (2008) model suggests that YSMMs’ behaviors are likely more swayed by how
they believe those around them would perceive their behavior (i.e., social reaction) as opposed to
a path guided by pros of behavior that directly impact the individual. According to this theory, if
the people around an individual are on PrEP, or supportive of PrEP use, the individual should be
more likely to see PrEP use as positive. Oppositely, if those around the individual are against
PrEP, the individual may perceive PrEP use to be negative and wish not to be associated with it.
Similarly, Erickson (1959), described this period of life as identity versus role confusion. He also
stated that individuals might come to conclusions about themselves via their perceptions of
others. From Erikson’s perspective, at this stage, the individual is determining who they are
based on others, and society becomes increasingly important. YSMM who are in this stage of
development are likely looking to those closest to them for cues about the world, and thus may
be more heavily influenced by perceived subjective norms. The TPB (Ajzen, 1991) suggests that
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subjective norms are associated with intentions to enact a behavior; thus, more positive
subjective norms should result in more intentions. At this time in an individual’s life, how social
norms are developed and influence behavior becomes increasingly important and may sway an
individual’s intentions to begin taking PrEP.
In order to understand how to increase PrEP uptake among YSMM, particularly those 24
years of age and younger who are disproportionately affected by HIV and least likely to engage
in PrEP use (AIDSvu.org, 2018; CDC 2018a; Siegler et al., 2018), it is essential to address where
they are regarding development. Different developmental and dual processing theories suggest
that how younger individuals make behavioral decisions differs from those who are older. ‘Hot’
cognitive processing is primal and develops first. Although both processes affect decision
making, ‘cold’ processing is developed over time. Health disparities in HIV transmission among
men show that those who are YSMM are at elevated risk for acquisition (CDC, 2018a)

, and

with the expansion of PrEP care to now include people under 18 years of age (NICHD, 2018),
understanding how YSMM make decisions about PrEP use becomes increasingly important.
In this chapter, I reviewed multiple developmental and dual processing theories that all
suggest the period between childhood and adulthood is vastly different. Those who are younger
may make more decisions based on how they believe other’s will perceive them, with less regard
for their actual risk, and with the limited information they have gained in the peripheral. To
engage YSMM 24 years of age and younger who are at-risk for HIV acquisition, it is imperative
that we understand how they are making decisions about their risk behavior. If they are coming
to conclusions based on PrEP via a quick affective ‘hot’ response, then targeting them with
information that requires attention and conscious ‘cold’ cognition may be futile. Additionally, if
they are making decisions about PrEP use based on how others may view them, more negative
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perception of use could deter intentions. Both have important clinical implications and potential
to impact uptake.
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CHAPTER FIVE
Overview of the Proposed Research
The overall aim for this dissertation is to identify points for potential intervention to
increase PrEP uptake among YSMM 24 years of age and younger who are at-risk for HIV.
Research for this dissertation is guided by multiple theories, models, and health disparities
among ages. These models include HBM (Becker, 1974), TPB (Ajzen, 1991), dual processing
(Abelson & Rosenberg, 1958; Gerrard et al., 2008; Lazarus, 1982; Metcalfe & Mischel, 1999;
Petty & Cacioppo, 2012), and theories of development (Arnett, 2000; Erikson, 1980; Levinson,
1978). Epidemiological findings from the CDC show that YSMM who are 24 years of age and
younger are at high risk for HIV, and make up one of the lowest PrEP using groups
(AIDSvu.org, 2018l; CDC 2018a; Siegler et al., 2018). Together, these theories suggest that
there are many developmental factors that differentiate decision making in YSMM from decision
making in adult SMM, and thus conclusions about PrEP uptake. In the following chapter, I
outline each of the studies, aims, and hypotheses of this research.
The first study aims to establish that age disparities for PrEP use exist among a large U.S.
national sample of SMM (YSMM who are less than 25 years of age, and SMM who are 25 years
of age and up). Findings from this study will provide some of the first published evidence that
there are distinct differences in trends of uptake among age groups. To do this, I will first
identify group differences in uptake, and second, examine how these group differences influence
PrEP uptake among YSMM and adult SMM. The second study aims to identify relevant
developmental factors that may help to increase the two primary psychological precursors to
PrEP uptake (i.e., PrEP acceptability, and PrEP intentions) among YSMM who are 24 years of
age and younger and at risk for HIV. To do this, I will utilize a large national sample of YSMM
for whom PrEP is already indicated. Results from both studies will provide evidence for
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potential intervention points that will help to increase PrEP uptake among YSMM at risk for
HIV acquisition. As such, the project is designed to test several hypotheses detailed below.
Study 1: Understanding Basic Trends in PrEP Uptake among YSMM in a large, diverse
sample of SMM
The first aim of this dissertation is to examine potential age disparities for PrEP use
among SMM, specifically, that those who are under 25 years of age have less experience with
PrEP than those who are older. To do this, I will examine fundamental trends in the prevalence
of PrEP uptake and discontinuation in a large sample of sexually active YSMM and adult SMM,
and second, examine how these group differences may influence PrEP uptake among these
groups.
As I describe in more detail in the following chapter, this is a very brief survey on a
substantial number of YSMM and adult SMM. The data for the first aim provides one of the first
epidemiological investigations of PrEP use among this vast age range. Though there are very few
variables given the length of the survey, this allows a preliminary investigation of factors
associated with PrEP use in a more generalizable sample. I will begin with the first set of
analyses for aim 1 by examining group differences in the prevalence of PrEP use across the
entire sample by age. In order to determine the appropriate age groupings for this research, I
turned to PrEP use disparities as reported by the Rollings School of Public Health (AIDSvu.org,
2018; Siegler et al., 2018) and the CDC (2018a). These age groups included the following, (1324, 25-34, 35-44, 45-54, 55+) with one change. I separated those 13-17 years of age and 18-24
years of age based on the very recent inclusion of recommendations for those at-risk who are
under 18 years of age.
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The second set of analyses for aim 1 will explore group differences associated with PrEP
use among those who are older verus younger SMM. To determine the appropriate age groups, I
again turned to both the CDC and Rollins School of Public Health findings for HIV transmission
rates and PrEP uptake, and developmental literature. There are significant changes that occur
through these periods in development (Arnett, 2000; Erikson, 1959; Levinson, 1986). The theory
of Emerging Adulthood (Arnett, 2000) suggests a higher ceiling for younger people (29 years of
age), however in the U.S. an individual is able to access health care through their parent until the
age of 26, which could directly impact YSMM’s access depending on a multitude of
developmental and identity factors previously discussed. Taking into consideration the
epidemiological research on HIV by the CDC and the developmental literature that does not
suggest hard cutoffs for changes due to age, I chose to divide the sample at 13-24 and 25 years of
age. This matches the CDC data while also not including those that can no longer legally be on
their parent’s insurance in the younger group. Group differences among both age samples
explored will be race, ethnicity, sexual orientation, health insurance, U.S. geographical location,
relationship status, engagement in CAS with a casual HIV unknown partner, recent diagnosis of
an STI, recent drug use, and recent heavy drinking.
Hypotheses for aim 1.
Hypothesis 1a: Odds of both current and former PrEP use among individuals under the
age of 24 will be lower compared to those 25 years of age and older.
Hypothesis 1b: All of the below-mentioned variables have been shown to be associated
with PrEP use among adult SMM and have not been examined in a larger population, including
YSMM under 18 years of age.
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Having shown that uptake is lower for those who are younger, I will examine those who
are 13-24 years of age and those 25+ years of age for demographic and behavioral risk
differences associated with PrEP use. The reasoning for these age groups has been explained
above. Among both age groups, I anticipate differences in PrEP use will appear for race, sexual
orientation, relationship status, sexual risk behavior, recent STI diagnosis, and recent substance
use. I anticipate that those who are White (compared to all other races), identify as gay
(compared to bisexual and queer), single (compared to in a relationship), those who have
engaged in recent CAS with an HIV status unknown partner (compared to those who have not),
those who have recently received an STI diagnosis (compared to those who have not received a
recent STI diagnosis), and those who have recently used a drug (compared to those who have
not) will be more likely to have current and former PrEP use compared to those that have never
used PrEP.
Hypothesis 1c: In the age group of YSMM (13-24 years of age), I hypothesize there will
be a difference in health insurance such that those who are on their parents’ health insurance will
have lower odds of having experience with PrEP compared to those that are on their own
insurance. This hypothesis has not been previously tested; however, YSMM who are on their
parents’ health insurance may face additional barriers to uptake that may impede uptake, which
has been discussed in the previous chapter.
Together and if confirmed, these hypotheses will provide evidence that current PrEP use
in the U.S. is lowest among YSMM, and that further research needs to be conducted to examine
how the uptake of PrEP can be increased among those YSMM at-risk for HIV. Further, these
findings are likely to indicate some disparities among YSMM that exist in terms of demographic
and behavioral risk associations with use. Although I will not be statistically comparing the two
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age groups (13-24 and 25 and up), these finding may highlight important trends in uptake among
the two groups. The second aim of this dissertation examines developmental factors I believe
will uncover potential intervention strategies for increasing uptake among YSMM.
Study 2: Identify developmental factors as they pertain to PrEP uptake among a large
national cohort of HIV at-risk YSMM
Having identified the prevalence of, and factors associated with, PrEP uptake among a
more generalizable and more extensive sample of YSMM in Study 1, the goal of Study 2 is to
examine developmental factors that may impede YSMM from actual PrEP uptake.
Understanding the unique psycholodevelopmental factors that influence decisions around PrEP
intentions for YSMM will provide evidence for future interventions aiming to increase uptake
among those at risk for HIV infection.
Aim 2. I will examine and identify developmental differences that are associated with the
primary psychological precursors to PrEP uptake that have been established in the literature to
date—the perception of PrEP candidacy and having PrEP intentions. The models of health
behavior and PrEP cascades reviewed in this project suggest that in order for an individual to
have intentions to begin taking PrEP, they must first view themselves as someone who is a PrEP
candidate (Ajzen, 1991; Fishbein & Ajzen, 1975; Kelley et al., 2015; Parsons, Rendina, et al.,
2017). Additionally, the dual processing theories reviewed for this dissertation also suggest those
who are younger may make decisions differently than those who are older (Gerrard et al., 2008;
Metcalfe & Mischel, 1999; Petty & Cacioppo, 2012). For younger individuals, ‘hot’ affective
processing is often utilized more, compared to the use of ‘cold’ cognitive processing, and viceversa for older individuals (Metcalfe & Mischel, 1999). Further, those who are younger are more
likely to be swayed in their decision making by perception of how others will view them, as
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opposed to those who are older who are likely more concerned with their own perceived benefits
of a behavior (Erikson, 1959; Gerrard et al., 2008; Levinson, 1978). Given these theories, I will
examine the role of age in modifying the association between both cognitive and affective
dimensions of HIV risk and viewing oneself as a PrEP candidate. I will also examine the
mediating role of PrEP candidacy between affective and cognitive dimensions of HIV risk and
PrEP intentions. Then, I will examine a scale that measures a social view of PrEP (PrEP stigma),
and a scale measuring individual perceived benefits of PrEP use. Lastly, I will examine two
different developmental factors that I believe will be differently associated with PrEP intentions
by age. Taken together, these findings will provide evidence of how those who are younger may
make decisions about PrEP, and highlight areas for potential intervention. As pictured in Figure
4, I hypothesize the following:
Hypothesis 2a: Affective dimensions of HIV risk will be positively associated with a
perceived candidacy.
Hypothesis 2b: Cognitive dimensions of HIV risk will be positively associated with a
perceived candidacy.
Hypothesis 2c: Age will moderate the association between affective dimensions of HIV
risk and perceived PrEP candidacy such that as age increases, the association between affective
dimensions of HIV risk and perceived PrEP candidacy weakens.
Hypothesis 2d: Age will moderate the association between cognitive dimensions of HIV
risk and perceived PrEP candidacy such that as age increases, the association between cognitive
dimensions of HIV risk and perceived PrEP candidacy strengthens.
These following hypotheses are guided by both the TPB (Ajzen, 1991), stating that the
perception of candidacy for a health change or behavior should be directly related to enacting the
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behavior, and the TRA (Fishbein & Ajzen, 1975), stating that the attitude of a behavior
(perceived candidacy) and a behavioral change are mediated by intentions of the change. As
such, I will next add PrEP intentions into the model, such that perception of self as a PrEP
candidate will mediate the association between affective and cognitive dimensions of HIV risk
and PrEP intentions. In other words, I believe I will find that in order for an individual to have
intentions to begin taking PrEP, they must view themselves as someone who would be a good
candidate for PrEP. These findings will demonstrate that affective dimensions of HIV risk will
be more strongly associated with the perception of PrEP candidacy for those who are younger,
whereas cognitive dimensions of HIV risk will be more strongly associated with the perception
of PrEP candidacy for those who are older. These findings will provide evidence of how
individuals come to a conclusion about their risk behavior is likely influenced by a differently
developed and utilized processing response. As pictured in Figure 5, I hypothesize the following:
Hypothesis 2e: There will be an indirect effect of affective dimensions of HIV risk on
intentions through perceived candidacy, but no direct effect.
Hypothesis 2f: There will be an indirect effect of the cognitive dimensions of HIV risk
on intentions through perceived candidacy, but no direct effect.
I will then explore other developmental factors that theoretically should differentiate
those who are younger from those who are older in terms of their intentions to begin taking
PrEP. As reviewed above in the developmental literature presented, as individuals move from
adolescence into adulthood, their focus for decision making changes. Those who are younger are
more likely to make decisions based on how they believe others will perceive them, and sexual
identity may shape their perception of whether PrEP use is relevant for them or not. As they
move into the next stage of development, their focus should change to their own independent
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goals or perceived personal benefits of a behavior. They will begin moving away from decisions
based on the perceived societal norms and into decisions where the outcome is more likely to be
in favor of their independent goals, which could also include intimate relationship formation, or
moving from “single” to “partnered” (Arnett, 2000; Erikson, 1959; Levinson, 1978). Similarly,
the dual processing model theorized by Gerrard (2008) states that those who are younger are
more likely to be focused on a social reaction in terms of decision making, instead of internally
motivated decision making. In terms of PrEP use, I have selected a measure that targets how an
individual perceives others who use PrEP (i.e., PrEP stigma), and a measure that focuses on the
individuals’ perception of how PrEP might benefit them (i.e., benefits of PrEP use). As pictured
in Figure 6, I hypothesize the following:
Hypothesis 3a: PrEP stigma will be negatively associated with PrEP intentions.
Hypothesis 3b: Perceived benefits of PrEP use will be positively associated with PrEP
intentions.
Hypothesis 3c: Age will moderate the association between PrEP stigma and PrEP
intentions such that as age increases, the association between PrEP stigma and PrEP intentions
weakens.
Hypothesis 3d: Age will moderate the association between perceived benefits of PrEP
use and PrEP intentions, such that as age increases, the association between perceived benefits of
PrEP use and PrEP intentions strengthens.
If confirmed, these two models will demonstrate there are significant differences in the
ways those who are younger compared to older SMM conclude if they are a good candidate for
PrEP and if they have actual intentions of beginning a regimen.
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CHAPTER SIX
Method
Aim 1: Understanding Basic Trends in PrEP Uptake among YSMM in a large, diverse
sample of SMM
As previously stated in the Introduction, the goal of the first aim of this dissertation is to
examine whether age disparities for PrEP use exist among SMM, specifically to examine if those
who are 24 years of age and under have less experience with PrEP than those who are 25 years
of age and older.
Data for this dissertation were collected with the support of a fellowship from the
National Institute of Mental Health (F31-MH116874). The aims of this fellowship included
secondary data analysis for this dissertation. The data for the first aim of this dissertation were
drawn from the brief online survey used to assess preliminary eligibility for participation in
UNITE, a longitudinal cohort study examining the psychosocial and biological predictors of HIV
seroconversion among SMM (UG3-AI133674). This online screener data for the parent project
and those specific to the first aim of this dissertation were collected as part of a single survey
prior to participants’ enrollment in the parent project. Below I describe relevant data collection
information for the first aim of this dissertation and then relevant information for the second aim
in the following section of this chapter.
Participants and Procedures
The goal of recruitment for UNITE was to enroll 8,000 SMM who are at-risk for HIV
acquisition. Between November 2017 and September 2018, targeted advertisements were placed
on popular dating/sexual networking applications and social media websites (e.g., Scruff, Grindr,
Adam4Adam, and FaceBook). When a potential participant clicked the ad, they were linked to a
Qualitrics survey and asked if they would like to complete a survey to see if they are eligible for
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a paid research study. Once the individual consented, they completed a short survey, lasting fiveten minutes. Participants were not paid for completion of this survey; however, those that were
preliminarily eligible for the parent project were provided a second link to an additional survey.
Only data collected during this first survey was used for the analyses of the first aim of this
dissertation. The subsequent survey and enrollment details for the parent project are described
under the second aim.
In total, 123,378 individuals completed the screener for eligibility into the study. As part
of consent, IP addresses were collected, and contact information was submitted at the conclusion
of the screener. IP addresses and contact information were cross-referenced, and duplicates were
removed from the sample. In order to be included in the following analyses, individuals had to
complete the full screener, be at least 13 years of age, currently identify as male, identify their
sexual orientation as something other than heterosexual, reside in the U.S. or other U.S. territory,
self-report an HIV-negative status, and indicated recent sexual behavior. This resulted in an
analytic sample of 96,243 (78%) individuals.
Measures.
Demographics. Individuals were asked a range of demographic questions. Participants
were asked their age, which was collected as a continuous variable and in response to the
question, “How old are you?” For bivariate analysis, ages were separated into the following
groups: 13-17, 18-24, 25-34, 35-44, 45-54, and 55+. Age was utilized as a continuous variable in
the age-stratified regression models, detailed below. Decisions around age groups were selected
to reflect relevant literature from the CDC on the epidemiology of HIV in the U.S. (CDC, 2018a)
and recent reports of PrEP use (AIDSvu.org, 2018; Siegler et al., 2018).
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Participants were asked about sex and gender separately. Sex was asked via the item,
“Which sex were you assigned at birth (as listed on your birth certificate)?” Response options
included “male” and “female.” Participants were then asked, “What is your current gender
identity?” Response options to this item included “male,” “female,” and “transgender.” Only
those who reported being assigned the male gender at birth and currently identified as a male
were included in the sample. This decision was made due to the various psychosocial factors that
have been identified in the literature that differentiates transgender individuals from cis-gender
individuals (Dowers, White, Kingsley, & Swenson, 2019). Participants responded to one
question about their sexual identity, “What do you consider your sexual identity?” Response
options included “gay,” “straight,” “queer,” “bisexual,” and “lesbian.” In an effort to control for
different HIV-risk processing that may exist between those who identify as SMM, only those
who reported a sexual identity as gay, queer, and bisexual were included in the final sample and
coded as 0 (gay), 1 (queer), and 2 (bisexual).
Participants were asked, “What is your race?” and provided the options, “Black/African
American/Afro Caribbean,” “White,” “Asian or other Pacific Islander,” “Native American or
Alaskan Native,” “Multiracial,” and “Other (please specify).” Race was coded as 0 (White), 1
(Black/African American/Afro Caribbean), 2 (Asian or other Pacific Islander), 3 (Native
American or Alaskan Native), 4 (Multiracial), and 5 (Other, please specify). Additionally,
participants were asked “Do you consider yourself to be Hispanic or Latino?” with response
options “yes” and “no,” and coded as 0 (no) and 1 (yes).
Participants were also asked about their HIV status, “What is your HIV status?”
Response choices included “Negative,” “Positive,” and “I don’t know.” Due to this study being
about PrEP use, those who reported being “Positive” were not included in the analyses. Location
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of the participant was asked via two questions. The first being, “Where do you currently live?”
Their response options included, “United States (including D.C.),” “Puerto Rico,” “Another U.S.
territory (e.g., Guan, U.S. Virgin Islands),” and “Other (Outside the U.S.) – Please specify:”
Those who reported living outside of the U.S. were not included in the analyses, and all others
were asked for their five-digit ZIP code, “What is your ZIP code?” The U.S. Census Bureau
(United States Census Bureau, 2016) has divided the U.S. into four geographic regions based on
U.S. zip codes (i.e., West, Midwest, South, and Northeast). Participant’s zip codes were matched
to their geographic region as determined by the U.S. Census Bureau. Those who are currently in
the military or reside in another U.S. territory have a geographic region coded as “U.S.
Territory/Military.” Responses were coded as 0 (South), 1 (Northeast), 2 (Midwest), 3 (West),
and 4 (U.S. territory/military). All other questions and measures assessed are detailed below.
Medical insurance. Participants were asked “Do you currently have medical insurance?”
and provided the response options, “No, I am currently uninsured,” “Yes, a private insurance
plan through my employer,” “Yes, a private insurance plan through my parent’s employer,”
“Yes, a private insurance plan through my partner’s employer,” “Yes, a private insurance plan I
pay for through the health insurance marketplace (e.g., through ObamaCare),” and “Yes, a public
insurance plan such as Medicaid”. Those who reported “Yes, a private insurance plan through
my parent’s employer” were coded as 0 (yes, parent’s), those who reported “Yes, a private
insurance plan through my partner’s employer” were coded as 1 (yes, partner’s), those who
reported “Yes, a private insurance plan through my employer,” “Yes, a private insurance plan I
pay for through the health insurance marketplace (e.g., through ObamaCare,” and “Yes, a public
insurance plan such as Medicaid” were coded as 2 (yes, own). Those who responded, “No, I am
currently uninsured” were coded as 4 (no).
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Sexual behavior. Participants were asked multiple questions about sexual behavior, in
similar ways that have previously been published (Golub, Rosenthal, Cohen, & Mayer, 2008;
Golub, Tomassilli, et al., 2010; Grov, 2012; Parsons, Grov, & Golub, 2012; Rendina et al.,
2016). Although we did not ask participants if they had reached their sexual debut, we asked
them about recent sexual behavior in the last six months. To first determine if they had recently
engaged in sexual behavior, those who reported being in a relationship were asked, “Within the
past 6 months, have you had anal sex with your main partner?” Response options included “yes”
and “no.” All participants were presented with the text, “For the next set of questions we want to
know about any male partners you had sex within the past 6 months. Please do not count your
main partner when answering these questions.” They were then asked, “How many male sex
partners have you had sex within the past 6 months? (We define sex as any physical contact that
could lead to orgasm.)” Participants were able to enter any number. Responses to the first
question were coded as 0 (no) and 1 (yes). Responses to the second question were could as 0 (no)
and 1 and up (yes). Participants that were coded as “yes” for either question were included in the
analysis. Participants were also asked questions about recent sexual risk behavior. All
participants were asked, “How many of your male partners in the past 6 months did not tell you
their HIV status OR told you there was a different HIV status than you?” Responses were open
and coded as “CAS with HIV status different or unknown partner” 0 (no) 1 or more (yes).
Recent STI diagnosis. Participants reported if they had received a positive STI diagnosis
in the last six months via a series of questions beginning with “In the past 6 months, have you
been diagnosed with any of the following,” and then separately queried for chlamydia,
gonorrhea, syphilis, hepatitis B, hepatitis C, herpes, or HPV/genital warts. Responses options
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included “yes” and “no” for each STI. Positive STI results for any of these presented were coded
as 0 (no) and 1 (yes).
Substance use. Participants reported on recent substance use, including recreational
drugs and alcohol. They responded to the following, “For the next section, we are interested in
knowing about your recent substance use. Please indicate how many days you’ve used each of
the following drugs within the past 3 months (90 days).” They were then provided ordinal
number options for the following substances “marijuana,” “cocaine,” “crack,” “crystal meth,”
“GHB/GBL,” “heroin/opiates,” “ketamine (K),” “MDMA (Ecstacy, Molly),” “Poppers,”
“Prescription drugs for fun or to get high,” and “Viagara/Levitra/Cialis”. If the participant
indicated one or more for any of these options, they were coded as 1 (yes), if not, they were
coded as 0 (no). Marijuana was included, as its use is not legal in all of the United States
(Dragone, Prarolo, Vanin, & Zanella, 2019), and poppers as their legal/intended use are not
sexual and have been linked to more sexual risk behavior (Mayer, Colfax, & Guzman, 2006).
Additionally, participants were asked about recent alcohol use. They responded to the question,
“How many days in the past 3 months have you had five (5) or more drinks on one occasion?”
Participants were able to write-in a numbered response. Those who indicated having at least five
drinks on one occasion were coded as “heavy drinking” 0 (no) and 1 (yes).
PrEP use. Participants were provided a brief description of PrEP and then asked about
past and current use (Holloway, Dougherty, et al., 2017; Morgan, Ryan, Newcomb, &
Mustanski, 2018; Parsons, Rendina, et al., 2017; Whitfield, John, Rendina, Grov, & Parsons,
2018a). The introduction read “PrEP (pre-exposure prophylaxis) is a biomedical strategy to
prevent HIV infection. PrEP involves HIV-negative guys taking anti-HIV medications (for
example, Truvada) once a day, every day to reduce the likelihood of HIV infection they were
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exposed to the virus.” Participants were then asked “Have you ever been prescribed HIV
medication (e.g., Truvada) for use as PrEP (pre-exposure prophylaxis)” Response options were,
“Yes, I am currently prescribed PrEP,” “Yes, but I am no longer prescribed PrEP,” and “No, I’ve
never been prescribed PrEP.” These responses were coded as 0 (never), 1 (former), and 2
(current).
Analytic Plan
All hypotheses for the first aim were conducted with SPSS version 25. To explore
differences in individual characteristics associated with the dependent PrEP use variable (i.e.,
never, former, current), group differences were explored and included age (13-17, 18-24, 25-34,
35-44, 45-54, 55 and up), relationship status (partnered versus single), sexual orientation (gay,
queer, bisexual), race (White, Black/African American/Afro Caribbean, Asian or other Pacific
Islander, Native American or Alaskan Native, Multiracial, Other), Hispanic/Latino (yes/no),
region (South, Northeast, West, Midwest, Other U.S. Territory/Military), health insurance status
(none, own, partner’s, parent/guardian), recent STI diagnosis (yes/no), CAS with an HIV status
unknown partner (yes/no) recent drug use (yes/no), and heavy drinking (yes/no). I utilized twotailed t-tests to examine differences in Hispanic/Latino ethnicity, relationship status, recent STI
diagnosis, CAS with an HIV status unknown partner, recent drug use, and heavy drinking.
Analyses of variances (ANOVA) were used to examine differences in age, race, sexual
orientation, region, and health insurance.
To test hypothesis 1a, that the percentage of current and former PrEP use is lowest among
individuals 24 years of age and younger, I first ran descriptive statistics to assess the number of
participants that fall into each of the three groups of PrEP use (i.e., never on PrEP, previously on
PrEP, and currently on PrEP) by age (13-17, 18-24, 25-34, 35-44, 45-54, 55 and up). Having
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shown that PrEP use is lowest among those 24 years of age and younger, I then split the sample
to examine those who are 13-24 years of age and those who are 25 years of age and older. These
age groupings were selected to match CDC age group categorizations for HIV risk (CDC, 2018a)
and the Rollins School of Public Health (AIDSvu.org, 2018; Siegler et al., 2018) groupings for
PrEP uptake across the use. Further rationale surrounding this decision can be found in the
previous chapter (CDC, 2018a).
To examine hypotheses 1b, that demographic and behavioral risk differences exist for
PrEP use among those 24 years of age and younger, and those 25 years of age and older, I
conducted two multinomial logistic regressions stratified by age, predicting PrEP use with all
variables of interest included in the models. These variables included age (continuous within
each age group), race (White, Black, Asian or other Pacific Islander, American Indian or Alaskan
Native, Multiracial, and Other), Hispanic/Latino Ethnicity (yes/no) sexual identity (gay,
bisexual, queer), relationship status (yes/no), geographic region determined by US Census data
(South, Northeast, Midwest, West, U.S. Territory/Military), recent CAS with an partner of
different or unknown HIV status (yes/no), recent STI diagnosis (yes/no), recent drug use
(yes/no), and recent heavy drinking (yes/no). All variables were dummy coded before being
entered into the model, as 0 (no) and 1 (yes).
Lastly, to test hypothesis 1c, that those who are under 24 years of age and on their
parent’s insurance will have lower odds of experience with PrEP compared to those who are on
their own insurance, I conducted a multinomial logistic regressions predicting PrEP use for the
stratified sample of YSMM with health insurance included in the model while controlling for all
other demographic and behavioral variables.
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Due to the large sample size of aim 1 (N = 96,243), and in effort to avoid Type I errors,
only analyses outside of the specific hypotheses of this aim that resulted in a p-value of 0.001 or
less will be presented in the results section and discussion of the findings. However, all
significant p-values of 0.05 and below are marked in their associated tables and figures. This
decision was made in order to reduce the chances of reporting an association among variables
that may be statistically significant yet not clinically meaningful.
Aim 2: Identify individual developmental factors as they pertain to PrEP uptake among a
large national cohort of at-risk YSMM.
As stated above, data for this dissertation were collected with the support from a
fellowship from the National Institute of Mental Health (F31-MH116874). The aims of this
fellowship included secondary data analyses of data collected as part of UNITE, a longitudinal
cohort study examining the psychosocial and biological predictors of HIV seroconversion among
SMM (UG3-AI133674). Participants of the parent project may be followed for as long as three
years; however, data for the second aim were primarily drawn from the baseline data collected
during the enrollment process for the longitudinal cohort. The only data from a different survey
comes from demographic characteristics that were collected via the online screener, which were
linked to this baseline data pool via identification numbers provided to the participants. These
analyses focus on the participants that are officially enrolled in the parent project, and as such,
relevant procedures for enrollment are described below.
Procedures and Participants
Relevant procedures from the parent project.
Data for the second aim came from the UNITE cohort, consisting of 7,952 HIV-negative
SMM (16 years old and up). Between November 2017 and September 2018, 123,378 individuals
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fully completed the screening survey, detailed above in methods of the first aim. Once
individuals were deemed preliminarily eligible, they were linked to a second survey. Before
completing the second survey, participants were presented with a brief video introducing the
research team, the purpose of the study, study procedures, and critical information for informed
consent. Participants were then asked to review the consent form and completed a brief consent
comprehension quiz. After consenting, participants proceed to the baseline assessment, which
took approximately 30-40 minutes to complete. After completion of the baseline survey,
individuals were sent an at-home HIV/STI testing kit and were required to send the specimen to
the lab before being officially enrolled in the cohort. Participants were paid $25 for completion
of the enrollment procedures.
Enrollment into the final UNITE cohort included: (1) reporting an HIV-negative or
unknown status; (2) being at least 16 years old; (3) currently identifying as male; (4) having sex
with another male in the past three months; (5) not currently prescribed PrEP and adhering to the
medication; (6) report sexual HIV transmission risk in the past six months, which has been
defined as meeting at least one of the following three criteria: (a) a self-reported STI diagnosis;
(b) CAS with a casual male sex partner; or (c) CAS with an HIV-positive/unknown main partner;
(7) able and willing to provide informed consent; (8) able and willing to complete the baseline
procedures, including the online survey and at-home resting procedures; and (9) living in the US,
including Puerto Rico or another U.S. territory. In total, 7,952 individuals completed the online
screener, completed the baselines assessment, HIV/STI testing, consented to be in the study, and
were enrolled in the final longitudinal cohort. The following analyses were conducted utilizing
participants that were enrolled in the longitudinal cohort, reported being 16-24 years of age
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during the completion of the screener survey, and not currently prescribed PrEP. This resulted in
an analytic sample of 2,003 (25.2%).
Measures.
Demographics. During the online screener, individuals reported on a range of
demographic features, including sex assigned at birth, gender identity, race, ethnicity, sexual
identity, age, relationship status, zip code, and medical insurance status. Collection of these
variables and coding is detailed above in the first aim and consistent throughout the second aim.
These descriptive variables from the online screener were merged with the data collected during
the baseline survey. Additional demographic characteristics collected during the baseline survey
included educational attainment and employment status. Educational attainment was asked with
the question, “What’s the highest grade of school you have completed?” and response options
provided included, “Some high school,” “High School Diploma or GED,” “Some College or
Associates Degree,” “Currently enrolled in college,” “4-Year College Degree (BA, BS, BFA),”
and “Graduate School”. Those who responded “Some high school” or “High School Diploma or
GED” were coded as 0 (Some High School/GED or less), “Some College or Associates Degree”
or “Currently enrolled in college” as 1 (Some College), and 4-Year College Degree (BA, BS,
BFA)” or “Graduate School” as 2 (4-Year College or More). Employment status was asked with
the question, “Which of the following best describes your current employment status?” Response
options included, “Full-time,” “Part-time,” “Part-time work – full time student,” “Permanent or
temporary disabled and NOT working,” “Permanent or temporary disabled BUT working ‘off
the books’ (or ‘under the table’),” “Unemployed – Student,” and “Unemployed – Other”. Those
who reported “Permanent or temporary disabled and NOT working,” “Unemployed – Student,”
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and “Unemployed – Other” were coded as, 0 (unemployed), “Part-time,” “Part-time work – full
time student,” 1 (part-time), and “Full-time” as 2 (full-time).
Dimensions of Risk Perception. Participants completed the Perceived Risk of HIV Scale
(Napper, Fisher, & Reynolds, 2012). This scale consists of three subscales that measure
affective, cognitive and salience dimensions of perceived HIV risk. Only the affective and
cognitive subscales were utilized for this study. The affective dimensions of perceived HIV risk
subscale included the items, “What is your gut feeling about how likely you are to get infected
with HIV?,” “I worry about getting infected with HIV,” “Getting HIV is something I am
concerned about,” “I feel I am unlikely to get infected with HIV,” and “I feel vulnerable to HIV
infection.” All questions were asked on 5-point Likert type scales were higher scores indicated
more feelings of HIV acquisition. The cognitive dimensions of perceived HIV risk subscale
included the items “I am sure I will not get infected with HIV,” and “There is a chance, no
matter how small, I could get HIV.” Responses for the cognitive dimension subscale were
collected on a 5-point Likert type scale, 0 (strongly disagree) to 5 (strongly agree). The first item
was reverse coded, such that a higher score indicated more cognitive dimensions of perceived
HIV risk. A mean total on each subscale was calculated for each participant. With this sample,
the internal consistency of the subscale was good for both affective dimensions of HIV risk
(Cronbach's α = 0.72) and cognitive dimensions of HIV risk (Cronbach's α = 0.71).
PrEP Measures. Before completing all PrEP measures, participants were provided with
the following statement “PrEP (pre-exposure prophylaxis) is a biomedical strategy to prevent
HIV infection. PrEP involved HIV-negative guys taking anti-HIV medications (for example,
Truvada) once a day, every day to reduce the likelihood of HIV infection if they were exposed to
the virus. Please note that PrEP is not the same as taking HIV medications for a brief period of
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time (i.e., 28 days) after a high-risk exposure to HIV through encounters such as having sex
without a condom. PrEP is intended for regular, long-term use.”
PrEP stigma. To better understand how participants view others who use PrEP we asked
eleven questions about PrEP stigma, a scale that was adapted from a scale measuring HIV stigma
(Berger, Ferrans, & Lashley, 2001). Example items include “I think people should take PrEP,”
“People who are on PrEP are irresponsible,” and “Many people on PrEP lie about whether or not
they take it every day.” Response options were provided on a 5-point Likert scale 0 (strongly
disagree) to 4 (strongly agree). Items that indicated positive views of PrEP were reverse coded,
such that higher scores on this scale indicated more PrEP-related stigma. With this sample, the
internal consistency of the scale was good (Cronbach's α = 0.79).
Benefits of PrEP use. Participants were asked 12 questions about the importance of
different factors in their decision making for PrEP use, which was recently published (John,
Rendina, Starks, Grov, & Parsons, 2019), however created from multiple researchers previous
work (Auerbach, Kinsky, Brown, & Charles, 2015; Ayala et al., 2013; Brooks, Landovitz,
Regan, Lee, & Allen, 2015; Carlo Hojilla et al., 2015; Cohen et al., 2015; Flash et al., 2014;
Gamarel & Golub, 2015; Grov et al., 2015; John, Whitfield, Rendina, Parsons, & Grov, 2018; H.
L. King et al., 2014; Kubicek, Arauz-Cuadra, & Kipke, 2015; Liu, Hessol, et al., 2014; Mantell
et al., 2014; Pérez-Figueroa, Kapadia, Barton, Eddy, & Halkitis, 2015; Underhill et al., 2015).
Examples of questions include “Taking PrEP would mean I have more freedom to decide when
to use and not use condoms,” “Taking PrEP would help me to feel less inhibited and ‘let go,’”
and “Taking prep seems like the responsible thing to do.” Response options were provided on a
5-point Linkert scale ranging from 0 (not at all important) to 4 (extremely important). Possible
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total scores range from 0-48, where higher scores indicating more perceived benefits to PrEP
use. With this sample, the internal consistency of the scale was good (Cronbach's α = 0.85).
Perceived PrEP candidacy. Participants were asked about their own perception of
themselves as PrEP candidates (Gallagher et al., 2014; Parsons, Rendina, et al., 2017; Rendina et
al., 2017). Participants were asked “Do you believe you are currently an appropriate candidate
for PrEP?” with response options, “Yes, I am definitely an appropriate candidate for PrEP,”
“Yes, I think I am an appropriate candidate for PrEP,” “I’m not sure if I am an appropriate
candidate for PrEP,” “No, I don’t think I am an appropriate candidate for PrEP,” “No, I am
definitely not an appropriate candidate for PrEP”. Responses were coded as a dichotomous
variable where “Yes, I am definitely an appropriate candidate for PrEP” and “Yes, I think I am
an appropriate candidate for PrEP” were coded as 1 (yes) and all other responses were be coded
as 0 (no).
PrEP intentions. In order to assess intentions to begin PrEP participants, were provided
with a statement informing the participant that doctors are currently able to prescribe PrEP and
asked if they begin to start taking PrEP. This statement and question have been used to assess
intentions in previous research (Parsons, Rendina, et al., 2017; Rendina et al., 2017).
Specifically, participants were provided the statement “PrEP is currently available with a
prescription from your doctor, and research has shown that a majority of insurance companies
cover most or all of the costs of PrEP,” followed by the question “Do you plan to begin PrEP?”
Response options included “Yes, I will definitely begin taking PrEP,” “Yes, I will probably
begin taking PrEP,” “I’m not sure – I might begin taking PrEP,” “No, I probably will not begin
taking PrEP,” and “No, I definitely will not begin taking PrEP.” The variable was not distributed
normally and therefore coded as an ordinal variable, 1 (No, I definitely will not begin taking
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PrEP), 2 (No, I probably will not begin taking PrEP), 3 (I’m not sure – I might not begin taking
PrEP), 4 (yes, I will probably being taking PrEP), and 5 (yes, I will definitely begin taking
PrEP).
Analytic Plan
I began by utilizing SPSS version 25 to explore differences in individual characteristics
associated with the primary independent variables (i.e., affective dimensions of HIV risk,
cognitive dimensions of HIV risk, perceived PrEP benefits, PrEP stigma). I first examined group
differences between those who are 13-17 years of age and those 18-24 years of age. Although I
did not expect there to be a difference between these two groups, I sought to understand how
many individuals were under the age of 18 in the final sample. Other group differences explored
included relationship status (partnered versus single), sexual orientation (gay, queer, bisexual),
race (White, Black/African American/Afro Caribbean, Asian or other Pacific Islander, Native
American or Alaskan Native, Multiracial, Other), ethnicity (Hispanic/Latino, yes/no), region
(South, Northeast, West, Midwest, Other U.S. Territory/Military), recent STI diagnosis (yes/no),
and recent drug use (yes/no). I utilized two-tailed t-tests to examine differences in ethnicity,
relationship status, recent STI diagnosis, and recent drug use. Analyses of variances (ANOVA)
were used to examine differences in race, sexual orientation, education, and employment.
To test all hypotheses in the second aim of this dissertation project, I utilized MPlus 7.
Beginning with hypotheses 2a – 2d, path analysis was conducted to assess if age moderates the
relationship between both affective and cognitive dimensions of HIV risk and perceived PrEP
candidacy. The independent variables of the regression are affective and cognitive dimensions of
HIV risk, age, and the interaction between both affective and cognitive dimensions of HIV risk
and age. All variables were centered on their grand mean, producing analytic variables with a
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mean of 0. The interaction was created by multiplying the affective dimensions of HIV risk and
age together after both variables had been mean-centered. The dependent variable of the
regression is the dichotomous variable PrEP candidacy. All demographic variables were dummy
coded and entered into the model simultaneously. If the interactions were significant, then
moderation was supported. For all path analyses, I utilized the default maximum likelihood
estimation with bootstrapped standard errors estimated from 10,000 draws.
For hypothesis 2e and 2f, a path analysis utilizing MPlus 7 was run with both affective
and cognitive dimensions of HIV risk as the independent variables, PrEP intentions as ordinal
the dependent variable, and PrEP candidacy as the mediator. All other variables of interest were
dummy coded and entered into the model simultaneously. I examined the direct effects of
affective and cognitive dimensions of HIV risk on PrEP intentions, as well as the indirect effects
of affective and cognitive dimensions of HIV risk on PrEP intentions, through PrEP Candidacy.
Similarly, hypotheses 3a-3d were tested with the same moderation analysis technique as
hypotheses 2a-2d, utilizing MPlus 7. For this model, the independent variables included benefits
of PrEP use, PrEP stigma, age, and the interaction between both benefits of PrEP use and PrEP
stigma with age. PrEP intentions was the dependent variable of the model. Additionally, all other
variables of interest were dummy coded and entered into the model simultaneously.
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CHAPTER SEVEN
Results of the First Aim
The first aim of this dissertation project was to examine whether age disparities for PrEP
use exist among SMM, specifically to examine rather those who are under 24 years of age have
less experience with PrEP than those who are 25 years of age and older. Further, I explored
group differences between those who had experience with PrEP and those who did not for
YSMM (13-24 years of age) and SMM (25 years of age and up). One such variable of focus is
health insurance status, as I hypothesized those who are under 24 years of age and on their parent
or guardian’s health insurance would have lower odds of having used PrEP compared to those
who have their own insurance. Bivariate analyses were conducted first, and then two
multinomial regression analyses predicting PrEP use (i.e., current, former, never) were run while
controlling for all covariates. The first multinomial regression analyses examined these variables
among only those 13-24 year of age, while the second examined the same set of variables among
those 25 years of age and up.
Demographic and Behavioral Characteristics
Table 1 presents the demographic and behavioral characteristic of the SMM included in
the sample (N = 96,243). As can be seen in the table, the majority of the sample was White
(63%). However, other races were well represented, with almost 40% identifying as people of
color. A large majority of the sample was gay-identified (78.9%) as opposed to bisexual (18.7%)
and queer (2.4%). Almost 70% of the sample reported being single. The geographic distribution
of participants spanned across all regions of the U.S., with a larger proportion in both the South
(34.4) and West (26.7%) compared to Northeast (19.7%) and Midwest (18.1%). Additionally,
more than 1,000 participants (1.1%) were located in a U.S. territory or the military.
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The bivariate analysis presented in Table 1 resulted in statistically significant withingroup differences for PrEP uptake among all demographics and behavioral variables at the p <
0.001 level. Among race, those who were American Indian or Alaskan Native, made up the
smallest percentage of those who had never used PrEP (1.8%), those who were White made up
the largest percentage of those who were current PrEP users (68.2%) and former PrEP users
(60.6%).In terms of ethnicity, those who reported being Hispanic or Latino made up the smallest
percentage of never (25.1%), former (21.2%), and current PrEP users (27.2%). In terms of
sexual orientation, those who identified as queer made up the smallest percentage of never
(2.1%), current (3.2%), and former (4.5%) PrEP users, while those who identified as gay made
up the largest percentage of never (76.3%), current (88.2%), and former (85.1%) PrEP users.
Relationship differences in PrEP use also emerged, and those who reported being in a
relationship made up the smallest percentage of those that never (29.5%) used PrEP, while those
who reported being single made up the largest percentage of those that were current (64.6%) and
former (68.6%) PrEP users. Regional differences showed that those who resided in the South
made up the largest percentage of those who have never used PrEP (36.2%) and those in the
West made up the largest percentage of both current (29.6%) and former (31.3%) PrEP users.
Those who reported being on their partner’s insurance made up the smallest percentage of those
that had never (2.0%) and formerly (2.3%) used PrEP, while those on their own insurance made
up the largest percentage of those that are current PrEP users (82.7%). In terms of behavioral
risk, those who had engaged in CAS with an HIV status unknown partner made up the largest
percentages of never (80.3%), current (84.8%), and former (81.5%) PrEP users. Those had been
diagnosed with an STI in the last 6 months made up the smallest percentage of never (8.4%),
current (27.5%), and former (20.5%) PrEP users. In terms of substance use, those who used any
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drug in the last 3 months made up the largest percentages of never (59.0%), current (75.8%),
and former (72.9%) PrEP use. Alcohol use was differently associated with PrEP use such that
those who had 5 or more drinks in the past 3 months made up a larger percentage of never
(61.5%), current, (64.8%), and former (65.7%) PrEP users.
Hypothesis 1a
Table 1 displays the results of analyses for Hypothesis 1a, where I proposed that the
percentage of those 24 years of age and under would have less experience using PrEP compared
to the percentage of those 25 years of age and older. This hypothesis was supported. Bivariate
analyses showed significant differences between age groups for those that reported never,
current, and former PrEP use, (χ2 (10) = 3,086.34, p <0.001). The age group reporting the least
current use were those 13-17 years of age (1.2%), followed by those 18-24 years of age (7.8%).
Current PrEP use increased to 18.1% for those 25-34 years of age, continued to increase for
those 35-44 years of age (23.0%), and then decreased to 21.5% for those 45-54 years of age, and
18.5% for those 55 years of age and up. Former PrEP use followed a similar pattern with the
lowest at 1.0% for those 13-17 years of age and highest at former use for those 25-34 years of
age (7.6%). Both current and former PrEP use statistics result in a curvilinear trend where PrEP
use increases with age, peaks, and then declines with age. The peak period is slightly different
for the two PrEP use outcomes, such that the peak age for current use is higher than the peak age
for former use. The relevance of this finding is discussed further in the discussion.
Hypothesis 1b
Table 2 displays the results of analyses for Hypothesis 1b among YSMM, whereas Table
3 displays the results of analyses Hypothesis 1b among adult SMM. There were many
demographic factors I wanted to investigate among the two age groups. As such, for ease of
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reading and comparison, I break the following findings into sections pertaining to each age
group, and demographic variables explored. Due to the focus of this project, I first present the
variables most closely associated with the developmental literature reviewed.
Demographic associations of PrEP use among YSMM
Beginning with sexual orientation, I hypothesized that those who identified as gay
(compared to bisexual and queer) would be more likely to have current and former PrEP use,
compared to never having used PrEP. I found partial support for this hypothesis. Those who
identified as bisexual versus gay had lower odds of being a former (AOR = 0.45, p < 0.001) and
current (AOR = 0.39, p < 0.001) PrEP user compared to never having used PrEP. Identifying as
queer, compared to gay, was associated with higher odds of being a former PrEP user compared
to never PrEP user (AOR = 1.45, p < 0.01). The differences between those who identify as gay
and bisexual are significant at the 0.001 level. However, the difference between those who
identify as gay compared to queer is only significant at the 0.01 level and therefore at risk of a
Type 1 error with a sample size this large.
I hypothesized that relationship status would also be associated with PrEP use history,
such that those who were single (compared to in a relationship), would be more likely to have
current and former PrEP use, compared to never having used PrEP. This hypothesis was partially
supported. Among YSMM, those who were single, compared to in a relationship, had higher
odds of being a former PrEP user compared to having never used PrEP (AOR = 1.26, p < 0.01).
However, YSMM may stop using when they enter a relationship or are simply more likely to
stop using PrEP due to other factors that impede continued use. Neither can be supported with
this cross-sectional data. Further, this association is significant at the 0.01 level, but not at 0.001
level, and as such, there is a risk of a Type I error with a sample size this large.
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I then examined factors associated with behavioral risk. Beginning with recent
engagement in CAS with an HIV status unknown partner, I hypothesized that those who had
recent engagement in CAS with an HIV status unknown partner (compared to those who had
not) would be more likely to have current and former PrEP use, compared to never having used
PrEP. This hypothesis was not supported. Among YSMM, there were no significant differences
in either former or current PrEP use for those who had engaged in CAS with an HIV status
unknown partner compared to those who had not.
In terms of having had a recent STI diagnosis, I hypothesized that those who had
received an STI diagnosis (compared to those who had not) would be more likely to have current
and former PrEP use, compared to never having used PrEP. This hypothesis was supported.
Among YSMM, those who had recently been diagnosed had higher odds of being both a former
(AOR = 3.57, p < 0.001) and current (AOR = 4.77, p < 0.001) PrEP user compared to never
having used PrEP.
In terms of recent drug use, I hypothesized that those who had recent use of a recreational
drug (compared to those who had not) would be more likely to have current and former PrEP
use, compared to never having used PrEP. This hypothesis was supported. Having recently used
a recreational drug was associated with higher odds of being both a former (AOR = 1.55, p
<0.001) and current (AOR = 1.50, p < 0.001) PrEP use.
Last, I examined the difference in PrEP use among YSMM of different races. I
hypothesized that those who were White (compared to all other racial groups) would be more
likely to have current and former PrEP use, compared to never having used PrEP. There was
only one significant difference by race. Those who were categorized as “other” due to not
identifying as any of the race options provided, had decreased odds (AOR = 0.61, p < 0.001) of

81

being a current PrEP user compared to those who were White. The remaining hypotheses
regarding other men of color having lower experience with PrEP were not confirmed among
YSMM.
Demographic associations of PrEP use among SMM
Beginning with sexual orientation, I hypothesized that those who identified as gay
(compared to bisexual and queer) would be more likely to have current and former PrEP use,
compared to never having used PrEP. This hypothesis was partially supported. SMM who
identify as bisexual versus gay had lower odds of being either a former (AOR = 0.46, p < 0.001)
or current (AOR = 0.36, p < 0.001) PrEP user compared to never having used PrEP. Identifying
as queer compared to gay was associated with higher odds of being a former (AOR = 1.85, p <
0.001) or current PrEP user (AOR = 1.37, p < 0.001) compared to never PrEP user.
I hypothesized that relationship status would also be associated with PrEP use history,
such that those who were single (compared to in a relationship), would be more likely to have
current and former PrEP use, compared to never having used PrEP. This hypothesis was partially
supported. Among SMM, those who were single, compared to in a relationship, had higher odds
of being a current PrEP user (AOR = 1.08, p < 0.001). This finding suggests that once SMM
begin a PrEP regimen, they may be less likely to stop using PrEP depending on relationship
status (i.e., they may not stop using when they enter a relationship).
Next, I examined behavior risk associations with PrEP use among SMM. Those who had
engaged in recent CAS had higher odds of being a current (AOR = 1.48, p < 0.001) or former
(AOR = 1.11, p < 0.01) PrEP user compared to never having used PrEP. Due to the sample size
of this group, it is possible that at the 0.01 level a Type I error is being made and as such, the
statistically significant differences between recent engagement in CAS and former versus never
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having used PrEP should be interpreted with caution. Those who had recently been diagnosed
had higher odds of being both a former (AOR = 2.36, p < 0.001) and current (AOR = 3.95, p <
0.001) PrEP user compared to never having used PrEP. And SMM having recently used a
recreational drug was associated with higher odds of being both a former (AOR = 1.78, p
<0.001) and current (AOR = 2.11, p < 0.001) PrEP user compared to never having used PrEP.
Last, I examined race among SMM and hypothesized that those who were White
(compared to all other racial groups) would be more likely to have current and former PrEP use,
compared to never having used PrEP. I found partial support for this hypothesis. In terms of race
difference among adult SMM and former PrEP use, compared to those who were White, only
those who identified as Multiracial (AOR = 1.19, p < 0.001) had a statistically significant
difference in PrEP use at the 0.001 level or below, such that they have increased odds of being a
former user PrEP user compared to never having used PrEP. Compared to those who were
White, those who identified as American Indian or Alaskan Native (AOR = 0.64, p < 0.001), and
something other than the majority (AOR = 0.77, p < 0.001) had lower odds of being a current
PrEP user compared to those that never used PrEP.
Hypothesis 1c
Table 2 displays the results of analyses for Hypothesis 1c that YSMM on their parent’s
insurance would have lower odds of being a former and current PrEP user compared to those on
their own insurance. This hypothesis was supported. Individuals who had their own health
insurance versus their parent or guardian’s had higher odds of being both a former (AOR = 1.26,
p < 0.001) and current (AOR = 1.20, p <0.001) PrEP user.
Other Significant Findings
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Although the above covers all of the hypothesized findings of the first aim of this
dissertation, there are other findings that I think are important and should be noted. I stated in
Hypothesis1a that those under 25 years of age would have less experience with PrEP use. This
was supported by the findings and is presented in Table 1. However, age was entered in the agestratified regression models as a continuous variable. Results are displayed for YSMM in Table
2. In the regression model for YSMM, age was positively associated with being a former PrEP
user compared to never PrEP user (AOR = 1.23, p < 0.001), such that every increase of one year
of age was associated with a 23% increase in the odds of being a former PrEP user. Similarly, for
YSMM, age was positively associated with being a current PrEP user compared to never PrEP
user (AOR = 1.31, p < 0.001), such that every increase of one year of age was associated with a
31% increase in the odds of being a current PrEP user.
In the regression model for adult SMM (Table 3), age was negatively associated with
being a former PrEP user compared to never PrEP user (AOR = 0.99, p < 0.001), such that every
increase of one year of age was associated with a 1% decrease in the odds of being a former
PrEP user. The association between age and current PrEP use compared to never having used
PrEP was not statistically significant for adult SMM (AOR = 1.00, ns).
These differences in findings among the two stratified age groups are in line with the
findings for PrEP use from the Rollins School of Public Health (AIDSvu.org, 2018; Siegler et
al., 2018) and provide more evidence that there are different barriers to PrEP use for those that
are younger. In order to increase uptake among YSMM , it is important to identify what those
factors are impeding uptake and clearly diminish with age.
Additionally, I did not have a hypothesis for the geographic location of the participants,
however significant difference where reported. Among the regression model with YSMM,
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compared to those living in the South, those living in the Northeast (AOR = 1.85, p < 0.001), and
West (AOR = 1.49, p <0001) had higher odds of being a former PrEP user compared to having
never used PrEP. Compared to those living in the South, those living in the Northeast (AOR =
2.01, p < 0.001), and the West (AOR = 1.42, p <0.001) has higher odds of being a current PrEP
user compared to a never PrEP user. Overall, there are significant regional differences across the
U.S. for PrEP use among YSMM. This suggests that either access to PrEP or knowledge about
PrEP is not evenly distributed across the country. Of particular concern are those who live in the
South.
Aim 1 Discussion
The first aim of this dissertation was to examine if age disparities for PrEP use exist
among SMM, specifically to examine it those under 25 years of age have less experience with
PrEP than adult SMM 25 years of age and older. These findings support that there were
significant differences in PrEP use by age groups. Those under 25 years of age had the lowest
percentage of current users, while the highest percentage was those 35-44 years of age. In the
two multinomial regression models stratified by age, age was also associated with use, such that
for YSMM, there was an increase of 31%in the odds of being a current PrEP user for each year
of age. This magnitude of change was not anticipated and highlighted the extreme barriers to
PrEP use that likely diminish with increases in age. Further, this highlights the need to fully
explore and examine the differences in barriers that exist for those who are younger and at-risk
for HIV seroconversion. These barriers are likely complex in nature and include biological,
psychological, and social factors.
I was also interested in examining how health insurance may be associated with
beginning PrEP. YSMM who had their own insurance had higher odds of being both a current
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and former PrEP user compared to those on their parent or guardian’s insurance. This suggests
that access to insurance alone is not likely to increase uptake among this population if that access
is through their parent or guardian. This could be due to sexual identity development and how
open about their sexuality an individual is to their parents. If the individual is not open about
their sexuality, they may not be comfortable utilizing the shared insurance to access a medication
that is associated with sexual orientation. Helping YSMM to obtain PrEP without insurance,
including those who do have insurance via their parent or guardian may be a key to increasing
uptake.
In terms of sexual orientation, those who identified as bisexual compared gay were less
likely to be both current and former PrEP users among both the samples of YSMM and SMM. I
had also hypothesized that those who identified as queer would have less experience with PrEP
use than those who identified as gay. Among the sample of YSMM, this was incorrect and those
who identified as queer had significantly higher odds of being a former PrEP user compared to
those who identified as gay. In the sample of SMM, those who identified as queer have higher
odds of both former and current PrEP use compared to those that identified as gay.
The term queer is defined by the Merriam-Webster dictionary in multiple ways,
“sometimes disparaging and offensive, of relating to, or characterized by sexual or romantic
attraction to member’s of one’s own sex,” “of relating to, or characterized by sexual or romantic
attraction that is not limited to people of a particular gender identity or sexual orientation,” “or,
relating to, or being a person whose sexual orientation is not heterosexual and/or whose gender
identity is not cisgender” (Merriam-Webster, 2019). In earlier LGBTQ history, queer was
perceived as a negative term whereas more recent literature has shown that many younger people
are reclaiming the term and proudly announcing their queer identity (Morandini, Blaszczynski, &
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Dar-Nimrod, 2017). Some research has also shown that many people choose to identify as queer
versus gay because identifying as queer is seen as a spectrum that could include sexual attraction,
sexual behavior, gender identity, and gender presentation (Morandini et al., 2017). According to
developmental literature (Erikson, 1959), identity development is extremely important and
carried out over a period of time. Due to the more nuanced nature and political purposes of
identifying as queer, it’s possible that those who identify as queer are more open to potential
information that may be ignored by someone who identifies as gay and assumes information may
not apply to them. Based on the ELM, those who identify as queer may be receiving a broader
spectrum of information along the central path as opposed to the peripheral, thereby closely
analyzing if that information pertains to them or not. As such, it may be possible that information
on PrEP may enter the central processing pathways for those with more complex identities like
queer. It’s also possible that those who identify as queer as coming out earlier than those who are
gay and therefore able to access PrEP with fewer barriers. Further research would need to be
done to confirm these theories, however understanding how those who identify as queer are
gaining knowledge and access to PrEP differently than those who identify as bisexual and gay
may inform interventions aiming to engage those at-risk for HIV and not taking PrEP.
For both YSMM and adult SMM, a recent STI diagnosis was associated with higher odds
of being a current and former PrEP user. These AORs are large within the stratified age groups
and suggest that testing positive for an STI can actually be a protective factor to HIV acquisition
by increasing PrEP uptake among those vulnerable. It is also possible that receiving an STI
positive result leads to PCPs recommending PrEP to their patients, or a patient is more interested
in PrEP use for prevention due to the increased risk perception.
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Recent CAS with an HIV unknown status partner was not significantly associated with
PrEP use for YSMM but was associated with current use for adult SMM. This difference
between age groups may have to do with risk perception. As presented in the HBM, perceived
susceptibility should be positively associated with health-promoting behavior. Engagement in
CAS with unknown partners may be perceived as increasing susceptibility for adult SMM, but
not for YSMM. In the second aim, I will examine how developmental factors may explain some
differences in YSMM perception of oneself as a PrEP candidate. Specifically, I will examine the
role of affective and cognitive dimensions of HIV risk as associated with perceived PrEP
candidacy, and moderated by age, among YSMM at risk for HIV acquisition. Additionally, in the
second aim, I will examine social factors associated with development and intentions to begin
taking PrEP. Specifically, the role of individual perceived benefits of PrEP use and perceived
PrEP stigma as associated with intentions to begin taking PrEP and moderated by age.
Together, these findings from the first aim suggest that PrEP use may be less likely for
YSMM, men of color, those on their parent or guardian’s insurance, and those who identify as
bisexual. Further, testing positive for an STI may actually be protective against HIV for some, as
it increases the odds of beginning a PrEP regimen. The results from this aim and the following
will help us to understand better what the strongest barriers may be that impede YSMM from
beginning PrEP, and inform future interventions aimed at increasing uptake among those at-risk.
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CHAPTER EIGHT
Results of the Second Aim
The second aim of this dissertation was to identify relevant developmental factors that
may help to increase two primary hypothesized precursors to PrEP uptake (i.e., PrEP
acceptability, and PrEP intentions) among HIV at-risk YSMM (16-24 years of age). Unlike the
first aim of this project, the second only consists of participants that were enrolled in the final
cohort of the longitudinal study, and as such, 16 is the lowest age available in this sample for
inclusion in the analyses. These hypotheses were developed to understand better how decisions
around PrEP uptake are made for this HIV at-risk and non-PrEP utilizing population. Further,
these hypotheses were designed to investigate how specific psychological constructs pertaining
to ‘hot’ and ‘cold’ processing may differently affect the perception of HIV risk and PrEP
intentions. As mentioned previously, all models were adjusted for the impact of demographic
and behavioral variables associated with PrEP use, which were previously explored in the first
aim.
Demographic Characteristics
Table 4 presents the demographic characteristics of the 2,003 HIV at-risk YSMM who
were enrolled in the final UNITE cohort. As can be seen in the table, the majority of the sample
was between 18 and 24 years of age (96.1%), white (57.5%), identified as gay (79.7%), and
single (81.9%). Both employment and geographic region were relatively evenly distributed
among the different categories. This sample was utilized for all analyses pertaining to hypotheses
2a-2f and hypotheses 3a-3d.
Correlations and Bivariate Analyses among Variables of Interest for Hypotheses 2a-2f
The variables of interest for the first set of hypotheses include age, affective dimensions
of HIV risk, cognitive dimensions of HIV risk, perceived PrEP candidacy, and PrEP intentions.
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The bivariate analyses in Table 4 and correlations presented in Table 5 should be interpreted
with caution as the sample size is large and many of these correlations may be statistically
significant yet not meaningful in their amount of variance accounted for. As such, a Bonferroni
correction was conducted post-hoc, and regardless of statistical significance, only those that have
at least a small effect size of 0.2 are presented here and discussed elsewhere (Bonferroni, 1936).
In Table 5, Affective dimensions of HIV risk was positively correlated with cognitive
dimensions of HIV risk (r = 0.58, p < 0.001) and perceived PrEP candidacy was positively
correlated with PrEP intentions (r = 0.37, p < 0.001). All results of the bivariate analyses for the
independent variables of interest for hypotheses 2a-2f are presented in Table 4, Significant
differences in mean scores for affective dimensions of HIV risk were observed such that those
who were single (M = 3.24, SD = 0.72) compared to partnered (M = 3.06, SD = 0.80) also
reported higher affective dimensions of HIV risk, t = 4.05, p < 0.000; d = 0.24. Lastly, compared
to those who had not recently been diagnosed with an STI (M = 3.18, SD = 0.73), those who had
been recently diagnosed (M = 3.37, SD = 0.76) reported higher affective dimensions of HIV risk,
t (2001) = 4.14, p < 0.001; d = 0.25.
Hypothesis 2a
Results for this hypothesis are displayed in Table 6 and Figure 6. Hypothesis 2a was that
affective dimensions of HIV risk would be positively associated with perceived PrEP candidacy.
I found support for this hypothesis in the fully adjusted model. The fully adjusted model showed
a conditional main effect of affective dimensions of HIV risk on perceptions of PrEP candidacy
(AOR = 1.44, p < 0.001), such that for every increase of one unit of affective dimensions of HIV
risk, there was an increase of the odds of self-identifying as a PrEP candidate by 44%.
Hypothesis 2b
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In Hypothesis 2b, I stated that cognitive dimensions of HIV risk would be positively
associated with perceived PrEP candidacy. I did not find support for this hypothesis in the fully
adjusted model (AOR = 0.92, p = ns).
Hypothesis 2c
In Hypothesis 2c I stated that age would moderate the association between affective
dimensions of HIV risk and perceived PrEP candidacy such that for every one-year unit increase
in age, the association between affective dimensions of HIV risk and perceived PrEP candidacy
weakened. This hypothesis was not supported. Results indicated the association between
affective dimensions of HIV risk and PrEP candidacy was stronger at higher levels of age (AOR
= 1.10, p < 0.05), as displayed in Figure 6, Table 6, and the interaction plot Figure 7. It is worth
noting this interaction was conditional upon a main effect of age in predicting perceiving PrEP
candidacy (AOR = 1.11, p < 0.001) such that for every increase in one year of age there is an
increase of 11% in the odds of perceiving oneself as a PrEP candidate.
Hypothesis 2d
In Hypothesis 2d I stated that age would moderate the association between cognitive
dimensions of HIV risk and perceived PrEP candidacy such that as age increased, the association
between cognitive dimensions of HIV risk and perceived PrEP candidacy strengthened. This
hypothesis was not supported. The interaction of cognitive dimensions of HIV risk and age was
not significant (AOR = 0.97, p = ns).
Hypothesis 2e
In Hypothesis 2e, I stated that there would be an indirect effect of the affective
dimensions of HIV risk on intentions through perceived PrEP candidacy, but no direct effect.
There was a direct effect of perceived PrEP candidacy on PrEP intentions (AOR = 3.56, p <

91

0.001). There was also a direct effect of the affective dimensions of HIV risk on intentions (AOR
= 1.35, p < 0.001), and a statistically significant indirect effect of affective dimensions of HIV
risk on intentions via PrEP candidacy (AOR = 0.46, 95% CI = 0.24, 0.68). As such, mediation
was supported, as displayed in Figure 6.
Hypothesis 2f
In Hypothesis 2f, I stated that there would be an indirect effect of the cognitive
dimensions of HIV risk on PrEP intentions through perceived PrEP candidacy, but no direct
effect. There was also a direct effect of the cognitive dimensions of HIV risk on intentions (AOR
= -0.20, p <0.05), and a statistically significant indirect effect of cognitive dimensions of HIV
risk on PrEP intentions (AOR = -0.01, 95% CI = -0.33, 0.10). As such, mediation was supported,
as displayed in Figure 6.
Correlations among Variables of Interest for Hypotheses 3a-3d
Analogous to the correlations and bivariate analyses for presented for hypotheses 2a-2f, a
Bonferroni correction was conducted post-hoc, and regardless of statistical significance, only
those that have at least a small effect size of 0.2 are presented here and discussed elsewhere
(Bonferroni, 1936). Table 5 displays the correlations among variables of interest for this set of
hypotheses; however, none met the above-stated effect size. These variables include age,
perceived benefits of PrEP use, and PrEP stigma.
Results of the bivariate analyses for the independent variables of interest for hypotheses
3a-3d are presented in Table 7. Beginning with perceived benefits of PrEP use, only those who
had recently been diagnosed with an STI (M = 3.67, SD = 0.68) compared to those who hadn’t
(M = 3.51, SD = 0.70) reported more benefits to PrEP use, t (2001) = 3.83, p < 0.01; d = 0.23.
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In terms of PrEP stigma, individuals who reported their race as White (M = 2.19, SD =
0.53) reported lower PrEP stigma compared to all other groups, including American Indian or
Alaskan Native (M = 2.23, SD = 0.50), multiracial (M = 2.26, SD = 0.57), Asian and other
Pacific Islander (M = 2.31, SD = 0.53), and those who reported the highest, Black (M = 2.35, SD
= 0.55) men and individuals who were of another race outside of the options provided (M =
2.38, SD = 0.56; F [5,1997] = 6.79, p < 0.000; d = 0.28). Those who reported their sexual
orientation as bisexual (M = 2.34, SD = 0.55), compared to both gay (M = 2.22, SD = 0.54) and
queer (M = 2.13, SD 0.54), also reported more PrEP stigma, F (2, 2000) = 8.14, p < 0.001; d =
0.23. Compared to those with some college (M = 2.21, SD = 0.54) and a 4-year college degree or
more (M = 2.22, SD = 0.53), those with some high school/GED or less (M = 2.32, SD = 0.57)
reported more PrEP stigma, F (2, 2000) = 7.13, p < 0.001; d = 0.20. Lastly, those on their
parents’/guardians’ insurance (M = 2.18, SD = 0.52) reported lower PrEP stigma than those on
their own (M = 2.26, SD = 0.55), without insurance (M = 2.31, SD = 0.58), and those who are on
their partner’s (M = 2.41, SD = 0.55) reporting more than all others, F (3, 1999) = 6.46, p <0.01;
d = 0.32.
Hypothesis 3a
Table 8 displays the full results of analyses, while Figure 8 displays the significant
associations between the variables. In Hypothesis 3a, I stated that PrEP stigma would be
negatively associated with PrEP intentions. I found support for this hypothesis. The fully
adjusted model showed a direct effect of PrEP stigma on PrEP intentions (AOR = 0.81, p <
0.05), such that for every increase of one unit of PrEP stigma, there was a 19% decrease of the
odds of a one-unit increase in PrEP intentions.
Hypothesis 3b
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In Hypothesis 3b, I stated that the perceived benefits of PrEP use would be positively
associated with PrEP intentions. I found support for this hypothesis. The fully adjusted model
showed a conditional main effect of perceived benefits of PrEP use on PrEP intentions (AOR =
2.15, p < 0.000), such that for everyone one unit increase in perceived benefits of PrEP resulted
in a 115% increase in the odds of a one-unit increase in PrEP intentions.
Hypothesis 3c
In Hypothesis 3c, I stated that age would moderate the association between PrEP stigma
and PrEP intentions such that as age increases, the association between PrEP stigma and PrEP
intentions weakens. There was no conditional main effect of age on PrEP intentions (AOR =
0.02, ns). However, there was an interaction effect (Figure 9) between age and PrEP stigma, such
that as age increased, the effect of PrEP stigma on PrEP intentions weakened (AOR = 0.93, p <
0.05). Additionally, this resulted in AOR = 0.74, a 26% decrease in the odds of being highest on
PrEP intentions versus lowest.
Hypothesis 3d
In Hypothesis 3d I stated that age would moderate the association between PrEP
perceived benefits of PrEP use and PrEP intentions, such that as age increases, the association
between perceived benefits of PrEP use and PrEP intentions strengthens. There was no
conditional direct effect of age on PrEP intentions (AOR = 0.02, ns). However, there was an
interaction effect (Figure 10) between age and perceived benefits of PrEP use. As age increased,
the effect of perceived benefits of PrEP use on PrEP intentions strengthened (AOR = 0.07, p <
0.05).
Aim 2 Discussion
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The second aim of this dissertation project was to test developmental differences among
YSMM that may help to explain disparities in PrEP use that were presented in the outcomes of
the first aim. Specifically, I sought to understand the role of development in psychological
processes that may impact the perception of self as a PrEP candidate and intentions of PrEP use.
I first tested my hypotheses that affective dimensions of HIV risk and cognitive
dimensions of HIV risk would be differently associated with the perception of PrEP candidacy
by age. I expected that affective dimensions of HIV risk would be positively associated with
PrEP candidacy, and this association would weaken at higher ages. I also expected that cognitive
dimensions of risk would be positively associated with PrEP candidacy, but that this association
would strengthen at higher ages. These hypotheses were constructed based on dual-processing
and developmental literature that suggests those who are younger would be utilizing more
affective processing compared to those who are older and integrating more cognitive processing.
Based on Erikson’s theory (1959), this sample contains individuals in the identity versus role
confusion and intimacy versus isolation stages of development. With that in mind, I expected
that as individuals age, they begin utilizing more cognitive processing and making decisions that
could potentially result in more identity solidification and intimacy. Results indicated that
affective dimensions of HIV risk were positively associated with the perception of PrEP
candidacy. However, the cognitive dimensions of HIV risk were not significantly associated with
the perception of PrEP candidacy. The interaction between affective dimensions of HIV risk and
PrEP candidacy was opposite of my hypothesis and became stronger at higher ages.
For many SMM, fear of HIV may contribute to a form of cognitive dissonance where
they do not view their sexual behaviors as risky but are rather moved to the perception of
potential HIV transmission based on affective fear of HIV. As such, they may not be accurately
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assessing their own risk behaviors, but rather relying on their instinct or emotion (i.e., affective
response). Additionally, during this period of development, individuals may be struggling with
obtaining intimacy, and there for the drive for intimacy may override their cognitive thought
processes that suggest their behavior is risky. For example, if an individual has fears that
changing their sexual risk behavior will lead to a lesser likelihood of obtaining intimacy, the
affective yearning for intimacy may be increasingly impactful in their self-perception of risk and
lead to a decrease in risk perception.
Next, I tested my hypotheses that perceived PrEP candidacy would mediate the
associations between the affective and cognitive dimensions of HIV risk and intentions to begin
a PrEP regimen. As expected, PrEP candidacy was significantly positively associated with PrEP
intentions, suggesting that individuals have increased odds of intentions to begin PrEP when they
first see themselves as candidates for PrEP. However, mediation was neither supported for the
affective nor cognitive dimensions of HIV risk. Affective dimensions of HIV risk were till
significantly positively associated with PrEP intentions through PrEP candidacy, and cognitive
dimensions of risk was significantly negatively associated with PrEP intentions through
perceived PrEP candidacy. These results indicate that the affective decision making may actually
lead to more PrEP uptake, whereas cognitive decision making around risk may lead to decreased
PrEP uptake. This suggests that interventions, which use cognitive-based evidence of risk to
increase uptake, may not be as effective as interventions that target affect for at-risk individuals.
One explanation for these findings is potentially stigma around PrEP use. This will be discussed
further in the conclusions.
The final set of analyses included examining the association between two variables
believed to change during development, and PrEP intentions. These variables were PrEP stigma
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and perceived benefits of PrEP use. Developmental literature suggests that as individuals age,
their decision making is more strongly associated with individual perceived benefits of the
outcome, whereas decision making when an individual is younger is more strongly associated
with avoiding potential negative outcome from peers (e.g., stigma) (Arnett, 2000; Erikson, 1959;
Gerrard et al., 2008). As such, I hypothesized that as age increases, the association between PrEP
stigma and PrEP intentions would weaken, whereas the association between perceived benefits
of PrEP use and PrEP intentions would strengthen by increases in age. These hypotheses were
supported by the findings from these analyses. In the fully adjusted model, age alone was not
associated with PrEP intentions; however, PrEP stigma and the interaction between PrEP stigma
and age were both significantly negatively associated with PrEP intentions. I had expected that
as age increased, PrEP stigma would be less associated with PrEP intentions, and this association
did weaken. Further, as expected, both benefits of PrEP use and the interaction between the
benefits of PrEP use and age were significantly positively associated with PrEP intentions. This
suggests that as age increases, an individual who is at risk for HIV may perceive more benefits to
PrEP use, and thereby have higher intentions to begin taking PrEP. To increase PrEP uptake
among at-risk YSMM, it may be important for providers to explore the benefits of PrEP use with
the patient, while simultaneously attempting to destigmatize the use of the medication.
Together, these two studies provide valuable insight into the psychological mechanisms
that impact YSMM’s decision to begin taking PrEP. Many of these findings were unexpected
(e.g., affective risk being more strongly associated with intentions); however, they shine a light
on the importance of developmental stage, and emotion and decision making for this at-risk
population. Similarly, PrEP stigma may affect decision making around an individual’s health
more when younger, but also continue into adulthood.
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CHAPTER NINE
Discussion
In the following chapter, I provide a brief overview of the relevance of this research area,
the theoretical framework for the hypotheses of this dissertation, and key findings. I then closely
examine findings within each of the two studies and explain why I believe some of my
hypotheses were supported, while others were unsupported. Additionally, I present mental
health, medical, and social implications of this work and how these findings can be used to
inform future interventions aiming to increase PrEP use among YSMM at-risk for HIV
seroconversion. Lastly, although there are many strengths to this work, the limitations cannot be
ignored, and are briefly discussed.
Background, Hypotheses, and Key Findings
YSMM are at high risk for HIV seroconversion and make up 92% of all new HIV
infections among men in their age group (CDC, 2018b). PrEP was approved by the USFDA in
2012 (CDC, 2012), and much research has focused on how to increase uptake among adult SMM
(Ayala et al., 2013; Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Galea et al., 2011;
Gallagher et al., 2014; Golub et al., 2013; Grov et al., 2015; King et al., 2014; Mimiaga, Case,
Johnson, Safren, & Mayer, 2009; Mustanski et al., 2013; Parsons et al., 2017; Rendina et al.,
2017; Smith, Toledo, Smith, Adams, & Rothenberg, 2012). However, more recently, PrEP has
been approved for all individuals at-risk and meeting the bodyweight requirement (NICHD,
2018), and little research has focused on the unique barriers YSMM may face when attempting
to begin a PrEP regimen. Past research models predicting PrEP uptake have identified selfperception as a PrEP candidate and having PrEP intentions as important precursors to PrEP
uptake (Kelley et al., 2015; Nunn et al., 2017; Parsons, Rendina, et al., 2017). These models are
supported by both the HBM (Becker, 1974) and TPB (Ajzen, 1991), such that an individual must
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view oneself as at-risk for a negative health outcome (i.e., perception of themselves as a PrEP
candidate), and have intentions to change a behavior, before steps are taken to enact a behavior
change.
Affective ‘hot’ processing and ‘cold’ cognitive processing are two components of
decision making, and may play different roles in how younger versus older individuals make
decisions (Barrouillet, 2011a; Chaiken & Trope, 1999; Metcalfe & Mischel, 1999; Sloman,
1996; Slovic, Finucane, Peters, & MacGregor, 2004). Affective ‘hot’ processing is automatic and
often an outcome of emotions or feelings, whereas ‘cold’ processing is more controlled and
includes conscious processing. Although these processing systems theoretically exist
independently from each other, they work simultaneously and together in decision making. ‘Hot’
processing is considered to be more primal, whereas ‘cold’ processing is strengthened during
development over time (Metcalfe & Mischel, 1999). As such, these two processes are likely
differently associated with decisions pertaining to PrEP use for YSMM compared to adult SMM.
The developmental literature reviewed for this dissertation suggests there are many
different stages and eras of the lifespan. However, much of this literature agrees that when an
individual is younger, they are more likely to be swayed by societal pressures and fears of
negative societal consequences, whereas they become more concerned with individual benefits
as they age (Arnett, 2000; Erikson, 1959, 1980; Levinson, 1978, 1986). For YSMM, the
decreasing stigma associated with PrEP use may be an important key in understanding how to
increase PrEP use among HIV at-risk YSMM, whereas examining individual benefits may be
less helpful.
The primary aims of this dissertation were to examine age disparities in PrEP uptake
among SMM, test a model of ‘hot’ and ‘cold’ processing in risk perception and the primary
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precursors to PrEP uptake (i.e., perception of PrEP candidacy and PrEP intentions), and test a
model of individual benefits and social risks associated with PrEP intentions.
In order to accomplish these aims, I utilized data collected as part of a larger study (i.e.,
parent project, UNITE). The first aim was accomplished using data collected during recruitment
into the parent project via an online survey. I conducted a series of multinomial regression
models with PrEP uptake (i.e., never, former, current) as the primary outcome, while stratified by
age and adjusting for potential covariates. To accomplish the second aim, I used data collected
during the baseline assessment of the parent project. In the second aim, I conducted two path
analyses. In the first model, I tested the associations between affective and cognitive dimensions
of HIV risk and perceived PrEP candidacy, moderated by age, and then I tested the association
between affective and cognitive dimensions of HIV risk on PrEP intentions, through PrEP
candidacy. In the last model, I tested the associations between perceived benefits of PrEP use
and PrEP stigma on PrEP intentions, moderated by age.
Results from these analyses supported eight of my thirteen hypotheses. In the first aim, I
examined PrEP use among two age groups of sexual minority individuals, YSMM (13-24 years
of age) and SMM (25 years of age and older). I first utilized a regression model for YSMM and
found that age was positively associated with former and current PrEP use, such that every
increase of one year of age was associated with an increase of 31% in the odds of being a current
PrEP user compared to never having used PrEP. In the second regression model for SMM, age
was negatively associated with former PrEP use compared to never have used PrEP, and age was
not significantly associated with current PrEP use compared to never having used PrEP. This
difference in the association of age and PrEP use suggests that there are many barriers to use that
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dissolve with increases in age and in order to intervene on these barriers, it is imperative that
these barriers are explored further.
Along with age, I also examined many other demographic and behavioral variables
predictors in the two age-stratified models. Lastly, I found support for my hypothesis that even
while adjusting for age, YSMM who are on their parent guardian’s health insurance had lower
odds of having experience using PrEP, compared to those that are on their own insurance. These
findings pertaining to health insurance suggest that for YSMM, just having health insurance may
not mean more access to PrEP. This is likely a prime area for clinical, medical, and public health
interventions aiming to increase uptake, all of which are discussed in detail below.
The findings for the second aim varied most from my hypotheses. Perception of affective
and cognitive dimensions of HIV risk were significantly associated with the perception of PrEP
candidacy. However, the age interaction was statistically significant, but in the opposite direction
of what I hypothesized for affective dimensions of HIV risk, and not statistically significant in
the cognitive risk association. As age increased, the association between affective dimensions of
HIV risk and the perception of self as a PrEP candidate strengthened. Further, in these models,
perception of PrEP candidacy only partially mediated the associations between affective and
cognitive dimensions of HIV risk and PrEP intentions. These findings were the most surprising
and are not consistent with the literature reviewed for this dissertation project. According to
Metcalfe and Mischel (1999), an affective ‘hot’ response to stimuli should weaken as an
individual develops, and ‘cold’ cognition becomes more consciously accessed. Similarly, the
ELM (Petty & Cacioppo, 2012) states that as an individual develops, they begin more frequently
accessing a more central route to processing for important decision making. Although I
anticipated that both affective and cognitive dimensions of HIV risk would be associated with
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the perception of oneself as a PrEP candidate, applying these dual-processing theories to these
new areas, I hypothesized that affective dimensions of HIV risk should have weakened as age
increased, and cognitive dimensions of HIV risk should have strengthened as age increased. The
data suggest that having a higher affective perception of HIV risk may lead to higher perceived
PrEP candidacy and intentions to begin PrEP. I theorize an explanation for these findings and the
many clinical implications below.
Unlike the first part of my second aim, I found support for almost all of my hypotheses in
the second. I found conditional main effects for both benefits of PrEP use and PrEP stigma on
PrEP intentions in the fully adjusted model, including the interaction variables. As expected,
perceived benefits of PrEP use were positively associated with PrEP intentions, and that
association became stronger with increased age. These findings suggest that as YSMM age, their
intentions to begin taking PrEP are guided by both their perceived benefits of use and also by
perception of stigma associated with use. PrEP stigma was negatively associated with PrEP
intentions, and this association became weaker with increased age.
Taken together, the findings of these studies suggest that in order to increase PrEP uptake
among HIV at-risk YSMM, there are access and developmental barriers that must be overcome.
These barriers are likely different for adult SMM, making current intervention models targeting
adult populations potentially ineffective in increasing uptake among YSMM.
One such barrier is access to PrEP without health insurance, or without having to use the
health insurance of a parent or guardian. In terms of identity development, even if an individual
has accepted their sexual identity, they may not have yet reached a point to where they are
willing or able to inform others of their sexual orientation. The process of coming out can be a
long and difficult one, and some YSMM may view this as a barrier they are unwilling or unable
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to overcome. Allowing such individuals to access the medication either for free or without the
use of their parent/caregiver's health insurance, may lessen this barrier and thereby increase
uptake.
Another potential barrier for YSMM is ‘hot’ and ‘cold’ processing of HIV risk. My
findings suggest that affective ‘hot’ processing may be more highly associated with PrEP
intentions through PrEP candidacy than cognitive ‘cold’ processing. This could be a barrier to
uptake as many YSMM may rely on how they are feeling in the moment, as opposed to critically
assessing their sexual risk behavior. Dimensions of HIV risk associated with PrEP use may also
be subconsciously connected with HIV acquisition, and therefore, responses triggered
affectively. The stigma of PrEP use may also affect dimensions of risk, which is discussed
further below. One other potential explanation for my findings is that my model did not test a
moderation term of age, affective, and cognitive dimensions of risk as a predictor. The addition
of this term in the model may explain more of the associations.
Lastly, perceived individual benefits and social costs were associated differently with
PrEP intentions. These findings suggest that individual benefits increased as age increased, while
PrEP stigma decreased as age increased. The stigma associated with PrEP use is discussed in
more detail below. In order to increase PrEP use among YSMM, it may be helpful to guide them
towards viewing more perceived benefits while simultaneously extinguishing stigma around use.
These findings and themes are discussed in further detail in the following sections.
Study 1: PrEP Use among YSMM
The first aim of this dissertation was to examine if age disparities in PrEP use exist
among SMM. Specifically, I aimed to examine if those who are 24 years of age and younger
have less experience with PrEP than those who are older. I tested a series of hypotheses that, if
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true, would support the idea that current interventions used to increase uptake among adult SMM
may need modification to incorporate the unique barriers YSMM face. In my first hypothesis, I
stated that those who are under 25 years of age would have lower odds of PrEP use experience
compared to those who are older. I also made several hypotheses about demographic and
behavioral risk differences that would be associated with PrEP use among both age groups. Last,
I hypothesized that those who were under 25 years of age and on their parent or guardian’s
health insurance would have lower odds of PrEP use. Results from these analyses largely
supported these hypotheses.
PrEP use among YSMM was lower than all other age groups. Bivariate analyses revealed
that both current and former PrEP use percentages were higher among higher age groups.
Current PrEP use was highest at 22% for those 35-44 years of age and then began to decline.
These findings show a curvilinear association, where increased odds of PrEP use were associated
with increased age, reaching its highest around the late thirties and early forties, then declines.
For those under 18 years of age, just over 1% reported current PrEP use, and just under 1%
reported former PrEP use. This provides further evidence that some individuals under 18 years of
age have been able to access PrEP even before approval by the USFDA for that age group. Due
to the USFDA restrictions that were in place when this data was collected, it logically makes
sense that those under 18 years of age would have less experience with PrEP use. However,
when data was collected, PrEP was already available for those between 18 and 24 years of age,
and this age group made up the smallest percentage of users (7.4%). This signifies that approval
of PrEP use alone does not necessarily increase uptake. Further, this is a strong indication that
PrEP is not being accessed by this highly at-risk population, and that current PrEP promotions
for this demographic are failing.
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The full multivariable models told a similar story. For YSMM, older age was associated
with odds of being both a former and current PrEP user. This could be due to many factors,
including an increase in sexual risk behaviors, sexual education, knowledge of PrEP, and access
to PrEP. In my analysis, I adjusted for sexual risk. However, I did not measure sexual education,
PrEP knowledge, or access to PrEP, all of which have been shown to impact PrEP use (Closson
et al., 2019; Doblecki-Lewis et al., 2017; Parsons, Rendina, et al., 2017; Strauss et al., 2017). I
also found that in the sample consisting of individuals 25 years of age and older, age was not
associated with odds of current PrEP use compared to never having used PrEP. However, age
was negatively associated with former PrEP use compared to never, and positively associated
with current use compared to former use. There may be barriers to initiating PrEP use that are
more easily overcome for adult SMM, and thereby making the continuation of a regimen easier
(Doblecki-Lewis et al., 2017). Erikson’s (1959), Levinson’s (1986), and Arnett’s (2000)
developmental theories suggest that as individuals enter adulthood, they have more stability,
including steady employment and income, and logically, thereby health insurance. These factors
likely increase PrEP feasibility and make long term use more appealing as a way of increasing
stability in sexual health.
There were many demographic and behavioral differences shown to be associated with
higher odds of current PrEP use. For YSMM, fewer demographic variables emerged as
significantly associated with current PrEP use. However, for adult SMM, there were many more.
This could be due to the multiple barriers that YSMM face when accessing PrEP, which are
beyond personal characteristics, and explored further in Study 2. In terms of race, only those who
identified as something other than the options presented were significantly less likely to be a
current user compared to White YSMM. Among adult SMM, many race differences were
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apparent with those who identified themselves as Black, American Indian or Alaskan Native,
Multiracial, or other, having lower odds of current PrEP use compared to individuals who
reported being White. Together, these findings suggest that as age increases the disparities
between PrEP use and race emerge, and if overall uptake of PrEP increased among YSMM,
those disparities may also emerge. Sexual minority individuals who are White have a lower rate
of HIV acquisition compared to people of color (CDC, 2018a). However, those who are White
make up almost 70% of all PrEP users (Ya-lin, Zhu, Smith, Harris, & Hoover, 2018). Disparities
in use are likely an outcome of both access (e.g., health insurance, cost, provider) and social
stigma. It is important that PrEP is made available to all racial and ethnic individuals at-risk.
Potential options for increase uptake among racial populations at-risk is discussed further below.
Differences in sexual orientation also appeared. Among YSMM, compared to those that
had never used PrEP, those who identified as bisexual had lower odds of being a former or
current PrEP user than those who identified as gay. Oppositely, those who identified as queer
had higher odds of being a former PrEP user. Trends were similar for adult SMM, however
among this group, identifying as queer was also associated with higher odds of being a current
PrEP user. There may be generational differences in sexual orientation identification. For
example, “queer” was presented as a sexual orientation option in this study, and research on
sexual identity has suggested that identifications have become more diverse in recent years,
leading to an increase in identities outside of gay, and bisexual (Watson, Wheldon, & Puhl,
2019). Having a queer identity is perceived as a spectrum that includes sexual attraction, sexual
behavior, gender presentation, and gender identity, making the identity far more complex and
nuanced then identifying as gay. Those who identify as queer may be involved in various aspects
of LGBTQ life, thereby presenting them with more opportunities to gain knowledge about PrEP.
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Similarly, due to having a more nuanced sexual/gender identity, identifying as queer may
broaden their spectrum of information or products that apply directly to them. In the literature
review for this project, I was unable to find other research that directly addressed PrEP
difference among those who identify as queer and gay. In this sample, identifying as queer was a
protective factor and was associated with more PrEP use. Conversely, identifying as bisexual
was associated with less PrEP use. Some research has shown that knowledge of PrEP and actual
PrEP use is lower among men who identify as bisexual (Hammack, Meyer, Krueger, Lightfoot,
& Frost, 2018; Holloway, Dougherty, et al., 2017; Okafor, Gorbach, Ragsdale, Quinn, &
Shoptaw, 2017). Those who identify as bisexual may view PrEP as something that is only for
gay men, and therefore not appropriate for them. This is discussed further below in the
implications for PrEP uptake.
In terms of geographic location, access to PrEP may not be the same for all adolescents.
YSMM who lived in the South had significantly lower odds of being a current PrEP user
compared to all other regions, aside from those in the military or another U.S. territory.
Similarly, adult SMM who lived in the South and the Midwest had lower odds of being a current
PrEP user compared to all other regions, again aside from those in the military or another U.S.
territory. These findings have been mirrored in other studies (aidsvu.org, 2018; Parsons,
Rendina, et al., 2017; Siegler et al., 2018; Sullivan et al., 2018), and provide further evidence that
changes need to be implemented in both non-coastal regions and the South to increase PrEP
uptake among those at risk. There are currently no federal guidelines pertaining to sex education
in the United States. Having PrEP education mandated into other safer-sex programs could
increase knowledge about PrEP and thereby uptake among all regions.
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Substance use behaviors were differently associated with PrEP use among YSMM and
adult SMM. For YSMM having recently used a drug was associated with higher odds of both
current and former PrEP use. However, having a recent day of heavy alcohol use was not
associated with either former or current PrEP use. These findings were mirrored for adult SMM
in terms of former PrEP use; however, for current PrEP use, recent drug and alcohol use were
both associated with higher odds of PrEP use. Some research has shown that PrEP use can be
associated with the use of party drugs (e.g., ecstasy, methamphetamines, cocaine) (Oldenburg et
al., 2016; Shrestha, Karki, Huedo-Medina, & Copenhaver, 2017). Further, the use of party drugs
is associated with more sexual risk behaviors (Folch et al., 2015; Halkitis & Parsons, 2002;
Rendina, Moody, Ventuneac, Grov, & Parsons, 2015; Sewell et al., 2017). This remains a key
population for PrEP utilization. It is important that more research is done on how to implement
more PrEP uptake among this at-risk population. Specifically, how are some YSMM who use
party drugs, gaining knowledge and access to PrEP while others are not? This particular question
could be easily answered with the use of survey data assessing PrEP knowledge and access to
PrEP among party drug users. Findings from that work would likely provide clear points of
intervention to help provide knowledge and access to those who using party drugs and are at-risk
for acquisition.
Having a recent STI diagnosis and recent CAS with an HIV statue unknown partner were
also differently associated with PrEP use among YSMM and adult SMM. For YSMM, having
had a recent STI diagnosis was associated with higher odds of both current and former PrEP use.
However, recent CAS with an HIV status unknown partner was not associated with PrEP use.
These findings were mirrored for adult SMM in terms of former PrEP use, however, for current
PrEP use, a recent STI diagnosis and recent CAS with an HIV status unknown partner were both
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associated with higher odds of PrEP use. For adult SMM, these findings suggest that their actual
sexual risk may be more related to actual PrEP uptake, however for YSMM, their actual risk may
not be as highly associated.
Although engagement in CAS with an HIV status unknown partner was not associated
with PrEP use among YSMM, being diagnosed with an STI was. There are a few different things
that may be going on which link an STI diagnosis to PrEP use. First, being diagnosed with an
STI may lead individuals to question their likelihood of acquiring HIV and thereby consider
PrEP use. This is supported by the HBM (Becker, 1974) that theorizes higher perceived
susceptibility is associated with a higher likelihood of engaging in health-promoting behavior.
Second, when an individual is diagnosed with an STI, the medical provider may also provide the
individual information about PrEP and helping them to navigate care. There are policy changes
that may be able to be implemented to ensure that knowledge and access to PrEP are provided at
all health clinics regardless of the population served. These potential policy changes are
described in more details in the implications section below. Third, for YSMM to access STI
testing and care, they may be more self-efficacious, have their own health insurance, or be at a
further stage in their sexual identity development. Those who are at a further stage in their sexual
identity development may be more open about their sexual orientation (Cass, 1979; SavinWilliams, 1990) and therefore more able to discuss risk with their provider and use their
parent/caretakers’ insurance.
The ELM (Petty & Cacioppo, 2012) would suggest that increased PrEP use associated
with a recent STI diagnosis could be explained by knowledge of PrEP being processed along the
central pathway upon diagnosis. The information may have been present before along the
peripheral pathway, but now perceived as more relevant and therefore lead to a perception of
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increased susceptibility and ultimately beginning a PrEP regimen. Additionally, being given an
STI diagnosis could also be interpreted as a cue to action and thereby increase the likelihood of
engaging in PrEP use.
Lastly, I hypothesized that YSMM who were on their parent or guardian’s health
insurance would have lower odds of being a current PrEP user. This hypothesis was supported.
YSMM who were on their own health insurance had higher odds of being both a current and
former PrEP user, than those who were on their parent or guardian’s insurance. Those without
any health insurance had the fewest odds of being a current and former PrEP user. This suggests
that having health insurance alone does not necessarily increase access to PrEP for YSMM,
especially if they are on their parent or guardians’. These findings can be explained by
examining identity development literature that suggests coming out to family is a pivotal role in
sexual identity development, however also one that YSMM report being extremely stressful
(Meyer, 1995; Rosario, Hunter, Maguen, Gwadz, & Smith, 2001; Ryan, 2001). For YSMM,
going on PrEP may mean having to discuss health insurance access with their parent or guardian,
discussing their sexual orientation as a reason for wanting access to the insurance, and also
potentially having to discuss their sexual behavior as reasoning for wanting to go on PrEP. Any
combination of these could be seen as large barriers to use for YSMM. It is also possible that
these individuals may not know their confidentiality rights in terms of medication use when they
are on someone else’s insurance. Future research may wish to assess participant’s ‘out’ness
about their sexual orientation in association with PrEP use, and additionally, what conversations
YSMM have had with their caregivers about protection from STIs and HIV. For some, helping
YSMM to begin these conversations with their caregivers may lead to increased PrEP uptake.
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There are also public health policies, discussed further below, that could be adapted and
implemented to help increase uptake among YSMM.
Together, this study provides evidence that when examining PrEP uptake among SMM, it
is imperative that researchers examine YSMM separately from adult SMM. In this research, I
chose to examine these age group by separating those who are 24 years of age and under from
those who are 25 years of age and older, then focusing solely on those 24 years of age and under
to assess what factors differentiate precursors to uptake among them. I believe these age
groupings would also be supported by some development literature, but not all. For example, the
literature on emerging adulthood suggests that the ceiling for age groups with this population
would be 29 years of age and not 24 (aidsvu.org, 2018; CDC, 2018a; Siegler et al., 2018). I
chose to separate the groups at 25 years of age based on the CDC and AIDSvu literature showing
that this population is highly at-risk and also least likely to engage in PrEP use, therefore, these
findings are easily able to be mapped onto their epidemiological and PrEP uptake findings.
Siegler et al. (2018) estimated that 11% of all PrEP users were 24 years of age and under. The
full sample of aim 1 showed that 12% of the total numbers of PrEP users were YSMM 24 years
of age and under.
In order to understand how PrEP uptake can be increased among YSMM at risk, we need
to understand how this population concludes that PrEP may be a viable option for them. Past
research has shown that in order to begin a PrEP regimen, an individual must first view
themselves as someone who is a PrEP candidate and then have intentions to begin taking PrEP
(Golub et al., 2013; Holloway, Tan, et al., 2017; Parsons, Rendina, et al., 2017; Rendina et al.,
2017). These variables have been heavily studied in adult populations of SMM, but less so in
populations of YSMM. Examining how YSMM assess their own HIV risk and intentions to
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begin taking PrEP, should provide evidence for the development of interventions that can help to
increase PrEP use among this highly vulnerable group. As such, HIV risk perception, and
individual and social factors associated with PrEP candidacy and intentions are examined in
Study 2.
Study 2: Psychological and Developmental Factors Associated with PrEP Candidacy and
Intentions.
The goal of Study 2 was to examine the associations between development factors that
may impede PrEP uptake among YSMM. I will first discuss the findings from the first part of
this aim, ‘hot’ and ‘cold’ cognition of HIV risk and age, associated with the perception of PrEP
candidacy and PrEP intentions. Next, I will discuss findings from the second part of this aim,
PrEP stigma and perceived benefits of PrEP use associated with PrEP intentions.
Affective and Cognitive Dimensions of HIV Risk on PrEP Candidacy and Intentions
The primary goal for part one of aim two was to examine the association between ‘hot’
affective and ‘cold’ cognitive dimensions of HIV risk and both perception PrEP candidacy and
PrEP intentions among YSMM. The set of hypotheses tested first examined the associations
between both affective and cognitive dimensions of HIV risk and PrEP candidacy, as moderated
by age. Specifically, I hypothesized that both affective and cognitive dimensions of HIV risk
would be significantly associated with the perception of self as a PrEP candidate; however, age
would moderate these associations. I hypothesized that the association between affective
dimensions of HIV risk and PrEP candidacy would become weaker with age, while cognitive
dimensions of HIV risk and PrEP candidacy would become stronger with age. Second, I
hypothesized, that perception of self as a PrEP candidate would fully mediate the association
between the risk perception variables and intentions to begin a PrEP regimen. Although there
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were many significant associations, my predictions were not entirely supported. Next, I briefly
present the broad findings from both sets of hypotheses and then examine the reasons that I
believe underlie these findings.
The second part of this aim was to test the associations between the affective and
cognitive dimensions of HIV risk and PrEP intentions through PrEP candidacy. In this fully
adjusted path model, I found that both affective and cognitive dimensions of HIV risk were still
significantly associated with PrEP intentions, even through the perception of self as a PrEP
candidate. Affective dimensions of HIV risk were still significantly positively associated with
PrEP intentions, and cognitive processing was significantly negatively associated.
The dual processing literature is expansive and contains a multitude of different models.
Metcalf and Mischel (1999) presented a model that suggests ‘hot’ and ‘cold’ processing run
parallel to each other, and nodes from within each connects over time, that lead to decision
making. Erikson’s (1959) theoretical eight stages of development state that adolescence stops
around 18 years of age, and adulthood begins. At this point, he theorizes decisions are made with
more focus on the future and long-term goals (i.e., ‘cold’ processing and planning). Levinson
(1978) theorized similarly, and suggested attention moves towards “me” and “not me,” again,
eliciting ‘cold’ processing around decisions that pertain to who an individual is, and what they
want for their future. Taken together, I hypothesized that as individuals age, the pathways
between affective and cognitive processing become more solidified, and ‘cold’ cognitive
processing becomes more prominent in goal-oriented behavioral decisions (e.g., staying HIVnegative). As such, I hypothesized that both affective and cognitive dimensions of HIV risk
should lead to more perception of oneself as a candidate for PrEP and PrEP intentions, and these
associations would change with age. This was not the case.
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First, these findings may be understood as consistent with Arnett (2000) and his theory of
emerging adulthood. He suggests that, due to the changes in westernized civilizations, the
transition from childhood to adulthood is not as abrupt, and individuals are able to spend more
time becoming independent adults. If this is true, then the timelines set forth by such researchers
as Erickson and Levinson may no longer be entirely applicable to current generations.
Second, the ELM (2012) theorized there are two pathways to information gathering or
stimulus intake, the peripheral and central. I incorrectly assumed that those who are YSMM
would intrinsically know the behaviors they are engaging in are risky for HIV acquisition, thus
confirmed via the central route of processing. However, their perception of risk may be more
influenced by the peripheral route, where perhaps they have the knowledge but have not yet
applied it to themselves. In their work, these authors draw a parallel between ‘hot’ and ‘cold’
cognition, and the central and peripheral routes. They suggest that ‘cold’ processing is most
similar to the central route, as it requires conscious effort, whereas the peripheral route is most
similar to ‘hot’ processing, and happens without conscious effort. Since these participants seem
to be making more accurate decisions about their PrEP candidacy via ‘hot’ processing,
information about PrEP and HIV they are receiving peripherally should be further examined. The
measurement for affective dimensions of HIV risk used in this study also requires some
cognitive processing as even asking how someone feels about their risk could trigger selfreflection of actual behavior and risk. Examining variables that may mediate this association,
should it exist, may help to increase uptake while simultaneous decreasing stigma.
Third, and last, affective dimensions of HIV risk were positively associated with PrEP
intentions, and partially mediated through PrEP candidacy. Cognitive dimensions of HIV risk
were negatively associated with PrEP intentions and partially mediated through PrEP candidacy.
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YSMM who utilize more cognitive ‘cold’ processing to make determinations about their sexual
risk, may be less likely to begin a PrEP regimen, compared to those that respond via more
affective ‘hot’ processing. Because ‘cold’ cognitive processing requires conscious effort
(Metcalfe & Mischel, 1999), it is important to investigate what thoughts and information YSMM
are using to assess their sexual risk. Sexual arousal has been linked to making quicker decisions
about risk and relying on the intuition of HIV status (Ariely & Loewenstein, 2006; Lowy &
Ross, 1994; Strong, Bancroft, Carnes, Davis, & Kennedy, 2005). It is possible that decisions
made when at elevated affect may also influence later perception of the event. For example, if an
individual utilizes quicker affective processing of the risk, they may be more likely to recall that
event utilizing the same processing, thus not reflecting on the decision utilizing all the
information available (i.e., how they knew the other’s status, or if the event was risky). Thus, the
information they are utilizing may not be accurate to their own behaviors.
The aim of this study was to examine how affective and cognitive perception of risk may
impact PrEP intentions among YSMM. Understanding risk perception has been a goal of many
HIV researchers have been asking since the beginning of the HIV epidemic and the question
addressed within this study. Although I found support for differences in type of risk perception,
it is unknown if the difference will lead to actual PrEP uptake. If the discordance between
objective and subjective risk hasn't changed in the last 30 plus years, there is little chance it will
now, even with advances in preventative medication.
One challenge with this study was whether the measures of risk perception adequately
captured differences in risk perception. It is well documented that fear of HIV is lower among
YSMM compared to adult SMM (Denison et al., 2015; Giménez-García, Ballester-Arnal, GilLlario, Cárdenas-López, & Duran-Baca, 2013; Prati, Mazzoni, & Zani, 2015; Woollett, Cluver,
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Hatcher, & Brahmbhatt, 2016), which may make risk perception less relevant for younger
populations. Covello and Johnson (1987) argued that risk is determined by social constructs,
such that risk perception can be heightened and lowered based on not only the knowledge of risk,
but also social, cultural, and moral acceptability of the action. To this degree, the scales used in
this study were successful in tapping into the participants perceptions of how others view those
on PrEP. Somewhat oppositely, others have suggested that risk can be determined based on if
the action is voluntary or involuntary (M. Finucane, 2000). In terms of sexual risk, those who are
engaging in sexual risk behavior and view their actions as voluntary are more likely to view the
behavior as less risky compared to those that view their behaviors as involuntary. The scale used
for this study did not ask about the individuals' perception of their control over their behavior,
which may be an important construct to consider with this population.
Although fear of HIV is largely decreasing among younger populations, fear may still
play a significant role in information processing (M. L. Finucane, Alhakami, Slovic, & Johnson,
2000). Fear of negative outcomes may result in implicit biases (Bar-Haim, Lamy, Pergamin,
Bakermans-Kranenburg, & Van Ijzendoorn, 2007) and impact risk perception (Lerner, Gonzalez,
Small, & Fischhoff, 2003; Lowenstein & Lerner, 2003), which means those who fear HIV also
perceive their likelihood of HIV acquisition to be higher. In some cases, this is accurate, a selffulfilling prophecy. Butler and Matthews (1987) found that students who feared failing on an
exam were more likely to fail the exam. As related to PrEP use, those who have increased fear of
HIV may reject PrEP due to the current stigma associated with use. They may fear being
associated with the medication and thereby HIV. In this way, their fear may actually put them at
more risk compared to someone who is not afraid of this association. By decreasing PrEP related
stigma, fear should decrease, and thus uptake increase.
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In this study I examined affective and cognitive perception of risk, however all
behavioral decisions are not determined by either affective or cognitive decision making.
Individuals also make many decisions or come to conclusions from their baseline state, or default
mode (Raichle et al., 2001). This is a mode in which thinking is occurring based on past
behaviors, knowledge, or social expectations that are not consciously calculated. With the use of
fMRI studies, it's been shown that default mode may be active while an individual considers
themselves (e.g., autobiographical information), while thinking about others (e.g., others
thoughts, feelings, moral reasoning, social categories), and while thinking about both the past
and future (e.g., episodic memory) (Andrews-Hanna, 2012).
In terms of HIV risk and PrEP uptake, not all participants may come to conclusions about
their sexual risk behavior via either affective or cognitive processing, some may via their sexual
risk from a baseline of function, their default mode. At this time, it is unknown what role default
mode may make in sexual decision making or PrEP uptake. However, the research conducted by
Andrews-Hanna (2012) included conducting fMRIs on participants while they were instructed to
consider different topics. Sexual behavior was not covered in their study, but could later be
examined. If decisions or thoughts around sexual decision making are considered in default
mode, it may be possible to create an experiment where participants are separated into three
groups, those with no PrEP knowledge, those with prior PrEP knowledge and no intentions to
begin taking PrEP, and those with prior PrEP knowledge and intentions to begin taking PrEP.
Participants would then receive an fMRI after being asked to consider their further sexual health.
If there are not significant differences among the groups, it's possible that sexual health decisions
around PrEP may also be considered within default mode. Given the wide variety of topics that
are able to be considered while staying in default mode, there are many different intervention
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points (e.g., past behaviors, social expectations) that could be utilized including decreasing
stigma and increasing benefits to use.
Although risk perception and fear may be a cue for some individuals to further
investigate PrEP use, even if they view themselves as being at risk, there are many parental
factors that may impede individuals from going on PrEP. These factors are described in further
detail below, as well as potential interventions that could be implemented to mitigate these
restraints. If there are significant restraints duo to these factors for YSMM, interventions
targeting risk perception may not be as valuable as interventions aiming to engage parents in
sexual health promoting behaviors benefiting YSMM. Further, for this population, risk
perception may not be as important as for those who are older. If Covello and Johnson (1987) are
correct, one way to increase PrEP uptake regardless of risk perception may be to destigmatize
PrEP use, making it more morally acceptable, as well as in society and culture.
PrEP Stigma and Perceived Benefits of PrEP Use on PrEP Intentions
The primary goal for the second part, two of aim was to examine how PrEP stigma and
perceived benefits of PrEP use are associated with intentions to begin a PrEP regimen. I
hypothesized that more perceived benefits to PrEP use and lower PrEP stigma would be
associated with higher PrEP intentions. Further, I hypothesized that these associations would be
moderated by age, such that as age increases, the association between perceived benefits and
PrEP intentions would strengthen, whereas the association between PrEP stigma and PrEP
intentions would weaken. These hypotheses are guided by the developmental theories of Erikson
(1959), Levinson (1978), and Arnett (2000), and Prototype Willingness dual-processing model
(Gerrard et al., 2008). These developmental theorists all believed that as individuals age, they
become more focused on positive outcomes for themselves, whereas when they are younger,
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they are more focused on positive social outcomes. Gerrard’s dual-processing model all stated
that individuals who are younger likely make more decisions based on social reaction, as
opposed to reasoned action. In these associations, perceived benefits of PrEP use refer to
potential positive outcomes for the individual, and PrEP stigma refers to potentially negative
social outcomes. These hypotheses were supported by my findings.
This evidence suggests that as YSMM move towards adulthood, the perceived benefits of
PrEP use increase and stigma associated with PrEP use decreases. Again, developmental theories
state that at this period of life individuals begin to set concrete goals for their future and focus
more on their own individual selves as opposed to how they think others may perceive them
(Arnett, 2000; Erikson, 1959; Levinson, 1978). These findings support these developmental
theories.
The Prototype Willingness Model of dual processing (Gerrard et al., 2008) states that
individuals make behavioral decisions based on reasoned action and social reaction. Reasoned
action and subject norm are closely related to the TRA for health behavior and theorizes that
when an individual is focused on how a perceived health-promoting behavior positively impacts
the individual, they are more likely to enact that behavior. Conversely, decisions made due to
social reaction, are focused on the perception of how others will perceive the individual. This
explains the results of these findings. Those who perceive more individual benefits to PrEP use
had more intentions, and those who were more concerned that others might negatively perceive
their use had lower intentions. The association between benefits and intentions strengthened with
an increase in age, while PrEP stigma decreased, again both providing evidence for
developmental theories suggesting that the individual becomes more important from the crowd
as they age. However, to increase uptake among YSMM, it may be useful to focus on any
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positive social aspects of PrEP use, like staying HIV-negative. Focusing on individual personal
benefits of use may not help move those who are younger towards increased intentions.
There are varying types of stigma examined throughout literature. Stigma is broadly
defined as a social process characterized by exclusion, rejection, and blame or devaluation about
a person or group (Earnshaw & Chaudoir, 2009). Stigma operates by influencing an individual's
thoughts and thereby behaviors based on avoiding negative appraisal from self or others. At the
person level, stigma can be conceptualized across three areas including experienced, anticipated,
and perceived, all which can be experienced via self or society (Sheehan, Nieweglowski, &
Corrigan, 2017). Individuals may feel stigma across any combination of these domains, and each
combination may influence behavior differently.
The measure used for this study examines stigma through the lens of both perceived and
anticipated stigma (i.e., how someone views others and how they expect they will be viewed).
Specifically, this scale measures responses to questions that ask about how the participant views
those who use PrEP and thereby how they anticipate others would view them. This measure did
not examine experienced stigma, which could be also be a factor for this sample. Experienced
stigma is different from the other two measures, it taps into experiences an individual has already
have pertaining to the desired behavior (i.e., going on PrEP). Stigma can be experienced in a
variety of different ways and some participants may have experienced stigma related to potential
PrEP use via conversations about PrEP with providers, friends, or sexual partners. Similarly,
PrEP is made up of a medication used to treat HIV, and thereby associated with HIV and HIV
risk, a health factor that carries its own stigma.
Future studies that examine stigma and PrEP use would benefit from utilizing a variety of
stigma questions that tap into all three domains of stigma, as one may be more predictive of PrEP
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use intentions than others. It may also be beneficial to include measures of HIV related stigma
and examine associations between HIV and PrEP stigma. This association has been heavily
studied among adults (Calabrese & Underhill, 2015; Dubov et al., 2018; Eaton et al., 2017;
Franks et al., 2018; Golub, 2018; Grace et al., 2018; Haire, 2015) and less among younger
populations. Some studies have shown that HIV is less stigmatized among younger populations
(Dubov et al., 2018; Harper, Lemos, Hosek, & Interventions, 2014) and as such, PrEP stigma
may be experienced less by YSMM compared to those who are older. Changes in public policy
and among health providers could also lead to decreases in stigma and are discussed further in
the following section.
The potential for HIV seroconversion is high among YSMM (CDC, 2018a), before an
individual may change the focus of their decision making. These findings suggest that perceived
benefits of PrEP use were lower, and PrEP stigma was higher, for younger YSMM. As such,
those who are 16 years old are likely experiencing the most PrEP stigma and focusing on the
benefits for this population as opposed to reducing stigma may lead to increases in PrEP use.
This finding has clear clinical implications, which are explained more below.
Clinical, Medical, Public Health and Policy Implications
The research conducted and findings in this project contribute to current literature by
providing the first large scale look into potential differences in processing and social factors that
may directly impact how YSMM make decisions about PrEP use. Simply providing YSMM with
knowledge about and access to PrEP may not be enough to help them engage in use. For young
people, there are many developmental factors that play a role in the decision to use PrEP, which
could be affective, cognitive, or default thought processes, the importance of social acceptance,
and family factors like 'out'ness. Additionally, there are important policy factors, like having
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health insurance and confidentiality for minors and those are on their parent's health insurance.
One of the largest takeaways from this project is that if we, as researchers or clinicians, attempt
to increase PrEP uptake in the same ways it is attempted among adults, these interventions will
surely fail. However, we are not starting from zero, there are many sexual health interventions
that have been developed and implemented, which could easily be adjusted to include sexual
orientation and other HIV prevention techniques besides abstinence and condom use (i.e., PEP
and PrEP).
I have demonstrated that PrEP uptake is lowest among YSMM and that multiple
developmental factors may impact their decisions around PrEP use. Specifically, for YSMM,
their perception of HIV risk, perceived benefits of PrEP use, and PrEP stigma all significantly
impacted their intentions to begin taking PrEP. Further, compared to those on their parent or
guardian’s insurance, individuals on their own health insurance had higher odds of being a
current PrEP user, and more PrEP intentions. These are all areas where clinical mental health,
medical, and public health interventions may help to guide at-risk YSMM towards PrEP uptake.
Mental health clinicians who are working with HIV at-risk YSMM may want to discuss
the individual’s thoughts about the potential for HIV acquisition. This could include assessing
how the individual views their own sexual identity and if that identity aligns with who they
believe PrEP is intended to be used by. This treatment could also include assessing where an
individual is in terms of their outness. Sexual identity literature suggests that identity
development is a process (DuBay, 1987; Erikson, 1959; Milton & MacDonald, 1984; Troiden,
1988) and knowing where a client is in their process may help to guide what aspects of coming
out are stopping them from engaging in a regimen should they be interested. Going on PrEP
requires going to regular appointments, discussing sexual risk behaviors with a medical provider,
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paying for the medication, appointments, and testing (USFDA, 2012), and potentially utilizing a
parent or guardian’s health insurance. Helping a client become more comfortable with their
sexual orientation and identity, and disclosing to others when safe, could weaken some barriers
to uptake.
Addressing how individuals view their own risk behavior and their beliefs around the
possibility of seroconversion may address their cognitive dissonance around their risk behaviors.
My findings suggest that if an individual is at risk for HIV, but focuses entirely on their ‘cold’
cognitive processing, they may be less likely to view themselves as a good candidate for PrEP.
However, if individuals address their risk affectively, they may be more likely to view
themselves as a candidate. In some ways, this finding suggests that fear of HIV acquisition may
drive some people towards PrEP use, which is contrary to theories suggesting fear of an outcome
may lead to higher chances of the undesired outcome (Butler & Mathews, 1987). Increasing fear
of HIV is unlikely to increase PrEP uptake and more likely to create additional stigmatization of
HIV-positive people or the LGBTQ community as a whole. Using PrEP during one period also
does not guarantee continued use during all periods of increased risk, and it’s possible that
someone who was once on PrEP may become HIV-positive in the future. If HIV fear was used
previously to get that person on PrEP, as an HIV-positive person, they might have more
internalized stigma. Additionally, if a client does not perceive many pros to going on PrEP, or
anticipates experiencing stigma related to PrEP, it may be important to address these beliefs.
This may include discussing the benefits of PrEP use, while also addressing how they believe
others may view them for using PrEP (i.e., reasoned action versus social reaction).
Cognitive-behavioral therapy (CBT) and motivational interviewing (MI) are two
behavioral change toolsets that have been utilized in various interventions addressing sexual
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behaviors among SMM (Hart, Tulloch, & O’Cleirigh, 2014; Melendez-Torres & Bonell, 2014;
W. R. Miller & Rollnick, 2012; Pachankis, Lelutiu-Weinberger, Golub, & Parsons, 2013;
Parsons, Lelutiu-Weinberger, Botsko, & Golub, 2014; Rollnick & Miller, 1995; Starks, Dellucci,
et al., 2019; Starks, Doyle, Shalhav, John, & Parsons, 2019; Starks et al., 2018; Starks &
Parsons, 2018). CBT is a psycho-social therapeutic intervention that aims to change maladaptive
thoughts, feelings, and behaviors by addressing how these mechanisms all influence each other.
Theoretically, by intervening on an individual’s thoughts, feelings, or behaviors, the pattern
between the three will slowly be broken, and a new pattern emerges.
In addition to CBT, MI has also been incorporated in health behavior change. MI is a
behavioral change technique based on the Transtheoretical Model of Change and focuses on
using an individual’s own intrinsic motivation for change (Rollnick & Miller, 1995). Much of the
work associated with MI has focused on the pros and cons of behavior changes while providing
the individual with unconditional support in whatever decision they make. As a technique, MI is
targeted on overcoming ambivalence about a particular behavior; however, the therapeutic
approach is that the behavior change is not valued as either positive or negative.
Both CBT and MI are currently being used in interventions aiming to decrease sexual risk
among YSMM populations. The Young Men’s Health Project (YMHP) is a 4-session MI
intervention for YSMM aimed at decreasing sexual risk and substance use, and increasing PrEP
use (Parsons et al., 2019). This intervention includes a novel approach to treatment as the
intervention is currently underway in three cities across as the U.S., as well as online via
telephone and video conference to reach broader participation. The Intervention is currently
underway and will compare outcomes among the participants who met in person versus those
that met virtually. If there are no significant differences in the outcomes of this intervention
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between the two intervention groups, this intervention would provide evidence that mobile
clinical interventions are possible that reach those who are at risk for HIV in rural areas.
Project: PARTNER is a 4-session one-to-one intervention utilizing MI aimed to help
YSMM who are in relationships navigate safer-sex behaviors (Starks, Robles, et al., 2019).
Along with MI, this intervention also uses videos showing couples engaging in both functional
and dysfunctional discussions about sex outside of the relationship, condom use, and PrEP use.
Targets of this intervention include HIV risk reduction, increased PrEP use, and decreased
substance use. HIV transmissions among men in relationships is high in the U.S., and such an
intervention could help to decrease this transmission disparity as well as educate YSMM on how
to have discussions about safer sex practices with future partners. This project is currently being
tested in NYC among 240 partnered YSMM and is expected to be completed in 2021.
As a technique, MI around PrEP use may help YSMM overcome ambivalence about
PrEP use. This conversation may include risk perception and provide the clinician with
information about how the individual views their behavior without telling them they are
engaging in risk or providing them with information they are not ready to hear (e.g., “you’re
engaging in risk and should go on PrEP”). MI would allow the individual to come to their own
conclusions about their risk by confronting cognitive dissonance. Another benefit to MI is it
would allow them to explore their concerns about HIV and the benefits and cons of going on
PrEP. Further, it would allow the participant to engage in a conversation about their specific
barriers to use that may or may not include being on their parent or caregiver’s insurance and
coming out.
MI has been shown to be highly effective in behavioral change when conducted in
medical settings (Lundahl et al., 2013; Resnicow et al., 2002; Rollnick, Heather, & Bell, 1992).
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Basic training on MI and PrEP uptake in the medical community could help those who are in
rural areas gain information and access to PrEP. Basic MI skills training can be conducted at
both minimal time and cost. Intervention utilizing MI to increase PrEP uptake has been
conducted in multiple sessions, however future research could easily assess PrEP uptake
outcomes following participants who engaged in brief conversations with providers. One way to
test this would be to compare outcomes of PrEP uptake among YSMM who speak with a
medical provider who utilizes MI around PrEP use versus a provider who does not utilize MI
around PrEP use. Further providers should come from LGBTQ affiliated practices, general
community providers, and private providers. Utilizing providers across these domains should
result in a sample that varies in openness about sexuality and socioeconomic status. If results
from this study show that short conversations utilizing MI result in increased PrEP uptake, it may
be easy to implement the intervention across various settings.
Specific to the variables examined in these studies, utilizing a CBT framework to address
‘hot’ and ‘cold’ processing in HIV risk perception could lead to changes in PrEP uptake, but
could also be risky. My findings showed that increasing ‘cold’ cognitive dimensions of HIV risk
might not lead to PrEP uptake. For example, if an individual does not feel or believe their risk
behavior is risky, a clinician could help to examine the thoughts and feelings that lead to the
individual not believing their behavior is risky, but this may move the individual further from
uptake. Based on the findings from these studies, the chances of increasing PrEP uptake may be
found in focusing on helping an individual perceive more benefits to their PrEP use, and
decrease stigma associated with use.
Education around PrEP use may also be a key point for intervention. A
HealthMpowerment program was run in Vancouver, Canada and offered participants of the
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longitudinal study the opportunity to attend two peer-led HIV program classes (Closson et al.,
2019). They found that YSMM who attended at least one of the two classes had statistically
significant higher knowledge on PEP, PrEP, and TasP compared to those who did not attend any
of the classes. Additionally, those who attended the classes reported higher HIV treatment
optimism, suggesting less HIV stigma following the classes. The authors did not report on
changes in PrEP stigma. However, as HIV stigma decreased it is also possible that PrEP stigma
decreased. As such, not only might those who attended the class be more likely to use PrEP in
the future, but they may also be more likely to be supportive of those in their social group who
decide to use PrEP. Based on the findings of this dissertation project, this may be an effective
intervention to decrease PrEP use.
Another HealthMpowerment intervention utilized a strength-based online approach to
help Black YSMM and adult SMM overcome barriers to HIV prevention and care (Barry et al.,
2018). Participants were encouraged to log onto the intervention website and communicate with
the other participants via messages boards. The messages posted were then analyzed for content.
Four primary resilience themes emerged among the messages, including exchanging support,
engaging in health-promoting cognitive processes, enacting healthy behavioral practices, and
empowering other YSMM. Engaging YSMM in social networks that support each other and their
sexual health may lead to a decrease in HIV and PrEP stigma, thus increasing other’s likelihood
of engaging in use. Further, those who are already able to engage in care may be able to help
others access care and answer the questions they have.
Along with mental health clinicians, medical providers also have the ability to affect
PrEP uptake. Research literature has shown that medical providers have varying views on
prescribing PrEP overall (Adams & Balderson, 2016; Blumenthal et al., 2015; Tellalian,
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Maznavi, Bredeek, & Hardy, 2013). Some have stated concerns about the long-term side effects
of the medication, while others have stated they do not feel comfortable prescribing the
medication due to sexual behavior concerns (Adams & Balderson, 2016; Blumenthal et al., 2015;
Karris et al., 2013; Tellalian et al., 2013). Others are unfamiliar with PrEP (Hart-Cooper et al.,
2018; Petroll et al., 2017; Tellalian et al., 2013; Tiu & Robles, 2019). The latter of these has
decreased over time (Smith et al., 2016; Turner, Roepke, Wardell, & Teitelman, 2018).
However, the first two could highly impact someone’s ability to access PrEP, even if there are no
other barriers.
Aside from a medical prescribers opinion of the medication itself, the Purview Paradox
(Krakower et al., 2014) states that some medical and primary care providers may believe PrEP
care is outside the scope of their practice, while HIV specialists also view PrEP as outside their
practice, leaving the potential user with fewer options. Many of these providers do not believe
they have the time to access risk, complete periodic testing, and quarterly medical appointments
for refills. Due to the somewhat complexity of maintaining a PrEP prescription, some providers
have simply said they do not prescribe PrEP. Some medical programs have begun teaching MI as
part of training to aid in health behavior change (Daeppen et al., 2012; Martino, Haeseler,
Belitsky, Pantalon, & Fortin IV, 2007; Poirier et al., 2004). Including MI training that pertains
specifically to sexual health would be beneficial and should include not only how to discuss
sexual health with YSMM. Specialized training in PrEP care may alleviate some of the abovementioned barriers for medical providers.
My finding that a recent STI diagnosis is associated with a higher likelihood of being a
current and former PrEP user highlights the important role for medical providers to be
knowledgeable about PrEP. Although I am inferring from these findings, it is possible that this
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association is due to potential PrEP users being offered information about PrEP and potentially a
prescription when they are diagnosed with an STI and thereby viewed as at-risk. If this is the
case, it may also be possible to expand PrEP uptake by expanding access to STI testing. STI
testing providers likely play a particularly influential role in increasing uptake among those atrisk. Specific guidelines put forward from the CDC or WHO about how to address risk and PrEP
uptake with YSMM would likely be helpful. Additionally, if it is true that YSMM are making
decisions about PrEP based on potential stigma, benefits to use, and affective processing, how
risk is discussed becomes more important.
Risk perception and appropriateness for use if not solely the responsibility of the
potential user, but also that of the medical provider. Degrees of risk may be valuable to
understand further decision making for potential users, any risk (intentional or planned) that
could lead to HIV acquisition should be interpreted as meeting the threshold for PrEP initiation
and thus prevention initiated from a provider standpoint. My findings suggest that being at-risk
does not necessarily mean a potential user will intend to begin taking PrEP, and thereby not
initiate a conversation with their provider. It is a provider's job to initiate conversations with their
patients around risk and help the patient to make a change in their prevention technique. One
way of doing this may be to focus on the benefits of PrEP use for the patient. Providers should
engage in brief conversations with their patients about the benefits of use versus asking their
patients why they think they need it. Focusing on the benefits of use could also positively impact
adherence should the patient decide PrEP use is right for them. If PrEP use is viewed as the
default for those who are potentially at-risk, the conversation changes from convince why I
should give you this medication to tell me all the ways PrEP may benefit you. This approach
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would allow the potential user to briefly reflect on what strategies their using, while also
considering PrEP.
Public health interventions have also been utilized to educate individuals about sexual
health. Safe in the City is a series of short videos totally 23-minutes that was shown in waiting
rooms or medical centers from 2003-2005. The series showed individuals and couples discussing
sexual behaviors and sexual risk. Findings from this intervention resulted in a 10% decrease in
new STI infections for those that were in the waiting rooms with the videos compared to those
that were in waiting rooms without the videos. Currently, there is another intervention being
conducted in San Francisco that uses the same format as Safe in the City, but the topic of the
series revolves around PrEP use, condom use, and continuation of condom use while taking PrEP
(Cardwell, 2018). Outcomes being tested with this intervention include increased condom use
and decreased STI. Results from this intervention are expected in 2021. Videos that include
information about PrEP use and being utilized in public places should be careful to only include
empowering messaging and avoid language related to “risky behavior” as it may stigmatize the
use of the medication.
Public health policies also need to be adjusted to incorporate the unique barriers that
YSMM may face when attempting to engage in PrEP use. One particularly salient finding from
this research is the role of health insurance access and the importance of being able to access
PrEP without a parent’s health insurance. Mental health providers may be able to utilize MI to
help some YSMM overcome health insurance barriers by increasing their self-efficacy, but
public health policies that can directly affect a larger population will make a bigger difference.
Most major metropolitan areas in the U.S. offer PrEP at low-cost or for free through
LGBTQ organizations or other community resources, but these are generally for the uninsured,
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so being on a parent’s health insurance could limit this access pathway. Further, some YSMM
may not feel comfortable accessing care through an LGBTQ organization due to issues around
outness and sexual identity development. For example, an individual may be engaging in sexual
risk with other sexual minority men, but not identify as LGBTQ and therefore not want to access
care through those avenues.
Public health policies should also target sexual education across the U.S., which there is
currently no federal guidelines. Although beyond the scope of this project, comprehensive sexual
education has been shown to be predictive of lower STIs and lower unplanned pregnancy
compared to other or no sexual education (Kirby, 2008; Kohler, Manhart, & Lafferty, 2008;
Stanger-Hall & Hall, 2011). Comprehensive sexual education should also include material on
other HIV prevention methods than only condoms. Providing information on PrEP, PEP, and
TasP would likely decrease stigma about use if the information is presented in an empowering
way that focuses on sexual health and not risk.
The above-mentioned interventions and promotion all focus on the patient directly,
however targeting the parents of potential users is also important for YSMM. A recent metaanalysis (Santa Maria, Markham, Bluethmann, & Mullen, 2015) reported that parent-child
interventions which focused on sexual health have been shown to result in significant increases
in communications, parent comfort discussing sexual topics, and decreases in sexual risk
behaviors among adolescents. Interventions varied in terms of modality, length, and involvement
of youth. At the time of this meta-analysis, no interventions had been tested that examined
outcomes among parents of known sexual minority youth. However, based on their findings, it is
possible that many of the following interventions could be adjusted for the needs of parents with
sexual minority kids.
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A Miami based intervention, and the most intensive in terms of treatment that I'll be
discussing in this paper, took place over three-months, included separate group meetings for
parents and youth, eight sessions, each lasting two hours (Prado & Pantin, 2011). Additionally,
these participants engaged in at-home family therapy for four one-hour sessions. Sessions
included sexual education and communication skills for both parents, youth, and peers.
Specifically, parents received training on being supportive and aiding their youth in decision
making. Youth received training in how to respond to peer pressure and increase self-efficacy,
pertaining to substance use and sexual behavior. Compared to the control group, youth in the
intervention group reported fewer STI's, higher chances of condom use at last sexual intercourse,
and increased parental-child communication. There were however no differences in terms of
substance use between the control and intervention group. Youth sexual orientation was not
reported, and as such, how this intervention may have impacted sexual minority youth or their
caregivers is unknown. Further, outside of condom use, other forms of protection were not
included (i.e., PrEP). Although this appears to be a highly effective intervention for decreasing
sexual risk, the time involved is potentially more than some families may be will to engage. The
following interventions have similar results, however are less time consuming and more
accessible.
One community-based intervention in Atlanta aimed to increase sexual communication
among fathers and sons, including topics pertaining to HIV, STIs, and condom use (Dilorio,
McCarty, Resnicow, Lehr, & Denzmore, 2007). This intervention consisted of seven two-hour
session, six with the fathers alone and the seventh including their sons. Utilizing social cognitive
theory, sessions included how personal, environmental, and social factors can have an effect on
decision making among young men. Sessions included videos, discussion, and role-playing as
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tools to guide communication skills training and provide sexual education. Fathers and their
sons completed three follow-ups at three, six, and 12-months following their initial assessment
before beginning the intervention. Results indicated that compared to the control group, fathers
who were part of the intervention group reported both increased sexual health discussions and
increased intentions of discussions with their sons. Sons in the intervention group, compared to
those in the control group, reported higher rates of abstinence and condom use, and significant
delays in sexual initiation. From this research, it is unclear what discussions, if any, included
topics of sexual orientation or sexual health among minority populations. An intervention similar
to this that includes all fathers of sexual minority young adults could be developed and
implemented with goals to increase communication about sexual health and other methods for
maintaining sexual health, including PrEP and PEP use. It is also possible that an intervention
specific for this population could result in a community of men who may be experiencing similar
unique barriers to sexual communication due to their child's sexual orientation.
For parents or children who are not able to engage in-person for sexual education and
communication training, online or computer assisted sexual education may also be effective. An
intervention developed and tested among Latino families, a population at increased risk for HIV,
resulted in increased sexual communication and parental comfort discussing sexual behaviors
after only two short sessions (Villarruel, Loveland‐Cherry, & Ronis, 2010). The first session
included educational materials about HIV/AIDS and STI's, as well as skills to overcome barriers
to sexual communication. Printed out homework was assigned to the participants to discuss with
their children between sessions. The second session occurred approximately one week after the
first and included further materials on communication skills. Parents and their children were
reassessed 3-months following the second session and compared to a control-wait group. Results
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showed increased sexual communication and comfort from the parents, as well as endorsement
of sexual communication from their children when compared to the control group. Together,
both sessions equaled 60-minutes, making the intervention short, effective, and easily accessible.
With the continued growth in technology, online interventions are becoming more
popular and may be a necessity for parents of YSMM. Online or technology-based interventions
will allow parents that are in rural areas, where access to LGBTQ groups or sexual education
may be less accessible, to acquire communication skills and knowledge pertinent to decreasing
sexual risk among their offspring. Due to some social stigma that is still prevalent, some parents
of LGBTQ youth may find sexual education online versus in-person more comfortable.
Technology based interventions focused on sexual health among parents of LGBTQ youth
should include information about PrEP and include outcomes measuring parental acceptance of
PrEP and comfort in communication pertaining to PrEP.
Interventions that target the parent-child relationship are one way to attempt to increase
PrEP use, however there are policy barriers as well. There are currently no federal policies in the
United States that protect the confidentiality of minors (those under 18 years of age) in
healthcare settings when attempting to access PrEP (Boldt, 2012; Burda, 2015). Laws for minors
and confidentiality protections vary state-by-state, and can broadly be broken down into three
categories, those that allow diagnosis and treatment of STIs, those that allow care for and
prescriptions for STIs, and those that include preventative care (e.g., PrEP) (Burda, 2015). At
this time, there is no consensus about exactly where PrEP falls, and it could be argued for all
three categories. Physicians in states that allow diagnosis and treatment for STIs could argue that
PrEP is not covered because it is preventative care and requires multiple appointments.
Physicians in states that allow for care and prescriptions could again argue that PrEP is not
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covered. States that do allow preventative care would protect a minor's confidentiality, however
only seven states have these laws in effect. For the other 43 states, minors are not guaranteed
confidentiality when accessing PrEP, which could be a barrier. Further, even in the seven states
where confidentiality is protected by law, YSMM may not know the laws and other interventions
may be necessary.
First, adding preventative medicine to legislature in all U.S. territories would allow
minors to access PrEP without needing to disclosure their sexual orientation or sexual behaviors
to their parents. Second, requiring sexual education to include information on preventative
medicine, including PrEP and PEP use, would provide youth with more information about best
practices for staying HIV-negative. Third, it should be required that all healthcare professional
explain the limits of confidentiality to all minors at medical appointments and ask if the minor
would like the parent to leave the room.
If the goal of the WHO is to stop all new transmissions of HIV by 2030 (WHO, 2018),
then public health policies around access to PrEP use and continuation must change. Policies
need to be put in place that requires all medical care providers to prescribe the medication when
it is requested by patients who are at-risk. Strict guidelines need to be put in place that includes a
risk assessment, psychoeducation about PrEP use (including the importance of adherence), and
also discussions about the limitations of confidentiality for minors and those who are on their
parent’s or guardian’s insurance. One other way that many of these may be accomplished is with
the use of medical prescriptions, STI testing, and risk assessments completed via mail. One
published study has examined preferences for this among SMM and reported the majority would
be open to access PrEP care that way (John, Rendina, Grov, & Parsons, 2017).
Implications for PrEP Uptake
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There are many implications to these studies that have the potential to increase uptake
among at-risk YSMM. Only 1% of YSMM in the first study were current PrEP users, and the
entire sample of study two is made up of individuals who are at risk for HIV, and not taking
PrEP. Simply put, this is a sample of over 2,000 YSMM who would benefit from PrEP use, but
are not taking it for a multitude of factors, many of which can be alleviated with changes in
health care policy.
First, it is important that all health care physicians assess HIV risk with their SMM
clients. CDC guidelines do not provide specific directions on how to assess risk, but rather what
the criteria for risk would be. As stated in the intro, PrEP is intended for those “at substantial
risk,” defined as having an HIV-positive sexual partner, a recent bacterial STI, a high number of
sex partners, a recent history (3-6 months) of inconsistent or no condom use, or be a commercial
sex worker in an area of high prevalence of HIV. Some criteria are left to the subjective views of
the provider; for example, “a high number of sex partners” does not specify what qualifies as
high and what does not. Some research has also shown that physicians are not asking patients
about recent risk behaviors when returning for follow-ups (Parsons, John, Whitfield, CienfuegosSzalay, & Grov, 2018). Other studies have compared services provided by PCPs versus HIV
specialists and reported that PCPs are less comfortable with assessing sexual risk (Petroll et al.,
2017).
Additionally, my findings suggest physicians should pay close attention to the specific
language their clients use when describing their risk. How a client discusses their perception of
their risk may not be accurate to their actual risk. When a physician is assessing risk for HIV,
only focusing on the number of partners, or the amount of risk engaged in, may not increase
uptake among YSMM. My findings indicate that decisions around PrEP are likely not made
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based solely on a logical risk assessment. Additionally, if a physician were to engage in dialogue
that suggests the patient is objectively at-risk when they do not perceive themselves as at-risk;
the physician may actually push them further from uptake. It may benefit the client for the
physician to explore the benefits of PrEP use for the client. Another research even suggested that
instead of asking patients about numbers related to their sexual behavior and labeling them as
risky or not risky, providers could ask about their sexual concerns when assessing for risk
(Golub, 2018). This would allow the patient to discuss any fears or anxiety around HIV, along
with opening the door to other potential conversation related to sexual health.
Second, the findings from this research provide more evidence that there is a stigma
associated with PrEP use, and this stigma may be more influential for those who are younger.
Both those who are PrEP users and those who may consider PrEP use have reported concerns
that use of the medication may lead some to think they are HIV-positive or engage in high risk
sexual behaviors with many people (Dubov et al., 2018; Eaton et al., 2017; Farhat, Greene,
Paige, Koblin, & Frye, 2017; Golub, Gamarel, & Surace, 2017; Haire, 2015; Knight, Small,
Carson, & Shoveller, 2016). Experiences with the stigmatization of PrEP has not been limited to
sexual partners but also reported to have come from providers, friends, and family members
(Haire, 2015). In this sense, it is ironic that a medication shown to be so highly efficacious in the
prevention of HIV is associated with negative behaviors. One qualitative study reported that
YSMM are even told by those who are older than they should be more careful and active in their
prevention instead of relying on PrEP (Dubov et al., 2018).
With stigma to PrEP use potentially coming from so many different sources and
experienced by both users and potential users, public health initiatives to destigmatize use may
be very effective at reaching PrEP user, potential users, and those who shame users. Some
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researchers have already begun to make suggestions for what these initiatives may look like
(Golub, 2018). Due to the commonly held belief that PrEP is used to avoid condom use,
advertisements and initiatives should focus on how PrEP is intended to be used in association
with other safe sex practices (i.e., condom use). This messaging could lead to the acceptance of
PrEP as a backup as opposed to instead of condoms, regardless of actual use.
Decreasing stigma around use may help some potential users, but may not help those who
have low PrEP stigma and still low intentions. One way that may impact both is a focus on the
benefits of PrEP use. For example, ads that support independence and building a stable and
sexually healthy future could be very effective. By focusing on the future, initiatives may be able
to reach younger people and show PrEP as a tool that could help them achieve their sexual health
goals. Positive messaging about the use of PrEP as a sexual health tool without the mention of
HIV may help both potential users and those who shame users to separate the use of PrEP with
the potential for HIV.
Fourth, without health insurance, PrEP can cost upwards of $14,000 per year, including
prescriptions, quarterly testing, and office appointments (San Francisco AIDS Foundation,
2015). Public health initiatives need to be implemented that would allow all individuals at-risk
for HIV to gain access PrEP at little or no cost. Additionally, this cannot be limited to only those
without health insurance. Our findings indicate that those on their parent or caregiver’s insurance
have lower odds of former or current PrEP use, and thus have health insurance, but do not feel
comfortable using it to acquire PrEP. This likely has to do with sexual identity development and
not wanting to either risk coming out to their parent or not wanting to discuss their sexual
behaviors with them.
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Lastly, there is limited research on how YSMM specifically are learning about PrEP. A
recent study in Canada showed that YSMM are gaining more knowledge about PrEP via youth
programs and interventions aimed to increase sexual education (Closson et al., 2019). Another
study surveyed a large sample of YSMM and asked them to report all the places where they had
heard about PrEP. More than 50% of the participants had learned about PrEP from their friends
or acquaintances, 37% from HIV services agencies, 34% from a health care professional, 31%
from newspapers and magazine, and 13% from TV and radio (Strauss et al., 2017). They also
reported that although the majority of the sample knew the medication existed, almost 50% did
not know to obtain it, and over 30% did not know what the effectiveness of the medication is.
Findings from these two studies show that simple awareness of the medication is not enough for
YSMM to seek out the medication. Our findings suggest there is an association between testing
positive for an STI and PrEP uptake, suggesting that YSMM may be learning about PrEP, and
gaining access to it, from health facilities where they are obtaining STI testing.
Since the approval of PrEP for individuals under the age of 18, many television networks
have begun to air ads for PrEP targeted at younger viewers (Marotta, 2019; POZ, 2018). More
funding should be spent on spreading awareness of PrEP, including who can benefit from it, and
how to access it. Public health messaging about benefits should include how using PrEP may fit
into long term health goals. This messaging should not include words like “risk” or “HIV” as
these terms carry a stigma and may push some away from use or continue to perpetuate the belief
that PrEP is only for sexually promiscuous individuals. Further, such ads should include diverse
populations of differing sexual orientations, gender identities, and ages. The inclusion of diverse
populations will help to destigmatize use among differing groups of people, not just those of
which the medication may be marketed. As such, it is also important that ads do not only include
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sexual minority populations as that could lead to further stigmatization of those groups. Taken
together, these factors and those mentioned above can be used to create and implement
interventions and advertisements that aim to increase uptake among all populations at risk,
including YSMM.
Limitations
Although there are many strengths to both of these studies, they are not without their
limitations. Study 1 aimed to provide evidence of disparities between PrEP use for YSMM and
adult SMM. These analyses were conducted with screening data for a larger study that recruited
participants from various dating/sexual networking apps and a popular social media website.
Other research has reported that individuals who use dating/sexual networking apps to find
sexual partners may engage in more sexual risk than those who do not use them (Grov et al.,
2016). Although this sample is very large overall, it may not be representative of sexual risk
behaviors for all SMM, particularly those that do not use dating/sexual networking apps. Second,
dating/sexual networking apps state they are only to be used for individuals who are 18 years of
age and older, however in addition to this study, other researchers have reported that YSMM
under 18 years of age to access these apps (Macapagal et al., 2018). Future studies that aim to
include SMM who are under 18 years of age, or not engaging in sexual risk behaviors, may want
to incorporate other recruitment techniques (e.g., youth LGBTQ organizations and college
campuses), while limiting the use of dating/sexual networking apps.
In both Studies 1 and 2, I aimed to capture the largest possible portion of individuals
potentially at-risk for HIV seroconversion. To do this, I assessed for sexual risk as having
engaged in any recent CAS event with an HIV-status unknown partner, and a recent STI
diagnosis. Although this casts a wide net, it is possible that participants had engaged in different
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degrees of risk (i.e., more or less CAS partners or events, locality of STI infection) and the HIVstatus unknown partner definition relies on an individual’s perceived status of the partner, which
may not match the reality of the partner’s status. It would have been potentially more meaningful
to have asked participants if they discussed or disclosed HIV statuses with the partners. Future
studies should investigate risk in a less participant dependent subjectively defined way and
utilize longitudinal data to investigate how these behaviors predict future PrEP use, or how
varying degrees of risk effect PrEP intentions.
Study 2 examined individual developmental factors as they pertain to PrEP uptake,
among HIV at-risk YSMM across two aims. In terms of recruitment, this cohort of SMM had to
complete a variety of steps to be enrolled, all outlined above in the methods chapter. Along with
having access to the social media site or dating/sexual networking apps used for recruitments,
participants also had to complete a lengthy baseline survey, and complete at-home HIV and STI
testing. The testing materials were required to be delivered to a permanent home address, albeit
in a discreet box. For individuals who do not have privacy at home, this could have been a
barrier to enrollment. Further, not all SMM have a long-term permanent residency and may have
been deemed ineligible. This could have led to a sample that is not generalizable to those without
stable housing and a steady income.
This is the first study completed that examines the association between ‘hot’ and ‘cold’
perception of HIV risk, and perception of self as a PrEP candidate and PrEP intentions. Across
both studies, the findings have various clinical and public health implications, and it is
imperative that these findings be replicated by other researchers with different samples.
Similarly, this data is cross-sectional, and therefore, I am unable to make predictions about how
these associations may change over time.
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It should be noted that PrEP was unexpectedly approved for individuals 17 years of age
and younger in May 2018, while these data were being collected. It is unknown how this
approval may have directly impacted YSMM’s knowledge of and access to PrEP. To date, there
are no studies that have shown an impact on uptake since this expansion, and I do not believe
that if this same data were collected today, less than a year later, there would be significantly
different results for either study. This assertion is backed up by our finding that although PrEP
was accessible for everyone above 18 years of age, it was still lowest among those 24 years of
age and younger. As highlighted in this work, there are a multitude of factors that significantly
contribute to YSMM’s decisions around beginning PrEP that are not simply USFDA approval.
For study 2, the target age group was 16-24 years of age. This restriction in age range
may have limited some findings. Age was utilized as the moderating variable, thus splitting the
sample into high and low age groups. It's possible that due to this limited range, some findings
may have also been restricted. It may be advantageous for future work aiming to increase uptake
among those younger to use a wider range where 16-24 years of age are all in the lower age
group and thus compared to those who are older, and as such without some age-related barriers.
Lastly, the outcome for Study 2 was PrEP intentions, argued to be the most predictive
variable associated with actual behavioral change by the TRA and TPB. This study focused on
barriers that could impede intentions, however these barriers may not matter without intentions.
For example, if someone meets objective criteria for PrEP use, but has no intentions to initiate
PrEP use, structural and parental barriers cease to be important. At the current understanding of
how to increase PrEP use among YSMM, it may be too soon to move away from models with
more steps (i.e., cascades) to simpler models as presented in Study 2.
Conclusions
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These studies provided evidence that not only is PrEP use lower among those who are
YSMM, but also the first evidence that differences in utilization of ‘hot’ and ‘cold’ processes of
HIV risk perception exist for YSMM and affect their perception of PrEP candidacy and
intentions to use PrEP. Affective ‘hot’ perceived risk was strengthened with increased age,
suggesting that in terms of HIV risk, SMM’s decision making around HIV prevention may be
more emotionally driven as opposed to more critical and logical ‘cold’ processing. PrEP stigma
and benefits of PrEP use were also examined. PrEP stigma was associated with lower PrEP
intentions, which weakened with increased age, and benefits of PrEP use were associated with
higher PrEP intentions, which strengthened with increased age. The use of CBT and MI
techniques may be helpful in aiding HIV at-risk YSMM in understanding their risk behavior,
along with an increasing perception of the benefits of PrEP use and decreasing stigma.
Physicians that have YSMM patients should keep these findings in mind when they assess for
HIV risk with their patient’s, and future PrEP implementation strategies should focus on
increases the perceived benefits of PrEP use while also destigmatizing PrEP use. Future research
should examine what other mediating and moderating factors may impact the perception of PrEP
candidacy and PrEP intentions among YSMM.
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Table 1. History of PrEP use among a U.S. National Sample of Young and Adult SMM

Table 1
History of PrEP Use among a U.S. National Sample of Young and Adult SMM (N=96,243)
PrEP Use
Full Sample
Never
Current
Former
n
%
n
%
n
%
n
%
96,243 100.0
74,482 77.4 15,922 16.5
5,839
6.1
Overall
2
χ (10) = 2,981.16, p < 0.001***
Age (m = 33.32)
1,291
1.3
1,263
97.8a
15
1.2a
13
1.0a
13-17
88.8b
1,911
7.8b
1,089
c
c
74.3
6,254
18.1
2,612
69.9d
3,937 23.0d 1,231
73.5c
2,526
21.5e
595
e
c
77.1
1,279
18.5
299
2
χ (10) = 334.58, p < 0.001***
76.3a 10,858 17.9a 3,537
80.5b
1,651 13.8b
689
a,c
a
76.2
888
17.3
332
d
c
82.7
190
11.6
95

4.4b
7.6c
7.2c
5.1d
4.3b

77.5c
1,522 14.8d
788
b,d
c
81.5
813
12.4
398
2
χ (2) = 94.58, p < 0.001***
77.0a 12,440 17.2a 4,250
78.7b
3,482 14.7b 1,589
χ2 (4) = 1,887.36, p < 0.001***

7.7b
6.1a

56,862

74.9a

14,057

18.5a

4,969

6.5a

18.7

16,073

89.2b

1,349

7.5b

607

3.4b

2.4

1,547

66.5c

516

22.2c

263

11.3c

24,599
34,547
17,146
11,765
6,895

25.6
35.9
17.8
12.2
7.2

21,599
25,681
11,978
8,644
5,317

60,664
11,986
5,124
1,645

63.0
12.5
5.3
1.7

46,269
9,646
3,904
1,360

10,272
6,552

10.7
6.8

7,962
5,341

72,484
23,759

75.3
24.7

55,794
18,688

Gay

75,888

78.9

Bisexual

18,029
2,326

18-24
25-34
35-44
45-54
55+
Race
White
Black
Asian or other Pacific Islander
American Indian or Alaskan Native
Multiracial
Other
Hispanic/Latino
No
Yes
Sexual Orientation

Queer
Relationship Status
Single
Partnered
Geographic Region

5.8a
5.7a
6.5a
5.8a

5.9a
6.7b

χ2 (2) = 215.75, p < 0.001***
66,827

69.4

52,529

78.6a

10,293

15.4a

4,005

6.0a

29,416

30.6

21,953

74.6b

5,629

19.1b

1,834

6.2a

χ2 (8) = 1,063.77, p < 0.001***

Northeast

18,997

19.7

13,528

71.2a

4,049

21.3a

1,420

7.5a

Midwest

17,423

18.1

13,870

79.6b

2,667

15.3b

886

5.1b

South

33,101

34.4

26,980

81.5c

4,454

13.5c

1,667

5.0b

West

25,666

26.7

19,126

74.5d

4,710

18.4d

1,830

7.1a

U.S Territory/Military

1,056

1.1

978

92.6e

42

4.0e

36

3.4c
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χ2 (6) = 3,492.55, p < 0.001***

Health Insurance
None

21,179

20.8

17,627

88.0a

1,123

5.6a

1,287

6.4a

Own

65,282

64.2

44,843

72.4b

13,172

21.3b

3,897

6.3a

Partner's

2,170

2.3

1,504

69.3c

529

24.4c

137

6.3a

12,124
Parent/Guardian
CAS with HIV status unknown partner
18,152
No

12.6

10,508

86.7d

1,098

9.1d

518

4.3b

18.9

14,663

80.8a

2,413

13.3a

1,076

5.9a

78,090

81.1

59,818

76.6b

13,509

17.3b

4,763

6.1a

Yes
STI Diagnosis in the past 6 months
No
Yes
Any drug use in the past 3 months
No
Yes
5 or more drinks in the past 3 months

χ2 (2) = 176.80, p < 0.001***

χ2 (2) = 4,813.16, p < 0.001***
84,419

87.7

68,227

80.8a

4,643

5.5a

11,824

12.3

6,255

10.1b

35,946

37.3

30,158

52.9b
4,373 37.0b 1,196
χ2 (2) = 1,864.12, p < 0.001***
84.9a
3,850
10.7a 1,578

60,297

62.7

43,964

72.9b

7.1b

11,549

12,072

13.7a

20.0b

4,261

4.4a

χ2 (2) = 94.39, p < 0.001***

No

36,306

37.7

28,704

79.1a

5,598

15.4a

2,004

5.5a

Yes

59,937

62.3

45,778

76.4b

10,324

17.2b

3,835

6.4b

Notes: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; SMM = sexual minority men;
Row percentages are displayed; Percentages within the same column with differing superscripts differ
significantly (p < 0.05) within post-hoc comparisons.
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Table 2
Demographic and Behavioral Predictors of PrEP Uptake among YSMM (Ages 13-24, N=25,890)
Former PrEP Use
vs. Never (ref.)
Age
Hispanic/Latino (ref. Yes)
No
Race (ref. White)
Black
Asian or other Pacific Islander
American Indian or Alaskan Native
Multiracial
Other
Sexual Orientation (ref. Gay)
Bisexual
Queer
Relationship Status (ref. Partnered)
Single
Region (ref. South)
Northeast
Midwest
West
U.S Territory/Military
Medical Insurance (ref. Yes, on parents)
Own insurance
Partner's insurance
No insurance
CAS with HIV status unknown partner (ref. No)
Yes
STI diagnosis in the past 6 months (ref. No)
Yes
Any drug use in the past 3 months (ref. No)
Yes
5 or more drinks (ref. No)
Yes

β
0.21

AOR
95% CI
1.23*** 1.19, 1.27

Current PrEP Use
vs. Never (ref.)
β
0.27

AOR
1.31***

95% CI
1.28, 1.35

0.09

1.09

0.93, 1.28

0.08

1.08

0.95, 1.23

0.10
-0.14
-0.19
0.12
-0.22

1.11
0.87
0.83
1.13
0.81

0.92, 1.33
0.66, 1.16
0.52, 1.34
0.94, 1.36
0.62, 1.05

-0.01
0.04
-0.19
0.01
-0.50

0.99
1.04
0.83
1.01
0.61***

0.85, 1.15
0.84, 1.28
0.56, 1.22
0.87, 1.18
0.48, 0.77

-0.80
0.37

0.45*** 0.38, 0.55
1.45** 1.10, 1.92

-0.95
0.16

0.39***
1.17

0.33, 0.45
0.92, 1.49

0.23

1.26**

1.09, 1.46

0.03

1.03

0.91, 1.17

0.62
0.20
0.40
-1.08

1.85***
1.23*
1.49***
0.34*

1.56, 2.20
1.01, 1.49
1.26, 1.76
0.12, 0.93

0.70
0.24
0.35
-2.29

2.01***
1.27**
1.42***
0.10**

1.76, 2.30
1.09, 1.48
1.24, 1.63
0.03, 0.41

0.22
0.15
-0.30

1.26*** 1.10, 1.45
1.16
0.62, 2.18
0.74** 0.61, 0.89

0.18
0.23
-1.24

1.20***
1.26
0.29***

1.08, 1.34
0.80, 1.99
0.24, 0.35

0.95, 1.31

0.12

1.13

1.00, 1.28

1.22

3.37*** 2.92, 3.89

1.56

4.77***

4.27, 5.32

0.44

1.55*** 1.34, 1.78

0.40

1.50***

1.34, 1.67

-0.01

0.99

0.88, 1.11

0.11

0.02

1.12

1.02

0.88, 1.18

Note: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; YSMM = young sexual minority men;
AOR for age represent each one year increase in age.
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Table 3
Demographic and Behavioral Predictors of PrEP Uptake among Adult SMM (Ages 25+, N = 70,353)
Former PrEP Use
vs. Never (ref.)
Age
Hispanic/Latino (ref. Yes)
No
Race (ref. White)
Black
Asian or other Pacific Islander
American Indian or Alaskan Native
Multiracial
Other
Sexual Orientation (ref. Gay)
Bisexual
Queer
Relationship Status (ref. Partnered)
Single
Region (ref. South)
Northeast
Midwest
West
U.S Territory/Military
Medical Insurance (ref. Yes, on parents)
Own insurance
Partner's insurance
No insurance
CAS with HIV status unknown partner (ref. No)
Yes
STI diagnosis in the past 6 months (ref. No)
Yes
Any drug use in the past 3 months (ref. No)
Yes
5 or more drinks (ref. No)
Yes

Current PrEP Use
vs. Never (ref.)

β
-0.02

AOR
0.99***

95% CI
0.98, 0.99

β
0.00

AOR
1.00

95% CI
0.99, 1.00

0.11

1.12**

1.02, 1.22

0.07

1.07*

1.01, 1.14

-0.02
0.12
-0.05
0.18
-0.17

0.98
1.12
0.86
1.19***
0.85*

0.88, 1.08
0.98, 1.29
0.67, 1.09
1.08, 1.32
0.73, 0.98

-0.09
0.05
-0.45
-0.11
-0.27

0.92*
1.05
0.64***
0.90**
0.77***

0.86, 0.98
0.96, 1.15
0.53, 0.76
0.83, 0.97
0.69, 0.85

-0.78
0.62

0.46***
1.85***

0.42, 0.51
1.58, 2.17

-1.02
0.32

0.36***
1.37***

0.34, 0.38
1.21, 1.55

-0.02

0.98

0.92, 1.05

0.08

1.08***

1.03, 1.13

0.39
-0.02
0.29
-0.63

1.48***
0.98
1.34***
0.53***

1.36, 1.61
0.89, 1.08
1.24, 1.45
0.37, 0.77

0.34
0.01
0.17
-1.50

1.40***
1.00
1.18***
0.22***

1.33, 1.48
0.94, 1.06
1.12, 1.24
0.16, 0.31

0.22
0.29
0.08

1.24*
1.33*
1.08

1.01, 1.53
1.01, 1.76
0.87, 1.33

0.42
0.49
-1.09

1.52***
1.63***
0.34***

1.32, 1.75
1.37, 1.95
0.29, 0.39

0.10

1.11**

1.02, 1.20

0.39

1.48***

1.40, 1.56

0.86

2.36***

2.17, 2.56

1.37

3.95***

3.875, 4.17

0.58

1.78***

1.67, 1.91

0.74

2.11***

2.01, 2.20

0.01

1.01

0.94, 1.07

0.08

1.09***

1.04, 1.13

Note: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; SMM = sexual minority men; AOR for
age represent each one year increase in age.
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Table 4
Demographics of YSMM at-risk for HIV and group differences in affective and cognitive dimensions of HIV risk scores
(N=2,003)
Full Sample
Affective Risk
Cognitive Risk
Overall
Age (M = 21.27)
13-17
18-24
Race
Black
White
Asian or other Pacific Islander
American Indian or Alaskan Native
Multiracial
Other
Hispanic/Latino
Yes
No
Sexual Orientation
Gay
Bisexual
Queer
Relationship Status
Single
Partnered
Education
Some High School/GED or less
Some College
4-Year College or more
Employment
Unemployed
Employed Part-Time
Employed Full-Time
Geographic Region

n

%

m
SD
t (2001) = 1.70, p = 0.09
3.34
0.72
3.20
0.74
F (5, 1997) = 1.78, p = 0.11
3.20
0.80

m
SD
t (2001) = 2.43, p = 0.84
3.65
0.67
3.46
0.69
F (5, 1997) = 1.90, p = 0.09
3.36
0.79

79
1,924

3.9
96.1

253

12.6

1,151
117
42
288
152

57.5
5.8
2.1
14.4
7.6

3.17
0.74
3.30
0.69
3.35
0.71
3.25
0.75
3.29
0.69
t (2001) = -2.33, p = 0.02*
3.27
0.75
3.18
0.74
F (2, 2000) = 1.77, p = 0.17

3.49
0.68
3.47
0.54
3.34
0.68
3.49
0.72
3.48
0.66
t (2001) = 0.93, p = 0.08
3.42
0.76
3.44
0.71
F (2, 2000) = 2.01, p = 0.13

496
1,507

24.8
75.2

1,597

79.7

3.21

0.74

3.48

0.69

334

16.7

3.22

0.74

3.40

0.70

72

3.6

1,641
362

81.9
18.1

462

23.1

1,118

55.8

423

21.1

473
811
719

23.6
40.5
35.9

3.04
0.69
t (2001) = -4.05, p < 0.001***
3.24
0.72
3.06
0.80
F (2, 2000) = 5.12, p < 0.001***
3.30a
0.73
3.19b

0.77

3.15b
0.67
F (2, 2000) = 0.55, p = 0.58
3.22
0.76
3.21
0.72
3.18
0.75
F (4,1998) = 4.18, p < 0.001***

3.54
0.72
t (2001) = 5.99, p = 0.36
3.46
0.71
3.35
0.75
F (2, 2000) = 1.96, p = 0.14
3.50
0.72
3.44

0.70

3.50
0.62
F (2, 2000) = 0.55, p = 0.58
3.45
0.72
3.49
0.67
3.46
0.70
F (4, 1998) = 0.61, p = 0.66

Northeast

339

3.07a

16.9

a,b

0.71

3.44

0.68

0.75

3.48

0.65

Midwest

363

18.1

3.19

South

763

38.1

3.25b

0.75

3.47

0.70

523

26.1

b

0.74

3.46

0.71

15

0.7

None

394

19.7

Own

706

35.2

3.16

0.75

3.42b

0.72

Partner's

17

0.8

3.21

0.72

3.61a,b

0.84

a,b

0.72

West
U.S Territory/Military
Health Insurance

3.23

3.47a,b
0.60
F (3, 1999) = 2.40, p = 0.07
3.29
0.76

886 44.2
3.20
0.89
Parent/Guardian
t (2001) = -4.14, p < 0.001***
STI Diagnosis in the past 6 months
No
1698 84.8
3.18
0.73
Yes
305 15.2
3.37
0.76
t (2001) = 0.34, p = 0.74
Any drug use in the past 3 months
No
678 33.8
3.20
0.75
Yes
1325 66.2
3.21
0.73
Note: ***p <0.001; **p <0.01; *p <0.05; YSMM = young sexual minority men.
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3.71
0.64
F (3, 1999) = 2.77, p = 0.04*
3.48a
0.65

3.54

t (2001) = 3.44, p = 0.10
3.42
0.72
3.50
0.75
t (2001) = 3.70, p = 0.99
3.39
0.73
3.46
0.72

Table 5
Correlations of Variables of Interest
Measures
1
2
3
4
1. Age
2. Affective Perception of Risk
-0.08***
3. Cognitive Perception of Risk
-0.04
0.58***
4. PrEP Stigma
0.05*
0.05*
-0.03
5. Perceived Benefits of PrEP
-0.01
0.19*** 0.08*** -0.24***
6. Perceived PrEP Candidacy
0.09***
0.11***
0.04
-0.13***
7. PrEP Intentions
0.01
0.11***
0.01
-0.12***
M
21.27
3.21
3.47
2.24
SD
2.11
0.74
0.69
0.55
Alpha
0.72
0.71
0.79
Note: *** p <0.001; ** p <0.01; * p <0.05; PrEP = Pre-Exposure Prophylaxis.
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5

6

7

0.24***
0.28*** 0.37***
3.53
3.91
3.45
0.70
0.92
0.97
0.85
-

Table 6. Cognitive and Affective Perceived Risk of HIV, and Age, Associations with Perceived
PrEP Candidcay and Intentions
Table 6
Cognitive and Affective Perceived Risk of HIV, and Age, Associations with Perceived PrEP Candidacy and Intentions (N=2,003)
Associations with PrEP Candidacy

Associations with PrEP Intentions

B
-

B
1.27

S.E.
-

AOR
-

95% CI
-

S.E.
0.10

AOR
95% CI
3.56*** 2.96, 4.29

Perceived PrEP Candidacy
Hispanic/Latino (ref. Yes)
No
0.18 0.15
1.20
0.90, 1.60
0.10
0.12
1.01
0.80, 1.28
Race (ref. White)
Black
0.23 0.16
1.26
0.92, 1.73
0.23
0.15
1.25
0.94, 1.68
Asian or other Pacific Islander
0.20 0.22
1.22
0.80, 1.87
0.11
0.19
1.12
0.77, 1.61
American Indian or Alaskan Native
0.66 0.41
1.93
0.86, 4.30
0.27
0.31
1.31
0.71, 2.42
Multiracial
0.13 0.15
1.14
0.85, 1.53
0.07
0.13
1.08
0.84, 1.38
Other
-0.29 0.22
0.75
0.49, 1.15
0.31
0.20
1.36
0.93, 2.00
Sexual Orientation (ref. Gay)
Bisexual
-0.29 0.13
0.75*
0.58, 0.97
-0.24 0.12
0.79* 0.63, 1.00
Queer
-0.17 0.26
0.85
0.51, 1.41
-0.15 0.25
0.86
0.53, 1.41
Relationship Status (ref. Single)
Partnered
-0.16 0.12
1.17
0.92, 1.49
-0.36 0.12 1.43** 1.14, 1.79
Region (ref. South)
Northeast
0.03 0.15
1.03
0.78, 1.37
-0.13 0.12
0.88
0.69, 1.12
Midwest
-0.14 0.14
0.87
0.66, 1.14
-0.09 0.12
0.92
0.73, 1.16
West
-0.05 0.13
0.95
0.74, 1.22
0.07
0.11
1.07
0.86, 1.33
U.S Territory/Military
-1.28 0.54
0.28*
0.10, 0.80
0.24
0.47
1.27
0.51, 3.18
Medical Insurance (ref. Yes, on parents)
Own insurance
-0.32 0.11 0.73*** 0.59, 0.91
0.35
0.09 1.41*** 1.18, 1.70
Partner's insurance
-0.34 0.54
0.71
0.18, 2.05
0.09
0.49
1.09
0.42, 2.86
No insurance
-0.49 0.14 0.61*** 0.43, 0.80
-0.07 0.13
0.94
0.73, 1.20
STI diagnosis in the past 6 months (ref. No)
Yes
0.34 0.14
1.40*
0.97, 1.86
0.14
0.13
1.15
0.89, 1.48
Any drug use in the past 3 months (ref. No)
Yes
0.11 0.10
1.12
0.87, 1.36
0.11
0.09
1.12
0.94, 1.33
Perceived Cognitive Risk of HIV
-0.09 0.09
0.92
0.77, 1.09
-0.20 0.08
0.82* 0.70, 0.96
Perceived Affective Risk of HIV
0.37 0.08 1.44*** 1.22, 1.70
0.30
0.08 1.35*** 1.16, 1.57
Age
0.10 0.02 1.11*** 1.06, 1.16
-0.01 0.02
0.99
0.95, 1.03
Age and Cognitive Risk of HIV Interaction
-0.03 0.04
0.97
0.89, 1.05
Age and Affective Risk of HIV Interaction
0.09 0.04
1.10*
1.02, 1.18
Note: *** p <0.001; ** p <0.01; * p <0.05; PrEP = Pre-exposure Prophylaxis; Perceived PrEP Candidacy is dichotomized as an
outcome variable, as such an increase in AOR represents increased odds of perception as a PrEP candidate; PrEP intentions is
ordinal as an outcome variable, as such a one-unit increase in AOR represents an increase in odds of a one-unit increase in PrEP
intentions.
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Table 7
Demographics of YSMM at-risk for HIV and group differences in perceived PrEP benefits and PrEP stigma (N=2,003)
Full Sample
Perceived PrEP Benefits
PrEP Stigma
Overall
Age (M = 21.27)
13-17

n

%

m

SD

t (2001) = 0.49, p = 0.62

m

SD

t (2001) = -0.04, p = 0.97

79

3.9

18-24
Race

1,924

96.1

Black
White

253
1,151

12.6
57.5

3.55
3.54

0.72
0.69

2.35a
2.19b

0.55
0.53

117
42

5.8
2.1

3.48
3.65

0.66
0.65

2.31a,b
2.23a,b

0.55
0.50

288
152

14.4
7.6

3.51
0.74
3.51
0.70
t (2001) = -2.96, p < 0.01**

2.26a,b
0.57
a
2.38
0.56
t (2001) = -2.75, p < 0.01***

496
1,507

24.8
75.2

3.61
0.69
3.50
0.70
F (2, 2000) = 2.41, p = 0.09

2.30
0.55
2.22
0.54
F (2, 2000) = 8.14, p < 0.001***

1,597

79.7

3.54

0.70

2.22a

0.54

334

16.7

3.51

0.71

2.34b

0.55

72

3.6

1,641
362

81.9
18.1

462

23.1

1,118

55.8

423

21.1

473
811
719

23.6
40.5
35.9

339

16.9

Asian or other Pacific Islander
American Indian or Alaskan Native
Multiracial
Other
Hispanic/Latino
Yes
No
Sexual Orientation
Gay
Bisexual
Queer
Relationship Status
Single
Partnered
Education
Some High School/GED or less
Some College
4-Year College or more
Employment
Unemployed
Employed Part-Time
Employed Full-Time
Geographic Region
Northeast

3.57

0.59

3.53
0.71
F (5,1997) = 0.49, p = 0.79

3.36
0.71
t (2001) = -1.13, p = 0.26
3.54
0.68
3.49
0.79
F (2, 2000) = 1.28, p = 0.28
3.51
3.55
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0.55

2.24
0.55
F (5, 1997) = 6.79, p < 0.001***

a

2.13
0.54
t (2001) = 1.56, p = 0.12
2.23
0.54
2.28
0.58
F (2, 2000) = 7.13, p < 0.001***

0.69

2.32a

0.57

0.69

b

0.54

3.49
0.73
F (2, 2000) = 0.65, p = 0.53
3.50
0.71
3.53
0.70
3.55
0.71
F (4, 1998) = 2.11, p = 0.08
3.46

2.24

0.74

2.21

2.22b
0.53
F (2, 2000) = 1.38, p = 0.25
2.23
0.52
2.22
0.56
2.26
0.55
F (4, 1998) = 0.46, p = 0.76
2.25

0.58

Midwest

363

18.1

3.49

0.72

2.22

0.53

South

763

38.1

3.57

0.66

2.22

0.55

West

523

26.1

3.58

0.71

2.26

0.53

15

0.7

None

394

19.7

3.62a

0.67

2.31a

0.58

Own

706

35.2

3.51a,b

0.70

2.26a

0.55

Partner's

17

0.8

U.S Territory/Military
Health Insurance

3.69
0.54
F (3, 1999) = 2.68, p = 0.05*

3.52

a,b

0.84

886 44.2
Parent/Guardian
3.50b
0.71
t (2001) = -3.83, p < 0.01***
STI Diagnosis in the past 6 months
No
1698 84.8
3.51
0.70
Yes
305 15.2
3.67
0.68
t
(2001)
=
-0.18,
p
= 0.86
Any drug use in the past 3 months
No
678 33.8
3.53
0.72
Yes
1325 66.2
3.53
0.69
Note: ***p <0.001; **p <0.01; *p <0.05; YSMM = young sexual minority men.
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2.19
0.56
F (3, 1999) = 6.46, p < 0.01***

2.41

a,b

0.55

2.18b
0.52
t (2001) = -0.77, p = 0.44
2.24
0.55
2.26
0.54
t (2001) = 0.19, p = 0.85
2.24
0.56
2.24
0.54

Table 8. Perceived Benefits of PrEP use, PrEP Stigma, and Age, Associated with PrEP
Intentions
Table 8
Perceived Benefits of PrEP use, PrEP Stigma, and Age, Associated with PrEP Intentions (N=2,003)
Associations with PrEP Intentions
β
S.E.
AOR
95% CI
Hispanic/Latino (ref. Yes)
No
-0.01
0.03
1.00
0.78, 1.27
Race (ref. White)
Black
0.06
0.03
1.39*
1.04, 1.85
Asian or other Pacific Islander
0.03
0.02
1.29
0.92, 1.81
American Indian or Alaskan Native
0.04
0.03
1.62
0.84, 3.14
Multiracial
0.02
0.03
1.12
0.87, 1.44
Other
0.05
0.03
1.44*
0.99, 2.10
Sexual Orientation (ref. Gay)
Bisexual
-0.05
0.02
0.77*
0.61, 0.97
Queer
-0.02
0.02
0.80
0.49, 1.32
Relationship Status (ref. Single)
Partnered
-0.08
0.02 1.48***
1.18, 1.85
Region (ref. South)
Northeast
-0.02
0.02
0.90
0.71, 1.14
Midwest
-0.02
0.02
0.90
0.72, 1.14
West
0.01
0.03
1.06
0.85, 1.33
U.S Territory/Military
-0.01
0.03
0.93
0.31, 2.79
Medical Insurance (ref. Yes, on parents)
Own insurance
0.06
0.02 1.28**
1.06, 1.53
Partner's insurance
0.01
0.02
1.04
0.44, 2.46
No insurance
-0.06
0.03
0.74*
0.58, 0.96
STI diagnosis in the past 6 months (ref. No)
Yes
0.03
0.02
1.16
0.90, 1.50
Any drug use in the past 3 months (ref. No)
Yes
0.04
0.02
1.16
0.98, 1.39
PrEP Stigma
-0.06
0.02
0.81*
0.68, 0.96
Benefits of PrEP Use
0.28
0.02 2.15***
1.87, 2.48
Age
0.02
0.02
1.02
0.98, 1.06
Age and PrEP Stigma Interaction
-0.05
0.02
0.93*
0.86, 1.00
Age and Benefits of PrEP Use Interaction
0.05
0.02
1.07*
1.00, 1.13
Note: *** p <0.001; ** p <0.01; * p <0.05; PrEP = Pre-exposure Prophylaxis; PrEP intentions is ordinal
as an outcome variable, as such a one unit increase in AOR represents an increase in odds of a one unit
increase in PrEP intentions.
ma, and
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FIGURES ONE THROUGH TEN

Perceived Benefits

Perceived Barriers

Perceived
Seriousness

Likelihood of
Engaging in HealthPromoting Behavior

Perceived
Susceptibility

Self-Efficacy

Cues to Action

Figure 1. The Health Belief Model (HBM). The HBM is aimed at understanding significant
predictors in an individual’s decision to enact a health-promoting behavior. Predictors included
in the model are perceived benefits, perceived barriers, perceived seriousness, perceived
susceptibility, self-efficacy, and cues to action. All predictors are presumed to have a directional
association with the outcome, the likelihood of engaging in the health-promoting behavior.
Figure 1. The Health Belief Model (HBM)
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Attitude
Intention

Behavior

Subjective Norm

Figure 2. The Theory of Reasoned Action (TRA). This theoretical model is aimed at
understanding behavior as an outcome of the intentions to enact the behavior. The intentions to
enact a behavior is directly influenced by the attitudes an individual has about the behavior and
also the subjective norm, or belief that the behavior will be supported or not supported by
significant others in the individual's social network.
Figure 2. The Theory of Reasoned Action (TRA)
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Attitude

Subjective Norm
Intention

Behavior

Perceived
Behavioral
Control

Figure 3. The Theory of Planned Behavior (TPB). This theoretical model is an evolution of the
TRA and has added perceived behavioral control as a predictor of intention and also associated
with the behavior. The addition of this factor to the TRA allows for the model to be utilized for
behaviors that may be outside of an individual’s volition to accomplish the behavior efficiently.
Figure 3. The Theory of Planned Behavior (TPB)
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Affective
Perceived Risk of
HIV
a
e

c
Perceived PrEP
Candidacy

Age
d

PrEP Intentions

f

b
Cognitive
Perceived Risk
of HIV

Figure 4. Hypothesis 2a suggests that higher affective dimensions of HIV risk will lead to higher
perceived PrEP candidacy. Hypothesis 2b suggests that higher cognitive dimensions of HIV risk
will lead to higher perceived PrEP candidacy. Hypothesis 2c suggests age will moderate the
association between affective dimensions of HIV risk and perceived PrEP candidacy such that
those who are younger will have higher perceived PrEP candidacy. Hypothesis 2d suggests age
will moderate the association between cognitive dimensions of HIV risk and perceived PrEP
candidacy such that those who are older will have higher perceived PrEP candidacy. Hypothesis
2e suggests the affective dimensions of HIV risk will have an indirect effect on PrEP intentions.
Hypothesis 2f suggests the cognitive dimensions of HIV risk will have an indirect effect on PrEP
intentions.
Figure 4. Hypothesized model to test affective and cognitive dimensions of HIV risk on
perceived PrEP candidacy and PrEP intentions
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PrEP Stigma
a
c
Age

PrEP Intentions
d
b

Benefits of
PrEP use

Figure 5. Hypothesis 3a suggests that higher PrEP stigma will lead to lower PrEP intentions.
Hypothesis 3b suggests that perceiving more benefits to PrEP use will lead to more PrEP
intentions. Hypothesis 3c suggests age will moderate the association between PrEP stigma and
PrEP intentions such that those who are younger will have more PrEP intentions. Hypothesis 3d
suggests age will moderate the association between perceiving more benefits to PrEP use and
PrEP intentions such that those who are older will have more PrEP intentions.
Figure 5. Hypothesized model to test PrEP stigma and the benefits of PrEP use on PrEP
intentions
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Affective
Dimensions of
HIV Risk
B = 0.37***
S.E. = 0.08

B = 0.05*
S.E. = 0.03

Age
B = -0.03
S.E. = 0.04

B = 0.30***
S.E. = 0.08

Perceived PrEP
Candidacy
B = -0.09
S.E. = 0.09

B = 1.27***
S.E. = 0.10

PrEP Intentions

B = -0.20*
S.E. = 0.08

Cognitive
Dimensions of
HIV Risk

Figure 6. The figure above displays the results of hypotheses 2a-2f. Hypotheses 2a-2d suggested
that age would weaken the associations between affective dimensions of HIV risk and perceived
PrEP candidacy, while age would strengthen moderate the association between cognitive
dimensions of HIV risk and perceived PrEP candidacy. These hypotheses were not supported.
Age strengthened the association between affective dimensions of HIV risk and perceived PrEP
candidacy, while all associations with cognitive dimensions of HIV risk were not significant.
Hypotheses 2e and 2f suggested that perceived PrEP candidacy would fully mediate the
associations between affective and cognitive dimensions of HIV risk and PrEP intentions. These
hypotheses were not supported, as affective and cognitive dimensions of HIV risk were still
associated with PrEP intentions through perceived PrEP Candidacy.
Figure 6. Results of the first hypothesized model
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Perceived PrEP Candidacy

Interaction of Affective Dimensions of HIV Risk
and Age on Perceived PrEP Candidacy
0.85
0.8
0.75
0.7
0.65
0.6
0.55
0.5
0.45
0.4

*

Low Affective Risk

High Affective Risk

Low Age

High Age

Figure 7. This plot shows the interaction of age and affective dimensions of HIV risk on the
perception of self as a PrEP candidate. For those who were in the high age group, having a
higher score of affective HIV risk was associated with increased odds of viewing oneself as a
PrEP candidate.

Figure 7. Interaction plot of affective dimensions of HIV risk and age on perceived PrEP
candidacy
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PrEP Stigma

β = -0.05*
S.E. = 0.02

β = -0.06*
S.E. = 0.02

PrEP Intentions

Age
β = 0.28***
S.E. = 0.02

β = 0.05*
S.E. = 0.02

Benefits of
PrEP use

Figure 8. The figure above displays the results of hypothesis 3a-3d. Hypotheses 3a-3d suggested
that age would weaken the association between PrEP stigma and PrEP intentions, while age
would strengthen the association between benefits of PrEP use and PrEP intentions. The
interaction of the benefits of PrEP use and age did results in strengthening the association with
PrEP intentions. The interaction of PrEP stigma and age also strengthened the association with
PrEP intentions, thus not supporting the hypotheses.
Figure 8. Results of the second hypothesized model
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Interaction of PrEP Stigma and Age on PrEP Intentions
0.58
0.56

*

PrEP Intentions

0.54
0.52
0.5
0.48
0.46
0.44
0.42
0.4

Low Stigma

High Stigma

Low Age

High Age

Figure 9. This plot shows the interaction of age and PrEP stigma on intentions to begin taking
PrEP. Lower levels of stigma were associated with higher PrEP intentions among both groups.
However, those who were in the high age group had higher PrEP intentions with lower stigma
than those in the low age group.
Figure 9. Interaction plot of PrEP stigma and age on PrEP intentions
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Interaction of Benefits of PrEP Use and Age on
PrEP Intentions
Benefits of PrEP Use

0.7

*

0.65
0.6
0.55
0.5
0.45
0.4
0.35
0.3

Low Benefits

High Benefits

Low Age

High Age

Figure 10. This plot shows the interaction of the benefits of PrEP use and age on PrEP
intentions. For both groups of low and high age individuals, low perceived benefits of PrEP use
were associated with low PrEP intentions, and higher perceived benefits of PrEP use were
associated with higher PrEP intentions. Those who were in the high age group and saw high
benefits to use had higher intentions to begin taking PrEP than those who were in the low age
group and perceived high benefits.
Figure 10. Interaction plot of benefits of PrEP use and age on PrEP intentions
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